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Los β-glucanos lineales y ramificados, especialmente aquellos unidos mediante enlaces 
β-(1,3) y sintetizados por plantas y hongos, pueden actuar como inmunomoduladores 
ejerciendo efectos beneficiosos sobre la salud humana. Estos homopolisacáridos (HoPS) 
se han utilizado extensamente en la medicina tradicional de ciertas culturas, y en 
nuestros días son considerados como compuestos bioactivos para el desarrollo de 
nuevos alimentos funcionales. Así también, los β-glucanos se utilizan como sustitutivos 
a los tratamientos antibióticos en industrias como la acuicultura y la ganadería. 
Se ha descrito un (1,3)-β-glucano ramificado en posición O-2 producido principalmente 
por las bacterias del ácido láctico (BAL), entre las cuales Pediococcus parvulus 2.6 es el 
prototipo de bacteria productora de este β-glucano. En este HoPS, se han investigado 
sus características físico-químicas, su producción y su influencia en el metabolismo 
bacteriano. Además, alguna de las propiedades probióticas de la bacteria como su 
resistencia al estrés gastrointestinal o su adhesión a células epiteliales han sido 
caracterizadas in vitro, así como la capacidad de su β-glucano de modular macrófagos 
humanos. 
En esta tesis, se ha descrito un método inmunológico capaz de detectar y cuantificar 
específicamente el β-glucano bacteriano (Capítulo 1). Esta técnica se basa en el 
reconocimiento de este β-glucano por un anticuerpo específico para Streptococcus 
pneumoniae serotipo 37. Este neumococo produce una capsula que se compone por un 
β-glucano muy similar al producido por BAL. El método se ha utilizado para la 
caracterización de la actividad enzimática de la glicosiltransferasa GTF, responsable de 
la producción del β-glucano en P. parvulus 2.6, mediante el uso de vesículas 
membranosas que contenían el enzima determinando las constantes catalíticas (Capítulo 
1). Por otra parte, este método fue validado para la cuantificación del HoPS en 
diferentes estados: (i) puro (Capítulo 1), (ii) contenido en sobrenadantes de cultivos 
bacterianos (Capítulos 1, 4, 5 y 7), (iii) unido a las bacterias productoras (Capítulo 5) y 
(iv) contenido en matrices alimentarias (Capítulo 6). 
Se ha descrito el borrador del genoma del P. parvulus 2.6 (Capítulo 2), siendo este el 
primer genoma secuenciado de esta especie. Su tamaño se ha estimado en 2.236 kpb y 
se han detectado 2.241 genes. El análisis del genoma reveló la ausencia de 
determinantes genéticos involucrados en actividades indeseadas como puede ser la 
resistencia a antibióticos o la producción de aminas biógenas. También, se ha descrito la 
presencia de la agrupación genética gutFRMCBA (operón gut), cuyos genes están 
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implicados en la utilización del sorbitol por la bacteria. El operón se compone de 6 
genes: el gen gutF que codifica una sorbitol-6-P deshidrogenasa; los genes gutR y gutM 
que codifican dos posibles reguladores; y los genes gutC, gutB y gutA que codifican el 
dominio EII de un sistema de transporte fosfotransferasa dependiente de 
fosfoenolpiruvato específico para el sorbitol. 
Por lo tanto, la utilización del sorbitol como fuente de carbono para el metabolismo de 
P. parvulus fue investigada (Capítulo 4). Primero, se estandarizaron las condiciones 
óptimas para su metabolismo (Capítulo 7). El cometabolismo de la glucosa y el sorbitol 
mostró que la cepa 2.6 metaboliza primero la glucosa y después el sorbitol, indicando 
que la expresión del operón gut se encuentra sujeta a represión por catabolito en el 
crecimiento en presencia de glucosa. El análisis de los flujos metabólicos y la 
producción del sorbitol en P. parvulus 2.6 han demostrado que el sorbitol puede actuar 
como precursor para la producción del β-glucano (Capítulo 4). 
Por otra parte, se ha desarrollado un vector para evaluar promotores que permite realizar 
análisis transcripcionales en BAL, basado en la expresión del gen mrfp que codifica la 
proteína fluorescente roja mCherry (Capítulo 3). Nos hemos valido de este vector para 
investigar la regulación transcripcional de la expresión del operón gut pediocócico de 
utilización del sorbitol (Capítulos 4 y 7). Para la realización de este estudio, la posible 
secuencia promotora (Pgut) así como los dos genes que codifican dos posibles proteínas 
reguladoras (GutR y GutM), fueron clonados, de forma independiente o en conjunto, 
produciendo fusiones transcripcionales con el gen mrfp. El estudio se llevó a cabo en 
dos huéspedes heterólogos, Lactobacillus plantarum y Lactobacillus casei, que también 
utilizan el sorbitol. Los resultados mostraron que en el crecimiento en presencia de 
sorbitol se produjo una trans-complementación en la activación de Pgut en L. plantarum, 
pero no así en L. casei. Los resultados también indicaron que GutR es un activador 
transcripcional y que GutM es necesaria para el correcto funcionamiento de Pgut. 
Además, se ha postulado un modelo para la regulación de la expresión de gutFRMCBA 
en P. parvulus 2.6. 
Se ha evaluado in vitro la respuesta de P. parvulus 2.6 y de su cepa isogénica 2.6NR a 
varios estreses tecnológicos (Capítulo 7). Los resultados mostraron un efecto protector 
del β-glucano frente a un estrés alcohólico, y además, el etanol puede ser un posible 
inductor de la producción de EPS. 
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Las cepas de P. parvulus 2.6 fueron marcadas fluorescentemente mediante la 
transferencia del plásmido pRCR12, el cual porta el promotor neumocócico fuerte Px 
fusionado al gen mrfp (Capítulo 5). Hasta donde nosotros sabemos, esta es la primera 
vez que se marca fluorescentemente P. parvulus. Además, la producción constitutiva de 
la proteína mCherry a partir de pRCR12 no afectó ni al crecimiento de las cepas ni a la 
producción del β-glucano por la cepa 2.6. También, se evaluó la capacidad de adhesión 
a enterocitos de 2.6[pCRC12] (2.6p) y 2.6NR[pRCR12] (2.6NRp) utilizando un modelo 
in vitro de células Caco-2. Los resultados revelaron que la presencia del β-glucano 
unido a la superficie de 2.6p aumenta la capacidad de unión de la bacteria, como ya se 
detectó previamente en la cepa 2.6. Además, la adhesión de 2.6NRp fue mejorada 
mediante la suplementación con el β-glucano purificado, demostrando así el efecto 
positivo del β-glucano en la interacción bacteria-enterocito. 
Las propiedades probióticas de P. parvulus, así como la capacidad inmunomoduladora 
de su β-glucano han sido investigadas usando modelos in vivo de pez cebra (Capítulo 5). 
Para el estudio de la colonización de las cepas marcadas fluorescentemente de P. 
parvulus se utilizó un modelo larvario gnotobiótico. La señal fluorescente roja emitida 
por las bacterias en el interior del tracto gastrointestinal (TGI) de las larvas fue 
detectada, lo que permitió monitorizar en tiempo real la colonización bacteriana. El 
análisis de las bacterias viables en el interior de las larvas reveló que la colonización del 
TGI del pez cebra por la cepa 2.6p fue mejor que por la cepa 2.6NRp, indicando un 
efecto positivo del β-glucano en la colonización. Además, las larvas gnotobióticas, 
pretratadas con las soluciones bacterianas, fueron infectadas con el patógeno Vibrio 
anguillarum. Ambas cepas fueron capaces de contrarrestar los efectos de la infección, 
reduciendo la mortalidad de los peces cebra, sin embargo la cepa 2.6p lo hizo de una 
manera más eficaz, poniendo en valor su potencial probiótico. Por otra parte, el modelo 
gnotobiótico del pez cebra fue utilizado para estudiar la modulación del sistema inmune 
innato del pez cebra por parte del β-glucano de P. parvulus 2.6 (Capítulo 5). El 
tratamiento con el β-glucano purificado provocó una reducción en la expresión genética 
de la IL8, TNFα y MyD88 en las células inmunes del pez cebra, lo que sugiere una 
respuesta antiinflamatoria. Posteriormente, la línea transgénica de pez cebra Tg(mpx: 
GFP) fue utilizada para desarrollar un modelo de inflamación inducida, mediante el 
seccionamiento de la región apical de la cola. Las larvas de esta línea transgénica 
expresan la proteína GFP de forma constitutiva en los neutrófilos, así se puede detectar 
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su reclutamiento a la zona de inflamación y su proliferación mediante medidas de 
fluorescencia. La exposición de las larvas al β-glucano bacteriano provocó una 
reducción significativa del reclutamiento y proliferación de los neutrófilos. Estos 
resultados mostraron el potencial del β-glucano pediocócico como un agente 
antiinflamatorio. 
Finalmente, se investigó la capacidad de las cepas de P. parvulus para fermentar 
matrices alimentarias basadas en avena, cebada y arroz (Capítulo 6). P. parvulus no fue 
capaz de fermentar la matriz de cebada, sin embargo fermentó las matrices de arroz y 
avena, esta última más eficazmente. Las fermentaciones tanto con 2.6 como con 2.6NR 
permitieron observar como la producción del β-glucano por la primera cepa resultó en 
un incremento de la viscosidad de las matrices. Además, el potencial prebiótico de estos 
alimentos generados, fortificados con la producción in situ del β-glucano bacteriano, ha 
sido validado con la cepa L. plantarum WCFS1. Tanto el crecimiento de WCFS1 como 
su supervivencia a condiciones de estrés del TGI fueron superiores cuando la bacteria 
fue incluida en los alimentos biofortificados con el β-glucano. 
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Linear and branched β-glucans, particularly those linked by β-(1, 3) bounds synthesised 
by plants and fungi, can act as immunomodulators and therefore can be beneficial to 
human health. These homopolysaccharides (HoPS) have been extensively used in 
traditional medicine, and now are considered to be potentially useful for the 
development of functional foods. Also, β-glucans have started to be used in the 
livestock and aquaculture industries as substitutes for antibiotics to prevent infection. 
A 2-substituted (1,3)-β-glucan produced primarily by lactic acid bacteria (LAB) has 
been described, in particular by Pediococcus parvulus 2.6, which is the architype of 
bacteria producing this β-glucan. For this reason, the physico-chemical characteristics 
of this HoPS from the 2.6 strain, its production and influence on metabolism have been 
previously investigated. Moreover, certain probiotic properties of the 2.6 strain such as 
resistance to gastrointestinal stress or adhesion to epithelial cells, as well as the 
modulating effect of its β-glucan on human macrophages, have been characterized in 
vitro. 
In this thesis, an immunological method for the specific detection and quantification of 
the 2-substituted (1, 3)-β-glucan is described (Chapter 1). This technique is based on the 
recognition of the bacterial β-glucan by a specific antibody against Streptococcus 
pneumoniae serotype 37. This pneumococcal strain produces a capsule composed of a 
similar β-glucan to the LAB producers. This method has been used for the 
characterization of the enzymatic activity of the GFT glycosyltransferase responsible for 
the β-glucan production in P. parvulus 2.6 (Chapter 1). The study was performed in 
membrane vesicles containing the GTF protein, and the catalytic constants were 
determined. In addition, this method was validated for quantification of this HoPS in 
different states: (i) pure (Chapter 1), (ii) included in bacterial cultures supernatants 
(Chapters 1, 4, 5 and 7), (iii) attached to the producing bacteria (Chapter 5) and (iv) 
included in food matrices (Chapter 6). 
The draft genome of P. parvulus 2.6 has been described (Chapter 2), this being the first 
genome sequenced for this species. Its size was estimated as 2.236 kbp, containing 
2.241 genes. Its analysis revealed the absence of genetic determinants for unwanted 
activities such as antibiotic resistance or biogenic amine production. It also showed the 
presence of the gutFRMCBA (gut) operon involved in sorbitol utilisation. This operon is 
composed of six genes: gutF encodes a sorbitol-6-P dehydrogenase; gutR and gutM 
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encode two putative regulators; and gutC, gutB and gutA encode the EII domain of a 
phosphoenolpyruvate:sorbitol phosphotransferase transport system. 
Therefore, the utilization of sorbitol as a carbon source by P. parvulus was investigated 
(Chapter 4). The conditions for the best sorbitol metabolism were standardised (Chapter 
7). A co-metabolism with glucose and sorbitol showed that the 2.6 strain first 
metabolises the glucose and then the sorbitol, indicating that the expression of the gut 
operon is subject to catabolite repression upon growth in the presence of glucose. 
Analysis of the metabolic fluxes and the β-glucan production in P. parvulus 2.6 has 
demonstrated that sorbitol can act as a precursor for the production of the β-glucan 
(Chapter 4). 
Furthermore, a promoter-probe vector was developed to perform transcriptional 
analyses in LAB, based on the expression of the mrfp gene which encodes the red 
fluorescent protein mCherry (Chapter 3). This vector was used to investigate the 
transcriptional regulation of the expression of the pediococal sorbitol utilisation gut 
operon (Chapters 4 and 7). For this study, the putative promoter sequence (Pgut) and two 
genes encoding two putative regulatory proteins (GutR and GutM) were cloned 
independently, or together, in transcriptional fusions with the mrfp gene. The study was 
carried out in two heterologous hosts, Lacobacillus plantarum and Lactobacillus casei, 
which also utilise sorbitol. The results demonstrated trans-complementation for 
activation of Pgut in L. plantarum but not in L. casei, upon growth in the presence of 
sorbitol. The results indicated that GutR is a transcriptional activator and GutM is 
needed for the correct functionality of Pgut. In addition, a model for regulation of 
expression of the gutFRMCBA in P. parvulus 2.6 has been postulated. 
Responses of P. parvulus 2.6 and its isogenic β-glucan non-producing 2.6NR strains to 
various in vitro technological stresses have been evaluated (Chapter 7). The results 
showed a protective effect of the β-glucan to alcoholic stress and, also that ethanol 
could be an inducer of the EPS production. 
P. parvulus strains were fluorescently labelled by transferring the pRCR12 plasmid 
which carries the strong pneumococcal Px promoter fused to the mrfp gene (Chapter 5). 
As far as we know this is the first fluorescent labelling of P. parvulus. In addition, the 
constitutive production of mCherry from pRCR12 did not affect growth of the 
pediococcal strains nor the β-glucan production by 2.6. Also, bacterial adhesion of 
Summary 
 
XV 
2.6[pRCR12] (2.6p) and 2.6NR[pRCR12] (2.6NRp) to enterocytes was assessed in an in 
vitro Caco-2 cells model. The results revealed that the presence of the β-glucan attached 
to the 2.6p surface enhances the bacterial binding capacity as previously detected for the 
2.6 strain. Also, the adhesion of 2.6NRp was improved by supplementation with the 
purified β-glucan, demonstrating the positive effect of the β-glucan in the bacterium-
enterocyte interaction. 
The probiotic properties of P. parvulus, as well as the immunomodulatory capacity of 
its β-glucan, have been investigated by using in vivo zebrafish models (Chapter 5). A 
gnotobiotic larval model was used to study the colonising ability of fluorescent-labelled 
P. parvulus strains. The red fluorescent signal emitted by the bacteria was detected 
inside the gastrointestinal tract (GIT) of the larvae, thereby monitoring the bacterial 
colonisation in real time. Analysis of viable bacteria inside the larvae revealed that the 
2.6p strain colonises the zebrafish GIT better than 2.6NRp, indicating a positive effect 
of the β-glucan in colonisation. Furthermore, the gnotobiotic larvae, pre-treated with the 
bacterial solutions, were infected with the pathogen Vibrio anguillarum. Both strains 
were able to counteract the infection, reducing the zebrafish mortality, but strain 2.6p in 
a more efficient manner, supporting the probiotic potential of the strain. In addition, a 
gnotobiotic zebrafish model was used to study the modulation of the innate immune 
system of zebrafish by the P. parvulus 2.6 β-glucan (Chapter 5). The treatment with the 
purified β-glucan provoked a reduction in the gene expression of IL8, TNFα and 
MyD88 in zebrafish immune cells, suggesting an anti-inflammatory response. 
Subsequently, the zebrafish Tg(mpx: GFP) line was used to perform an induced 
inflammation model, by cutting the tail´s apical region off. This transgenic line 
expresses the GFP protein constitutively in the neutrophils, so their recruitment to the 
inflammation zone and their proliferation can be detected and quantified by fluorescent 
measurements. The exposure to the bacterial β-glucan provoked, in the treated larvae, a 
significant reduction of neutrophilic recruitment and proliferation. These results showed 
the potential of the pediococcal β-glucan as an anti-inflammatory agent. 
Finally, the ability of P. parvulus strains to ferment oat, barley and rice matrices was 
investigated (Chapter 6). P. parvulus was not able to ferment the barley matrix, and 
fermented the oat matrix better than the rice one. Fermentations with both 2.6 and 
2.6NR strains showed that the β-glucan production by the former results in an increase 
of viscosity of the matrices. In addition, the prebiotic potential of the fermented cereal-
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based foods fortified with the β-glucan produced in situ by P. parvulus 2.6 has been 
validated with L. plantarum WCFS1 strain. The growth and survival under GIT 
condition of the WCFS1 strain was superior when the bacterium was included in the 
bacterial β-glucan enriched foods. 
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1. Functional food 
The denomination of functional food refers to those foods that, in addition to having 
nutritional value, contain a biologically active component that confers some benefit to 
the health of the consumer. Thus, the consumption of these foods could lead to the 
improvement of certain physiological functions, and/or to the prevention or the 
reduction of risk of suffering a disease. Biologically active components may be living 
microorganisms such as bacteria or yeasts that are called probiotics; or they may be 
indigestible carbohydrates called prebiotics. Many of these foods are fermented foods, 
where probiotics can be part of these fermentation processes. Thus, in ancient times the 
human beings transformed milk into fermented dairy products through the use of 
bacteria and yeasts, without knowing the scientific basis of the processes. These dairy 
products were easily transported, stored and preserved for long periods of time. In 
addition, their healthy properties were known, as they were used to treat certain diseases 
(Ozen and Dinleyici, 2015). Therefore, yogurt and other fermented milks can be 
considered as the first functional foods. 
1.1. Probiotics 
The term ‘probiotic’ literally means ‘for life’, and comes from the combination of the 
Latin word ‘pro’ and the Greek word ‘bios’. It was introduced in 1953 by the German 
scientist Werner Kollath to designate ‘active substances essential for a healthy 
development of life’; and in 1965, this term was used by Lilly and Stillwell to represent 
‘substances secreted by one organism which stimulate the growth of another’ 
(Gasbarrini et al., 2016). Already at the beginning of the 20th century, Elie Metchnikoff 
associated the improved longevity of Bulgarian people with the regular consumption of 
yogurt. He proposed that the Bulgarian bacillus (discovered by Stamen Grigorov) 
responsible for yoghurt fermentation counteracted the rotting effects of gastrointestinal 
metabolism, which contributes to disease and aging (Gasbarrini et al., 2016).  
Currently, the most accepted definition is that offered by a consensus of the Food and 
Agriculture Organization (FAO) and the World Health Organization (WHO), which 
described probiotics as ‘living microorganisms which when administered in sufficient 
quantities confer a benefit to the health of the host’ (FAO/WHO, 2002). 
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1.1.1. Criteria for probiotic selection 
Fuller (1989) listed all the characteristics that a probiotic must possess, and they were: 
(i) It should exert a beneficial effect on the animal host. (ii) It should be a non-
pathogenic and non-toxic microorganism. (iii) It should remain in the form of viable 
cells, preferably in large quantities. (iv) It should be able to survive and have metabolic 
activities in the intestinal environment, e.g. must be resistant to low pH and organic 
acids. (v) It should be stable and able to remain viable for long periods under storage 
and field conditions. 
Probiotics, being living organisms and being used in human food and animal feed, must 
satisfy certain safety requirements, and thus must have GRAS (Generally Recognized 
As Safe) status by the Food and Drug Administration (FDA) in the United States, or 
QPS (Qualified Presumption of Safety) status by the European Food Safety Authority 
(EFSA) in Europe. Historically, lactobacilli and bifidobacteria associated with food 
have been considered to be safe (Adams and Marteau, 1995). Nevertheless, over the 
years different side-effects have been related with the use of probiotics, such as 
systemic infections, deleterious metabolic activities, excessive immune stimulation in 
susceptible individuals and promotion of deleterious gene transfer (FAO/WHO, 2002). 
Thus, in the report of FAO/WHO (2002), it was recommended that even when the 
bacteria have the GRAS or QPS status, before their usage as new probiotics, they 
should be subjected at least to the following tests: 
1. Determination of antibiotic resistance patterns. 
2. Assessment of certain metabolic activities. 
3. Assessment of side-effects during human studies. 
4. Epidemiological surveillance of adverse incidents in consumers (post-market). 
5. Assessment of haemolytic activity or toxin production if the strain under 
evaluation belongs to a species known to possess these activities. 
1.1.2. Types of probiotic 
Most probiotics are bacteria, with the exception of some yeasts and fungi (FAO, 2016). 
Among the bacteria, the most representative group of probiotics consists of the lactic 
acid bacteria (LAB), which include members of the Lactobacillales order, and whose 
most important representatives belong to the Lactobacillus genus. Description of this 
group is presented in detail in section 2 of this introduction. Another very important 
group of probiotics are members of the Bifidobacterium genus, which is naturally 
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abundant in the gastrointestinal tract (GIT), mainly in the colon, of humans and some 
other animals. Thus, they have been widely studied as probiotics in humans (Sarkar and 
Mandal, 2016; Linares et al., 2017), carrying out studies with different species of 
Bifidobacterium such as B. animalis, B. bifidium, B. bifidus, B. thermophilus, B. 
longum, B. pseudolongum and B. lactis for application in both humans and animals.  
Nowadays, spore forming bacteria, particularly from the Bacillus genus, are 
increasingly being used as probiotics, because of their resistance to physical and 
environmental factors, such as heat, desiccation and UV radiation (Setlow, 2014), 
enabling them to maintain their viability during feed pelleting, storage and handling 
(FAO, 2016). Bacillus spores may survive extreme acidity and tolerate bile salts and 
other hostile conditions of the GIT (Setlow, 2014; Elshaghabee et al., 2017). The most 
commercialized species are B. subtilis, B. coagulans and B. licheniformis. Some strains 
have antimicrobial activities producing bacteriocins belonging to the lantibiotics group 
(Abriouel et al., 2011), such a subtilin, subtilosin or mersacidin produced by B. subtilis, 
or coagulin produced by B. coagulans. Also, Bacillus strains can produce several 
vitamins, enzymes and peptides that promote the growth and diversity of beneficial 
microorganisms in the intestine (Elshaghabee et al., 2017). In addition, there are other 
spore-forming bacteria belonging to the Clostridium genus that are used as probiotics. 
Among them, Clostridium butyricum is the most representative species and is able to 
produce short-chain fatty acids (SCFA), promote the growth of lactobacilli and 
bifidobacteria, and inhibit diarrhoea (Yang et al., 2012). This bacterium also has 
immunomodulatory effects on colon inflammation by suppressing cytokine secretion 
(Kanai et al., 2015; Cassir et al., 2016). 
Another Gram-positive bacterium, Faecalibacterium prausnitzii is considered the most 
abundant bacterium in the human intestinal microbiota (up to 5% of the total bacterial 
population) and it is also present in the intestine of all animals so far investigated. This 
bacterium is related to the healthy microbiota and variation in its abundance has been 
linked to dysbiosis in several human disorders. In the last few years, the bacterium has 
been intensely studied because of its influence on the immune system and it has been 
postulated as a potential new probiotic for use in human immune diseases (Miquel et al., 
2013). 
Several Gram-negative bacteria are considered human and animal pathogens, like 
enterohemorrhagic Escherichia coli strains. But there are non-pathogenic E. coli strains 
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living in the intestine as commensal microorganisms. Thus, in 1917 the scientist Alfred 
Nissle isolated one strain from the faeces of a First World War soldier who did not 
develop enterocolitis during a severe outbreak of shigellosis (Guarner et al., 2017). This 
strain named E. coli Nissle 1917 was tested against Salmonella and other coliform 
enteropathogens and showed great antagonist activity inhibiting the growth of the 
pathogens (Sonnenborn, 2016). This strain became one of the most utilized probiotics 
under the name of Mutaflor. 
Among the eukaryotic microorganisms used as probiotics in human beings or animals, 
yeasts are the most representative group. Effects have been reported at the 
immunological level, against diarrhoea and enteric pathogens, or in maintaining the 
integrity of the epithelial barrier (Moslehi-Jenabian et al., 2010). For use in human 
health, Saccharomyces cerevisiae and S. boulardii are the most commercialized yeasts 
(Nayak, 2011), and for use in animal feed strains belonging to the genera Pichia, 
Candida, Metschnikowia, Yarrowia or Debaryomyces are also used (Vohra et al., 2016). 
Their probiotic interest is due to their antibacterial properties against pathogens such as 
Staphilococcus aureus, E. coli, Salmonella sp. or Pseudomonas aeruginosa (Seddik et 
al., 2016) and also for their anti-inflammatory effects, and the production of substances 
of high biological value such as vitamins, oligoelements or extracellular enzymes such 
as amylases, β-galactosidases and phytases that promote the digestibility of food (Vohra 
et al., 2016). Compared to probiotics of prokaryotic origin they have advantages such as 
their use during antibiotic treatments or the impossibility of transferring antibiotic 
resistance genes. Nonetheless, they also have disadvantages such as a low ability to 
produce antagonistic compounds and to colonize the intestine (Nayak, 2011). 
1.1.3. Mode of probiotic action 
Different probiotics exert their effects through various mechanisms, many not yet fully 
understood, and even closely related strains can act via different modes of action. 
Probiotics exert their beneficial effect mainly in the GIT and they are postulated as the 
main substitute for the use of antibiotics (FAO, 2016). The main mechanisms of action 
of probiotics (Fig. 1) are to strengthen the intestinal barrier, stimulate the immune 
system or counteract the effects of pathogens through acidification of the environment, 
the production of bacteriocins and competition for nutrients and adhesion to the 
epithelium (Guarner et al., 2017). 
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Figure 1. Mechanism of action of probiotic bacteria. They can interfere with growth or survival of 
pathogenic microorganisms in the gut lumen (level 1). They can improve the mucosal barrier 
function and mucosal immune system (level 2) and, beyond the gut, they have an effect on the 
systemic immune system as well as other cell and organ systems such as liver and brain (level 3). 
Reproduced from Rijkers et al. (2010). 
 
1.1.3.1. Mechanisms against pathogens 
Probiotics prevent the process of pathogenicity by inhibiting growth or eliminating 
pathogenic bacteria from the intestinal lumen through various direct or indirect 
mechanisms. Probiotics can produce a wide range of molecules that can reduce the 
number of pathogens by modifying their metabolic or toxin production capabilities 
(Liao and Nyachoti, 2017). Bacteriocins are antimicrobial peptides synthesized 
ribosomally by Gram-negative and Gram-positive bacteria (Al Kassaa et al., 2014). 
They generally have a narrow spectrum of activity and, unlike antibiotics, act on the 
target pathogenic bacteria without harming the surrounding population. They have non-
toxic and non-immunogenic characteristics (Cotter et al., 2012). Some examples of 
bacteriocins are: (i) plantaricins produced by Lactobacillus plantarum, active against 
Clostridium, Salmonella, Staphylococcus or Pseudomonas (Seddik et al., 2017); (ii) 
pediocins produced by Pediococcus acidilactici, active against a large number of Gram-
positive pathogen bacteria (Rodríguez et al., 2002); (iii) enterocins produced by 
Enteroccus faecium, active against Clostridium perfringens, S. aureus, E. coli and 
Salmonella (Grande Burgos et al., 2014; Al Atya et al., 2016; Caly et al., 2017) and (iv) 
Introduction 
 
8 
salivaricins such as that produced by Lactobacillus salivarius B-30514 which inhibits 
Campylobacter jejuni in poultry (Stern et al., 2008). 
Organic acids produced by LAB, such as lactic acid or acetic acid, have a broad 
spectrum of action because they act by reducing intracellular pH and inhibiting active 
transport, as well as different metabolic functions, and are capable of altering the 
growth of pathogens (Zhitnitsky et al., 2017). Other type of metabolites such as reuterin, 
a secondary metabolite derived from the fermentation of glycerol produced by 
Lactobacillus reuteri with a broad spectrum of activity, inhibits DNA synthesis and is 
resistant to proteolytic and lipolytic enzymes (Singh, 2018). 
Furthermore, probiotics may exclude or reduce the growth of other microorganisms in 
the GIT, either through direct or indirect competition for nutrients or adhesion sites 
(Oelschlaeger, 2010). LAB probiotics such as L. plantarum or Lactobacillus rhamnosus 
GG strains stimulate mucin production in intestinal cells, which prevents the adhesion 
of pathogenic strains such as Salmonella, Clostridium and E. coli (Oelschlaeger, 2010). 
By competitive exclusion, lactobacilli are able to displace Clostridium difficile or Vibrio 
parahemolyticus (Arruda et al., 2016; Sha et al., 2016). In addition, different lactobacilli 
strains showed inhibitory activity against a Salmonella enteriditis infection and the 
reduction of its associated damage (Penha Filho et al., 2015). The administration of a L. 
salivarius 59 and E. faecium PXN-33 mix obtained a similar effect on a S. enteriditis 
infection (Carter et al., 2017). 
1.1.3.2. Stimulation of the immune system 
The immunomodulatory effects of probiotics have been proposed as strain specific, and 
probably also specific for host species (Vlasova et al., 2016). There are many 
compounds such as carbohydrates, lipids and proteins that are components of microbial 
structure, mainly the wall or cell membrane, that are known as pathogen-associated 
molecular patterns (PAMPs). These PAMPs mediate the recognition of the probiotics 
by the innate immune system through the pattern recognition receptors (PRRs) (Modlin 
et al., 1999). PRRs are expressed on immune cell and the intestinal epithelium surfaces, 
and are divided into three main families: Toll-like receptors (TLRs), retinoic acid 
inducible gene I (RIG-I)-like receptors (RLRs) and nucleotide oligomerization domain-
like (NOD) receptors (NLRs). PRRs lead signalling cascades that implement the 
recruitment of adaptor molecules such as myeloid differentiation primary response gene 
88 (MyD88), which in turn activates the mitogen-activated protein kinase (MAPK) 
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pathway and the nuclear factor kappa B (NF-κB) pathway (Wells, 2011). Probiotics can 
modulate the immune response, through these pathways, stimulating the expression of 
genes encoding several cytokines such as IL-1β, IL-6, IL-8, IL-12 or IFN-γ by 
macrophages or dendritic cells (DCs). As a consequence, increased levels of these 
cytokines are secreted and they trigger the recruitment of other immune cell types, 
activation of phagocytosis and induction of different T cell subsets (Shida and Nanno, 
2008; Wells, 2011; Brisbin et al., 2015; Quinteiro-Filho et al., 2015). In addition, 
probiotics can also have an anti-inflammatory effect, inhibiting the secretion of pro-
inflammatory cytokines and promoting the secretion of the anti-inflammatory IL-10 that 
induces the maturation of DCs and regulatory T cells (Dwivedi et al., 2016). Among 
probiotics, LAB have been reported to have a positive effect on the immune system, 
affecting both innate and adaptive immune responses, modulating the cytokine profiles 
as describe above, mainly triggered by the TLR2 signalling pathway, and also by the 
TLR2 receptor in combination with the TLR6 forming heterodimers (Wells, 2011; Tsai 
et al., 2012; Ashraf and Shah, 2014). 
1.1.3.3. Intestinal barrier 
The ability of the intestinal epithelium to act as a barrier between the external and the 
internal environments is absolutely essential for human and animal health, acting as the 
first defence against pathogens (Arrieta et al., 2006). Thus, when the intestinal barrier is 
damaged it causes internalisation of the microbial antigenic material, and in addition 
this event can significantly alter the immunogenicity of the microbial antigens (Madsen, 
2012). Intestinal epithelial cells are the first and most important target cells for probiotic 
action (Lebeer et al., 2008). Probiotic strains have been shown to have beneficial effects 
related to certain aspects of these epithelial cells. Thus, some metabolites produced by 
probiotic bacteria, such as butyrate, act as substrates for further metabolism by colon 
mucosal cells and it has been suggested to be also important for the maintenance of the 
intestinal epithelium (Donohoe et al., 2011). 
Epithelial cells bind to each other through a series of intercellular joints along their 
lateral margins called tight junctions. These structures are very complex and are 
composed of lipoid and proteinaceous components. Occludin, claudins, junctional 
adhesion molecule and tricellulin are the major transmembrane proteins involved in 
tight junction assembly (Rao and Samak, 2013). Toxins from pathogens target these 
proteins. There are several studies supporting that some probiotics such as L. rhamnosus 
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and B. lactis strains can contribute to the epithelial resistance by promoting an increase 
in the phosphorylation activity over these proteins (Mathias et al., 2010), or other 
probiotics such as L. plantarum strains that promote an increase in the expression levels 
of certain genes associated with the formation and stabilization of the tight junctions 
(Anderson et al., 2010). 
Probiotics may also improve the function of the intestinal barrier by increasing the 
production of cytoprotective molecules such as heat shock proteins. These proteins 
participate in many regulatory pathways and act as molecular adjuvants of other cellular 
proteins contributing to the maintenance of homeostasis. Certain probiotics such as L. 
rhamnosus GG and B. subtilis strains induce the expression of these heat shock proteins 
(Madsen, 2012). Finally, probiotics can also prevent epithelial damage induced by 
cytokines and oxidants by promoting cell survival and preventing entry into apoptosis 
(Madsen, 2012). 
1.1.4. Probiotics in the diseases 
The probiotics through the mechanisms described above (and others that are still 
uncertain) are able to mediate in the pathology of various diseases or alterations of 
human and animal health. Their effects on the treatment of infectious processes such as 
diarrhoea, by affecting the bacterial homeostasis and the strength of the intestinal barrier 
are well known (Pattani et al., 2013; Guarino et al., 2015; Goldenberg et al., 2017; 
Santos do Carmo et al., 2018). The involvement of the probiotics in the modulation of 
the immune system make them important tools for the treatment of symptoms of various 
inflammatory diseases: (i) inflammatory bowel diseases (Saez-Lara et al., 2015; 
Wasilewski et al., 2015; Abraham and Quigley, 2017; Nishida et al., 2018), (ii) celiac 
disease (Tavakkoli and Green, 2013; de Sousa Moraes et al., 2014), (iii) obesity (Tsai et 
al., 2014; Borgeraas et al., 2018), (iv) diabetes (Samah et al., 2016), and (v) allergies 
(Satya et al., 2014; Żukiewicz-Sobczak et al., 2014). Many of these diseases are 
autoimmune, where chronic inflammation occurs. Prolonged inflammatory events can 
trigger other diseases such as cancer, and it has been reported that probiotics can exert a 
beneficial effect to prevent them and to act as adjuvant in their treatment, particularly 
for colorectal cancer (Ambalam et al., 2016; Yu and Li, 2016; So et al., 2017). In 
addition, probiotics can affect blood pressure and the serum cholesterol level, which in 
combination with their benefits in obesity and diabetes are valuable for the treatment of 
cardiovascular diseases (Ebel et al., 2014; Thushara et al., 2016). In the last years, 
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numerous studies have been performed with the aim to unravel the relationship between 
intestinal microbiota and nervous functions, the so called “gut-brain axis”. Also, to 
determine the scientific bases of how the use of probiotics can affect central nervous 
system disorders such as anxiety depression, obsessive-compulsive disorder, bipolar 
disorder, autism spectrum disorder and memory abilities (Mangiola et al., 2016; 
Umbrello and Esposito, 2016; Vlainić et al., 2016; Wang et al., 2016; Rios Adiel et al., 
2017). 
1.2. Prebiotics 
Since the beginning of the 20th century, carbohydrate intake has been associated with 
the enrichment of Lactobacillus and Bifidobacterium in human faeces. As already 
mentioned, many species of these two genera are considered probiotic microorganisms, 
as since their origins both concepts, probiotic and prebiotic, have been reported. Thus, 
in 1995 prebiotics were defined as “non-digestible food ingredients that beneficially 
affects the host by selectively stimulating the growth and/or activity of one or a limited 
number of bacteria already resident in the colon” (Gibson and Roberfroid, 1995). Over 
the years, this definition has changed because knowledge of these substances has 
progressed, always relating their ability to modulate the microbiota with beneficial 
effects for the host. However, definitions suggested by FAO or Bindels et al. (2015) 
where limiting the concept to modulate just the gut microbiota and the requirement for 
selective fermentation was no longer used, provoking disagreements among experts. For 
this reason, the International Scientific Association for Probiotics and Prebiotics 
(ISAPP) has made a consensus to define prebiotic as “a substrate that is selectively 
utilised by host microorganisms conferring a health benefit” (Gibson et al., 2017). First, 
this definition emphasizes that a prebiotic needs a specific fermentation by a limited 
range of microorganisms that could affect composition of the microbiota. Thus, other 
substances, such as antibiotics, vitamins or minerals that can affect microbiota in a 
generalized way, are excluded by definition. On the other hand, this definition includes 
action areas of prebiotics beyond the GIT such as the vaginal tract and the skin (Gibson 
et al., 2017). 
1.2.1. Types of prebiotics and their mode of action 
The best recognised prebiotics are the galactooligosaccharides (GOS), the fructo-
oligosaccharides (FOS) and inulin-type fructans, which have been validated by 
numerous studies. Human milk oligosaccharides are very important, particularly in the 
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new-born where they are essential in the election of the microbiota and the correct 
development of the metabolic and immunological systems (Oozeer et al., 2013; Garrido 
et al., 2015). Bifidobacteria preferentially ferment these types of oligosaccharides and 
others such as xylooligosaccharides (XOS), which is why these carbohydrates promote 
the so-called bifidogenic effect of probiotics. In addition, the fermentation of these 
oligosaccharides promotes the formation of SCFA with acetic, propionic and butyric 
acids being the most abundant. These SCFA can affect locally the gut health, but also 
can serve as signalling molecules, or enter the systemic circulation and exert their 
benefits in other places (Canfora et al., 2015; Rastall and Gibson, 2015; Sun et al., 
2017). Other carbohydrates such as lactulose or certain fermentable fibres are 
considered prebiotics, as well as different types of polysaccharides produced by 
bacteria. Furthermore, there are reports showing that non-carbohydrate substances such 
as polyphenols and polyunsaturated fatty acids exert prebiotic effects (Peluso et al., 
2014; Duda-Chodak et al., 2015; Moreno-Indias et al., 2016; Costantini et al., 2017). 
Prebiotics can exert their effects through mechanisms of action similar to those of 
probiotics and affect similar processes of health alteration. For example, scientific 
reports, mainly performed with FOS and GOS, have revealed the health effect of 
prebiotics on primarily GIT: (i) by helping to maintain homeostasis by microbiota 
modulation, (ii) by preventing or acting on dysbiosis, (iii) by inhibiting pathogens 
colonisation and (iv) by contributing to the treatment of the symptoms of inflammatory 
bowel diseases as well as to the prevention of colorectal cancer (Ambalam et al., 2016; 
Louis et al., 2016; Holscher, 2017; Lane et al., 2017; Rasmussen and Hamaker, 2017).  
In addition, prebiotics have also positive effects on human metabolism contributing to 
reduce blood lipid levels as well as to modulate the factors involved in obesity, insulin 
resistance and the metabolic syndrome (Beserra et al., 2015; O’Connor et al., 2017; 
Choque Delgado and Tamashiro, 2018). Moreover, they have a positive effect on: (i) the 
bones, by increasing the bioavailability of minerals (McCabe et al., 2015; Whisner and 
Castillo, 2018), (ii) the nervous system modulating behaviour and reducing anxiety and 
stress (Kao et al., 2016; Burokas et al., 2017), and (iii) the prevention and relief of 
allergies and skin diseases such as eczema and acne (Osborn and Sinn, 2013; Baquerizo 
Nole et al., 2014; Boyle et al., 2016; Cuello-Garcia et al., 2017). 
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1.2.2. Prebiotics as immunomodulators 
Section 1.1.3.2 has already described how one of the most important beneficial actions 
of probiotics is to modulate the immune system, making these microorganisms, mainly 
bacteria, very important immunomodulators. These immunomodulatory responses are 
due to the recognition of PAMPs by the host (Wells, 2011). Prebiotics, are mainly 
carbohydrate compounds that can be recognized by the PPRs and exert some of their 
reported benefits through immune system modulation.  
1.2.2.1. Oligosaccharides 
FOS, GOS and XOS, as well as other olygosaccharides, promote anti-inflammatory 
effects by acting on the expression of cytokines by the immune cells. This effect is to 
provoke either reduction of secretion of pro-inflammatory cytokines (e.g. IL-1β, IL-6, 
IL-8, IL-12, TNFα and IFN-γ), or increase of release of anti-inflammatory cytokines (e. 
g. IL-10 and IL-13) (Hoentjen et al., 2006; Vulevic et al., 2008; Lecerf et al., 2012; 
Dehghan et al., 2014). In addition, the fermentation of prebiotics by the microbiota can 
result in the production of compounds such as SCFA that in turn can affect the immune 
system. SCFA are absorbed in the gut and can modulate immune cells of the gut-
associated lymphoid tissues (GALT), by binding to the G-protein-coupled receptors 
GPR41 and GPR43 (Brown et al., 2003a). SCFA, mainly butyrate, reduce TNFα 
production and inhibit expression of IL-1β and IL-6 genes via the NF-κB pathway 
(Segain et al., 2000; Tedelind et al., 2007). Another study reported that butyrate reduces 
pro-inflammatory IL-2 and IFN-γ production, while acetate and propionate increase 
anti-inflammatory IL-10 production (Cavaglieri et al., 2003). 
1.2.2.2. β-glucans from eukaryotic organisms  
β-glucans from yeast, fungal and plant cell wall have been reported as interesting 
prebiotics for the development of functional foods (Lam and Chi-Keung Cheung, 2013; 
Arena et al., 2016). They are non-digestible carbohydrates of high molecular weight, 
which have immunomodulatory properties. In ancient oriental cultures such as those 
developed in China or Japan, they used extracts of mushrooms and plants to treat a wide 
variety of diseases, and a large part of that potential is due to the glucans contained in 
those extracts (Novak and Vetvicka, 2008; Martel et al., 2017). β-glucans seem to 
activate the immune response against various infections, exert numerous beneficial 
effects on: (i) cardiovascular diseases, (ii) metabolic diseases such as diabetes and 
obesity, (iii) inflammatory processes and their related diseases as well as acting as anti-
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cancer agents (Chen and Seviour, 2007; Chan et al., 2009; Driscoll et al., 2009; Du et 
al., 2015; Zhu et al., 2015; Baldassano et al., 2017; Jayachandran et al., 2018; Jin et al., 
2018). 
Depending on the β-glucan source, they can be composed of β-(1,3) and/or β-(1,6)- 
and/or β-(1,4)-linked β-D-glucopyranose units, and they can present side chains with β-
(1,3) or β-(1,6)-linkeages (Wasser, 2002; Synytsya and Novák, 2013). For example, 
cereal (oat and barley) β-glucans are linear β-(1, 3) and β-(1, 4)-linked (Daou and 
Zhang, 2012; Shah et al., 2017), while fungal β-glucans are usually linear β-(1, 3) with 
or without branching β-(1, 6)-linkeages (Chen and Seviour, 2007; Zhu et al., 2015). 
Because of their complexity in composition, length and structure, β-glucans can be 
recognized by different kind of PRRs (Fig. 2) located on the surface of several immune 
cells such as monocytes, macrophages, DCs, neutrophils and natural killers (Chan et al., 
2009; Turvey and Broide, 2010). Thus, the main receptors involved in the recognition 
of β-glucans are dectin-1, toll-like receptors (TLRs), complement receptor 3 (CR3), 
lactosylceramide (LacCer) and scavenger receptors (SRs).  
 
Figure 2. Receptors for the recognition of β-glucans. Reproduced from Chan et al (2009). 
 
Dectin-1 is a small type II transmembrane receptor containing a single extracellular C-
type lectin-like domain (CTLD), which recognizes β-(1, 3) and/or β-(1, 6)-linked 
glucans and intact yeasts. CTLD is involved in calcium-independent ligand interactions, 
connected to a single-pass transmembrane domain by a stalk region (Brown and 
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Gordon, 2001; Taylor et al., 2002; Plato et al., 2013). Although its name originates from 
“dendritic-cell-associated C-type lectin 1”, dectin-1 is not exclusively expressed on 
DCs, indeed it can be found expressed at higher levels on other immune cell types 
including macrophages, neutrophils and monocytes (Taylor et al., 2002; Brown et al., 
2003b). Dectin-1 can recognize fungi belonging to several genera, through their β-
glucans, such as Aspergillus, Candida, Coccidioides, Penicillium, Pneumocystis and 
Saccharomyces. Focus on its immunological role, the signalling route through dectin-1 
can induce a vast array of cellular effects including actin-mediated phagocytosis, 
activation of the respiratory burst through production of reactive oxygen species (ROS), 
endocytosis, DCs maturation and changes in cytokine and chemokine expression 
patterns (Brown, 2005; Huysamen and Brown, 2009; Plato et al., 2013). To carry out 
these innate responses requires TLRs to generate pro-inflammatory responses (Brown et 
al., 2003b). In addition, dectin-1 is able to activate the CR3, resulting in a combined 
signalling to enhance phagocytosis and ROS production by neutrophils at the site of 
infection (Li et al., 2011; Plato et al., 2013). 
The TLRs seem to be the primary sensing receptors of the innate immune system and 
are involved in the defence against invading bacteria, fungi and viruses, among other 
pathogens. TLRs are the most extensively studied family of PRRs and, to date, 13 
members have been identified. TLRs are type I transmembrane receptors containing a 
horseshoe-shaped ligand-binding domain (LBD) and a signalling tail connected by a 
transmembrane region. TLR signalling often results in activation of NF-κB and 
MAPKs, both major components of the regulation of gene expression (Leulier and 
Lemaitre, 2008; Yamamoto and Takeda, 2010; Plato et al., 2013). 
CR3 is a specific receptor of the complement system that takes part in cellular 
immunity. CR3 is a heterodimer integrin composed of α and β chains, activated by the 
carbohydrate present on the surface of a bacterium, a virus or a transformed cell. Its 
activation induces inflammatory responses including chemotaxis of different lymphatic 
cells such as neutrophils, eosinophils, basophils and macrophages. The function of CR3 
has been extended to include adhesion, activation of oxidative burst, cytokine 
production and cytotoxicity (Yefenof, 2002). 
LacCer is a glycosphingolipid found in the plasma membranes of many cells and was 
identified as a β-glucan receptor from biochemical analyses of the interactions between 
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β-glucan and isolated human leukocyte membrane components (Zimmerman et al., 
1998). 
SRs are present on the surface of a variety of cell types and although typically 
associated with cholesterol metabolism, also recognize and respond to pathogens. SRs 
present in macrophages and monocytes recognize a variety of PAMPs including β-
glucans. SR interactions with carbohydrate polymers depend on the structure, but also 
on charges and other structural determinants (Gough and Gordon, 2000; Rice et al., 
2002). 
1.3. Evaluation of probiotics and prebiotics 
Probiotics and prebiotics are formulated to be used in both human beings and animals, 
as part of functional foods or administered as drugs. For this reason, before they can be 
commercialised, a validation of their safety and their action on health has to be 
performed. Moreover, the evaluation of new probiotics and prebiotics should follow an 
order of complexity, starting with simple in vitro models, then moving to in vivo models 
and ending with human trials. 
1.3.1. In vitro assessment 
The first step in the evaluation of a probiotic is to assess its safety, which involves 
assessing its antibiotic resistance profile and its ability to produce substances (e. g. 
(biogenic amines), enzymes or toxins (e. g. proteases, haemolysins or cytolysins) that 
could negatively affect its potential host. These characteristics can be assessed by the 
use of growth techniques in the presence of antibiotics and detection of compounds by 
chromatographic techniques. For antibiotic resistance, EFSA has determined the 
minimum inhibitory concentration (MIC) for the most commonly used antibiotics 
(EFSA, 2012). 
In addition, in vitro techniques are used for the detection of compounds with 
antimicrobial activity, such as the production of organic acids or antimicrobial peptides. 
These techniques consist of inhibition tests using the strain or its supernatant against the 
selected pathogens. Tests with neutralized supernatants are carried out for the detection 
of antimicrobial compounds such as bacteriocins, whose effect is not due to a decrease 
of the pH produced by the bacterial metabolism. Subsequently, the characterisation of 
these compounds is carried out using chromatographic techniques. 
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1.3.1.1. In vitro GIT simulation models 
As already mentioned, probiotics must reach, alive, the site of action, that is usually the 
colon, to exert their beneficial effects. To do this, they must resist the stresses associated 
with the GIT, both the action of pH and the action of different enzymes. Prebiotics must 
also survive the action of these agents, to arrive intact and be fermented by the intestinal 
microbiota.  To test bacterial resistance, there are models where the simulated stresses 
are evaluated independently or sequentially by direct addition of the stressors: (i) the 
oral stress subjecting the bacteria to lysozyme, (ii) gastric stress subjecting the bacteria 
to low pH and the action of pepsins, and (iii) intestinal stress subjecting the bacteria to 
bile salts and pancreatic juices (Fernández de Palencia et al., 2009). More sophisticated 
models have also been developed, in which the human GIT is simulated in an 
autonomous way, each section (oral cavity, stomach, and diverse regions of the 
intestine) is simulated in compartments connected to each other. The probiotics or 
prebiotics pass sequentially, and all the parameters are computer-controlled. In addition, 
these systems can harbour a complex microbiota, that in some cases try to represent the 
common composition of particular regions of the colon, or even the whole human gut, 
to evaluate the effect of the probiotics and prebiotics on the microbial environment 
(Marteau et al., 1997; Lo Curto et al., 2011; Sarbini et al., 2011). The most used is the 
simulator of the human intestinal microbial ecosystem (SHIME), that consists in a five-
stage reactor that simulates the small intestine by a two-step (duodenum-jejunum and 
ileum) system and the large intestine by a three-step (ascending, transverse and 
descending colon) reactor (Molly et al., 1993). This model has been widely used and 
updated including a stomach-step (Alander et al., 1999) or recently incorporating a 
mucosal environment, containing mucin-covered microcosms, to assess lactobacilli 
colonization (Van den Abbeele et al., 2012). 
1.3.1.2. In vitro adhesion and immunomodulation models 
Probiotics need to extend their residence time in the GIT in order to modulate the 
microbiota. To this end, they must be able to interact with the intestinal mucosa and 
epithelium. In addition, this type of interaction, of both probiotics and prebiotics, is 
necessary to exert their modulation of the immune system. In order to evaluate the 
adhesion capacity of probiotics two models are currently used either: (i) models 
containing mucin absorbed onto abiotic surfaces like polystyrene (Jonsson et al., 2006; 
Ruas-Madiedo et al., 2006; Laparra and Sanz, 2009; Arboleya et al., 2011) or (ii) 
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confluent intestinal cell layer cultures, mainly the Caco-2 and the HT-29 human cell 
lines derived from carcinoma, and also the mucus overproducing HT-29-MTX cell line 
(Fernández de Palencia et al., 2009; Arboleya et al., 2011; de los Reyes-Gavilán et al., 
2011; Archer et al., 2018). However, there is no standard procedure for testing bacterial 
adhesion, since the first type emphasizes more the interaction with mucus and the other 
emphasizes more direct host-microbe cellular interaction, and wide variation between 
models can be found. For this reason, more complex models could be used like the co-
culture of Caco-2 and HT29-MTX cell lines that reproduces a more physiological cell-
type ratio of mucosal and epithelial tissues (Chen et al., 2010; Béduneau et al., 2014); or 
even, fragments of colonic tissue excised from the host can be used for in vitro adhesion 
studies where, in addition to the mucosal layer and epithelial tissue, the interaction with 
the commensal microbiota is taken into account (Henriksson et al., 1991; Vesterlund et 
al., 2005). In addition, an in vitro cellular line model can be used to test competition 
activity of probiotics against intestinal pathogens such as Listeria monocytogenes 
(Garriga et al., 2014; Winkelströter and De Martinis, 2015), E. coli (Gopal et al., 2001; 
Candela et al., 2008) or Salmonella typhimurium (Candela et al., 2008); and also to 
study their effects on cytotoxicity produce by the toxins of C. difficile (Valdés-Varela et 
al., 2016). 
In order to study the immunomodulatory characteristics of probiotics and prebiotics, it 
is possible to analyse the response they provoke on epithelial cell lines such as HT-29 
(López et al., 2012; Patten et al., 2014; Sánchez et al., 2015) or Caco-2 (Yanagihara et 
al., 2012; Wang et al., 2017). Also, there are several human monocyte cell lines that can 
be used for this purpose. The most common is the THP-1 cell line due to its similarity 
with human macrophages derived from monocytes. THP-1 differentiation to 
macrophages is induced by exposure to phorbol 12-myristate 13-acetate (PMA), and 
this model has been used to assess the effect on cytokine profile exerted by bacteria 
(Yanagihara et al., 2014) and carbohydrate compounds (Notararigo et al., 2014; Gill et 
al., 2016; Balzaretti et al., 2017). In addition, human monocytes isolated from buffy 
coats can be differentiated to pro-inflammatory M1 macrophages or anti-inflammatory 
M2 macrophages, by exposure to granulocyte-macrophage colony-stimulation factor 
(GM-CSF) or macrophage colony-stimulation factor (M-CSF) respectively, and used as 
an in vitro immunomodulation model (Fernández de Palencia et al., 2009; Garai-Ibabe 
et al., 2010; Notararigo et al., 2014). Moreover, mouse peritoneal macrophages are 
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commonly used as an in vitro model (Ciszek-Lenda et al., 2011; Kang et al., 2011). 
Finally, the control of intestinal homeostasis is closely linked to the communication 
between epithelial cells and immune cells from the lamina propia, acting on the integrity 
of the intestinal barrier and on the transduction of the immune response. Transwell in 
vitro models try to mimic this environment by using co-cultures of epithelial cells such 
as Caco-2 in the upper compartment and cultures of macrophages or DCs in the lower 
compartment. This model is ideal to study the signal transduction triggered by 
probiotics and prebiotics (Bermudez-Brito et al., 2015; Brufau et al., 2017; Kishimoto et 
al., 2017). 
1.3.2. In vivo animal models 
Before performing human trials to evaluate the effects and safety of probiotics and 
prebiotics, the usage of animal models is required that provide a complex environment 
and a global response to them. For an animal model to be valid, the mechanisms 
involved in the response studied must be scientifically correlated with the mechanisms 
in humans, and also it is essential in the use of in vivo models, to adhere to the 
application of the 3Rs (Replacement, Reduction and Refinement), which supports 
animal welfare (Sneddon et al., 2017). 
Rodents, mainly rat and mice, are the most used animal models. There are many 
lineages available as well as knock-out models that are of great interest, e. g. an IL-10 
knock-out model that produces a chronic intestinal inflammation can be useful to 
evaluate the effect of probiotics and prebiotics (Ganesh et al., 2012). Inflammatory 
processes can be induced by exposure to agents such as dextran sodium sulphate (DSS) 
and 2,4,6-trinitrobenzene sulfonic acid (TNBS), providing effective models to study the 
anti-inflammatory effects of bacteria and immunomodulatory compounds (Lavi et al., 
2009; Dogi et al., 2016; Hidalgo-Cantabrana et al., 2016; Lim et al., 2017; Panpetch et 
al., 2017). In addition other models that recreate various diseases such as obesity 
(Dardmeh et al., 2017), diabetes (Li et al., 2016b) and cancer (Li et al., 2016a) may also 
be appropriate. Citrobacter rodentium is a murine enteric pathogen used to generate a 
diarrheal infective model, in which protective effects of certain strains of Lactobacillus 
have been observed (Rodrigues et al., 2012; Kumar et al., 2016). Other rodent models, 
such as guinea pig (Tsunemine et al., 2011), rabbit (Copeland et al., 2009), hamster 
(Huang et al., 2015) or chinchilla (Nhan et al., 2017) can be used. Nevertheless, rodent 
models have limitations due to several important physiological and metabolic 
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differences with human beings. Thus, pig is the current best in vivo model due to the 
physiological similarity, in terms of digestive and associated metabolic processes, with 
humans (Heinritz et al., 2013). However, this model is more expensive, the number of 
individuals is more limited and the ethical considerations more severe. Thus, simpler 
animal models, such as the Caenorhabditis elegans (Clark and Hodgkin, 2013) and 
Drosophila melanogaster (Daisley et al., 2018) invertebrate models, or the zebrafish 
model are more suitable for initial stages of evaluation. 
1.3.2.1. Zebrafish model 
Danio rerio is a small subtropical freshwater fish that belongs to the Cyprinidae family. 
This fish is commonly found in shoals of 5-20 individuals in slow-moving or standing 
waters of rivers and ponds with aquatic vegetation. Its optimal temperature is about 28 
ºC, but can tolerate a range of 15-35 ºC, and they usually occur in water with a slightly 
alkaline pH of 8 and with a salinity range of 0.25-0.75 ppt (Spence et al., 2007; Ribas 
and Piferrer, 2014). 
One of the advantages of the zebrafish as an animal model is its life cycle (Fig. 3), 
having a very fast embryonic development (Ribas and Piferrer, 2014). The hatching of 
eggs occurs between 60-72 hours after fertilization and at 120 hours most of their 
organs are already functional. They are considered embryos until they are able to feed 
actively, around 96-120 hours, earlier they feed from the yolk sac. They reach sexual 
maturity at 2-3 months of age. Females can spawn every 2-3 days and a single clutch 
may contain several hundred eggs. All these characteristics, within the small space 
required for breeding (adult size is about 4 cm) make this model very advantageous. In 
addition, according to the EU directive 2010/63/EU, zebrafish embryos are considered 
to be a suitable alternative animal model, so their use is not restricted by regulation for 
animal welfare (Strähle et al., 2012). 
Introduction 
 
21 
 
Figure 3. Vital cycle of the zebrafish. All the stages of development from the fecundation to the 
reproduction age are depicted. Reproduced from Ribas and Piferrer (2014). 
 
Although the zebrafish is a non-mammal model, it possesses important similarities with 
the human digestive and immune systems (Farber et al., 2001), which makes it a useful 
model. Except for a functional stomach, the main digestive organs are present in the 
zebrafish such as the intestine, liver, pancreas and gallbladder. The intestine is divided 
into three regions (intestinal bulb, mid intestine and posterior intestine) which resemble 
the small and large intestines of mammals (Wang et al., 2010). Enterocytes, endocrine 
cells and mucus-producing goblet cells are present in the intestinal epithelium. Adjacent 
to this epithelial layer is the lamina propia, which harbours several cellular types 
involved in gut immunity such as macrophages and neutrophils. The zebrafish has 
innate and adaptive immune systems equivalent to mammals (Trede et al., 2004), but 
the adaptive system does not develop until the 4-6 week of life, this fact allows the 
study of the innate response during an inflammatory process without the intervention of 
the adaptive immunity. In zebrafish there also exist PRRs like TLR receptors, adaptor 
proteins like MyD88, signalling pathways like NF-κB pathway and several cytokines 
homologous to those from mammalians. Thus, the zebrafish model seems to be very 
attractive for the evaluation of the influence of probiotics and prebiotics on the health 
and immune response. 
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2. Lactic acid bacteria 
LAB are a heterogeneous group of Gram-positive bacteria with less than 50 mol % G+C 
content in their DNA, thus they are included in the Firmicutes phylum. LAB are 
characterized by being coccus- or rod-shape bacteria, non-spore-forming, sessile, 
catalase negative, oxidase negative, acid-tolerant, aero-tolerant, facultative-anaerobic 
and with a strictly fermentative metabolism which generates lactic acid as a major 
metabolite. Normally, LAB are mesophilic bacteria with growth temperature ranging 
from 20 to 37 ºC, but there are several LAB like Streptococcus thermophilus that are 
considered as thermophilic bacteria with optimum growth temperature ranging from 40 
ºC to 45 ºC. LAB have several nutritional requirements for grow such as vitamins, 
aminoacids or nitrogen bases. Nevertheless, they can metabolise a great number of 
different carbohydrates and resist stressful conditions (e. g. osmotic, oxidative and 
acidic shocks) that lets them adapt to a wide range of habitats (van de Guchte et al., 
2002; Gänzle, 2015). Because of their versatility, they can be found in many different 
environments like food (fermented meat and vegetable products, dairy products, 
sourdough, beverages or ensilages), plants, residual waters, as well as in the 
gastrointestinal, genital and respiratory tracts of human beings and other animals (Leroy 
and De Vuyst, 2004; Holzapfel and Wood, 2014). 
They are widely known for their industrial applications as food fermentation starters, 
biocontrol agents, and probiotics. Moreover, they can produce a wide quantity of 
different metabolites with application in the food and pharmaceutical industries (Leroy 
and De Vuyst, 2004; Mazzoli et al., 2014). Traditionally, the most important application 
of LAB is in the dairy industry, but they are also utilised at industrial scale for the 
fermentation of other food raw materials such as meat and vegetables. Many LAB are 
considered safe following the criteria discussed in the probiotics section, and are 
therefore included in the list of microorganisms with QPS status by EFSA (Ricci et al., 
2017). Besides, all lactobacilli are generally considered to be QPS. Finally, LAB are 
considered as important candidates for metabolic engineering strategies due to several 
well-characterized properties, including knowledge of the genomes of industrial bacteria 
belonging to Lactococcus lactis or Lactobacillus species (Gaspar et al., 2013). 
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2.1. Taxonomy 
At the beginning of the 20
th
 century, Orla-Jensen (1919) described how LAB were able 
to acidify milk, correlating these bacteria with lactic acid production and establishing 
this fact, along with other characteristics, as rules for their classification. This included 
such criteria as cellular morphology, mode of glucose fermentation, range of growth 
temperature, and sugar utilization patterns. Using this classification, the LAB were 
grouped into four genera: Lactobacillus, Leuconostoc, Pediococcus and Streptococcus. 
Subsequently several researchers revised the taxonomy by inclusion of several more 
genera (Holzapfel and Wood, 1995; Garrity and Holt, 2001; Ludwig et al., 2009; 
Holzapfel and Wood, 2014). Recently, Ludwing et al. (2009) based on the analysis of 
the 16S rRNA genes sequences, postulated the LAB taxonomy including 38 genera 
clustered into 6 families (Fig. 4) belonging to the phylum Firmicutes, class Bacilli, and 
order Lactobacillales. 
 
Figure 4. Consensus dendrogram reflecting the phylogenetic relationships of the order 
Lactobacillales. Reproduced from Ludwing et al. (2009). 
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Currently, on specialised websites such as https://www.ezbiocloud.net/ and 
http://www.bacterio.net/ new genera such as Pisciglobus, Lactosphaera or 
Bavariicoccus have been added to the LAB group, reaching a total of 44 genera. 
Traditionally, the bifidobacteria were included in the Lactobacillus genus, based on 
physiological and metabolomic criteria. Moreover, the bifidobacteria were considered 
LAB due to sharing with this group certain characteristics such as the production of 
lactic acid. However, molecular and phylogenetic studies, mainly by rRNA 16S gene 
sequencing, revealed that bifidobacteria, which have a mol % G+C content higher than 
50%, belong to the Actinobacteria phylum (Holzapfel and Wood, 2014). 
2.2. Carbohydrate metabolism 
LAB display a relatively simple carbon and energy metabolism in which the sugar 
source is converted mainly to lactic acid. From the point of view of their hexose 
fermentation metabolism, LAB are classified as either homofermentative (producers of 
only lactic acid) or heterofermentative (producers of lactic acid and other metabolites) 
(Fig. 5). Previously, it was assumed that LAB obtain energy only by fermentation, 
because they do not have porphyrins and cytochromes, thus they do not obtain energy 
from the phosphorylation by the electron transport chain (Pessione, 2012; Von Wright 
and Axelsson, 2012). However, in the last decades, it was demonstrated that certain 
bacteria like the homofermentative L. lactis and some heterofermentative lactobacilli 
can take heme and menaquinone from the culture medium and in aerobic conditions are 
able to obtain energy more efficiently by a respiratory pathway (Pedersen et al., 2012; 
Gänzle, 2015; Zotta et al., 2018).  
Nevertheless, in this review we will only describe in detail the fermentative capacities 
of LAB. The homofermentative (or homolactic) pathway is based on glycolysis (or 
Embden–Meyerhof–Parnas pathway), where the fructose-1,6-bisphosphate is obtained 
by the action of a fructose-1,6-bisphosphate aldolase, and yield a glyceraldehyde-3-
phosphate and a dihydroxyacetone-phosphate (Figure 5A). In this pathway, the unique 
end-product is lactic acid (two molecules for each molecule of hexose) and generate 2 
ATP molecules (Von Wright and Axelsson, 2012). In the heterofermentative (or 
heterolactic) pathway, a 6-phosphate-gluconate is produced by the dehydrogenation of 
the hexose, and then it is transformed into xylulose-5-phosphate that by the action of a 
xylulose-5-phosphate phosphoketolase, and yield a glyceraldehyde-3-phosphate and an 
acetyl-phosphate (Figure 5B). In this pathway, the end-products from each molecule of 
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hexose are one molecule of lactic acid, one molecule of ethanol and one molecule of 
carbon dioxide. The ATP yield of the heterofermentative pathway is one molecule per 
hexose molecule, but if acetyl-phosphate is converted to acetic acid instead of ethanol, 
an extra ATP molecule is formed (Von Wright and Axelsson, 2012). 
 
 
Figure 5. Major fermentation pathways of glucose. (A) Homolactic fermentation and (B) 
Heterolactic fermentation. Selected enzymes are numbered: 1. Glucokinase; 2. Fructose-1,6-
bisphosphate aldolase; 3. Glyceradehyde-3-phosphate dehydrogenase; 4. Pyruvate kinase; 5. Lactate 
dehydrogenase; 6. Glucose-6-phosphate dehydrogenase; 7. 6-Phospho-gluconate dehydrogenase;8. 
Phosphoketolase; 9. Acetaldehyde dehydrogenase; 10. Alcohol dehydrogenase. Reproduced from 
Von Wright and Axelsson (2012). 
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Generally, pentoses are utilised only in the heterolactic metabolism, by entering as 
either ribulose-5-phosphate or xylulose-5-phosphate (in this case carbon dioxide is not 
produced). Nevertheless, there exist examples of homolactic metabolism of pentoses via 
the pentose phosphate pathway (Tanaka et al., 2002; Gänzle, 2015). 
Other hexoses like fructose, galactose and mannose can be isomerized or 
phosphorylated to either glucose-6-phosphate or fructose-6-phosphate and then enter 
into one of the above pathways for their metabolism (Pessione, 2012; Von Wright and 
Axelsson, 2012). Usually, these hexoses like glucose are internalized into the cell by 
specific membrane transports as permeases or symporters with no ATP waste in 
membrane translocation, but ATP is needed for the intracellular generation of glucose-
6-phosphate or fructose-6-phosphate. In addition, the hexoses can also be transported by 
a phosphoenolpyruvate (PEP): sugar phosphotransferase system (PTS), that couple 
carbohydrate translocation and phosphorylation (see details in the next section). Thus, 
for example depending on how galactose enters in the cell will be differentially 
metabolised. If it is transported by a permease, galactose will follow the Leloir pathway 
via galactose-1-phosphate, whereas if it is transported by a PTS system galactose will 
follow the tagatose-6-phosphate pathway via galactose-6-phosphate (Pessione, 2012; 
Von Wright and Axelsson, 2012). 
Thus, depending on the metabolic pathways that they use, LAB are generally clustered 
in three groups (Von Wright and Axelsson, 2012; Gänzle, 2015): 
a) Obligate homofermentative. These bacteria lack the phosphoketolase, thus are 
unable to metabolize pentoses. They have a constitutive fructose-1,6-
bisphosphate aldolase and use only the glycolysis route. LAB belonging to 
genera Pediococcus, Lactococcus, Streptococcus and Group I lactobacilli (L. 
acidophilus, L. delbrueckii, L. helveticus and L. salivarius) are included. 
b) Obligate heterofermentative. Contrary to the last group these bacteria lack the 
fructose-1,6-bisphosphate aldolase, having a constitutive phosphoketolase, so 
they use only the 6-phospho-glucanate route to metabolize hexoses. LAB 
belonging to the genera Leuconostoc, Oenococcus, Weisella and Group III 
lactobacilli (L. brevis, L. buchneri, L. fermentum and L. reuteri) are included. 
c) Facultative heterofermentative. These bacteria metabolize hexoses by 
homolactic pathway, and pentoses by heterolactic pathway. The 6-
phosphogluconate route is inhibited by glucose in these bacteria. Member of the 
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Group II lactobacilli (L. casei, L. curvatus, L. plantarum and L. sakei) and other 
LAB are included. 
In addition, pyruvate has a central role in the fermentation pathways, acting as an 
electron acceptor to form primarily lactic acid, but depending on the availability of 
oxygen and substrates, pyruvate can have different fates. Pyruvate could be the substrate 
of different enzymes like, lactate dehydrogenase, pyruvate dehydrogenase, pyruvate 
oxidase or pyruvate-formate lyase, therefore many different end-products could be 
formed such as lactate, acetate, formate, acetyl-CoA, acetoin, ethanol, diacetyl or 2,3-
butanediol (Von Wright and Axelsson, 2012; Gänzle, 2015) 
2.2.1. PTS system 
The PTS is the main system of sugar transport in LAB fermenting hexoses via the 
Embden–Meyerhof pathway (homolactic and facultative heterolactic LAB). It is 
characterized by linking the sugar translocation with its phosphorylation using the 
energy from the hydrolysis of PEP (Postma et al., 1993; Boels et al., 2001). 
The PTS system is a multienzymatic system composed of two common cytoplasmic 
enzymes (EI and HPr) and of different membrane-associated enzymatic complex (EII), 
specific for each carbohydrate or groups of carbohydrates. The EII component has 
several domains which can be part of one polypeptide (IIABC), two polypeptides (IIA 
and IIBC), or several polypeptides (IIA, IIB, IIC and in some cases IID too) and among 
them at least IIC and IID are bound to the membrane. All of these components form a 
phosphorylation cascade to transport the phosphate group from PEP to the sugar 
through transfer to EI, HPr, EIIA and EIIB (Fig 6). EIIC component (sometimes 
together with EIID) constitutes a one-way transport or permease, which manages the 
sugar translocation. 
 
Figure 6. Representation of a typical PTS system in LAB.  
EIIB Sugar 
Pi 
Sugar-6-P 
EIIA 
Pi 
HPr 
PEP 
Piruvate 
HPr 
Pi 
EI 
Pi 
EI EIIA 
EIIC 
Introduction 
 
28 
Based on the protein sequence alignments of the EII components, the PTS of Gram-
negative and Gram-positive bacteria have been clustered into 4 classes (Postma et al., 
1993): (i) glucose class, e.g. EII
glc
 from E. coli (EIIA
glc
/EIICB
glc
) or B. subtilis 
(EIICBA
glc
); (ii) mannitol class, e.g. PTS
mtl
 from E. coli (EIICBA
mtl
), while in Gram-
positive, the EIIA component is an independent protein; (iii) lactose class, e.g. PTS
lac
 
from L. casei or L. lactis (EIIA
lac
/EIICB
lac
); (iv) mannose class, that has the particularity 
of possessing a EIID component, e.g. PTS
man
 from E. coli (EIIAB
man
/EIIC
man
/EIID
man
) 
or PTS
lev
 from B. subtilis (EIIA
lev
/EIIB
lev
/EIIC
lev
/EIID
lev
), which corresponds to a 
specific PTS system for mannose and fructose also called levulose. Furthermore, 
regarding the EIIC phylogeny, the PTS permeases are classified in 7 families: glucose, 
mannitol-fructose, lactose, galactitol, glucitol or sorbitol, mannose and L-ascorbate 
(Barabote and Saier, 2005). In the LAB group the PTS system for transport of glucose is 
the most common, although the other permease families are represented (Barabote and 
Saier, 2005). Nevertheless, in some bacteria like L. casei the transport of glucose occurs 
preferentially by the mannose class PTS system (Yebra et al., 2006). 
In addition to their role in sugar transport, the PTS systems play an important role in 
cellular homeostasis allowing the bacterial cells to adjust their biochemical and 
physiological processes according to the energy and carbon sources available (Saier and 
Reizer, 1994; Saier et al., 1995; Deutscher et al., 2006). 
The 3´, 5´-cyclic adenosine monophosphate (cAMP) is the main element of the 
regulatory mechanisms known as catabolic and transient repression in Gram-negative 
bacteria. cAMP levels can vary depending on the enzymatic activity of adenylate 
cyclase, which is activated by the phosphorylated form of EIIA
glc
. Thus, the variation of 
cAMP levels can affect its linkage to the transcriptional regulator CRP (catabolic 
repression protein), which controls the expression of the appropriate catabolite operons 
(Postma et al., 1993; Zhou et al., 2013). 
By contrast, in BAL as well as in others Gram-positive bacteria with low G+C content, 
the phospho-carrier HPr protein is the main element in the catabolic regulatory 
processes. HPr is able to be phosphorylated on His-15 by transfer from EI (P-His-HPr) 
(Fig. 6), participating in the carbohydrate transport by the PTS systems, and can also 
transfer its phosphate to other non-PTS proteins, regulating their functions (Stülke et al., 
1998; Deutscher et al., 2002). In addition, HPr can be phosphorylated or 
dephosphorylated on Ser-46 (P-Ser-HPr) by the bifunctional enzyme HPr 
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kinase/phosphorylase (HprK/P) (Deutscher, 2008; Görke and Stülke, 2008), taking part 
in the regulatory mechanism of sugar uptake known as carbon catabolite repression 
(CCR), mainly produces in the presence of glucose. The uptake of glucose increases the 
concentration of the intermediate glycolytic metabolite fructose-1,6-bisphosphate and 
the ATP, which triggers the kinase activity of HprK/P, catalysing the formation of P-
Ser-HPr. By contrast, under nutrient limitation conditions, inorganic phosphate is 
accumulated promotes the phosphorylase activity of HprK/P (Deutscher, 2008). P-Ser-
HPr binds to the major global transcription regulator of CCR, the catabolite control 
protein A (CcpA). This union provokes a slight rotational movement into the CcpA core 
(Schumacher et al., 2004). This conformational change promotes the binding of the 
HPr-CcpA complex to a consensus sequence denominated catabolite repression element 
(cre) located in the promoter regions of genes and operons subject to CCR. 
2.2.1.1. PTS systems for the use of sorbitol in LAB 
Sorbitol, also known as glucitol, is present in many fruits and is widely used in the food 
industry as a sweetener, moisturizer and stabilizer (Silveira and Jonas, 2002). Its 
prebiotic effect has been also demonstrated, so it could be used for the manufacture of 
functional foods (Sarmiento-Rubiano et al., 2007). 
Sorbitol as a carbon source has been reported in some bacteria like E. coli (Yamada and 
Saier, 1988), Erwinia amylovora (Aldridge et al., 1997), Clostridium beijerinckii 
(Tangney et al., 1998), Streptococcus mutans (Boyd et al., 2000) and L. casei (Yebra 
and Pérez-Martínez, 2002). In all cases, the sorbitol transport is by the PTS system. 
EII proteins responsible for the sorbitol uptake (EII
gut
) have an unusual structure, 
consisting in EIIA, EIIBC and EIIC, where EIIC corresponds only to the N-terminal 
region of the domain and the C-terminal region is fused to the EIIB domain (Aldridge et 
al., 1997; Tangney et al., 1998; Boyd et al., 2000; Alcántara et al., 2008). 
The enzymes involved in the metabolism and transport of sorbitol are clustered and 
expressed in the gut operon. This operon includes the gene gutF that encodes the 
sorbitol-6-P dehydrogenase, which transforms sorbitol-6-P into fructose-6-P; the genes 
gutR and gutM that encode regulatory proteins; and the genes gutC, gutB and gutA that 
encode for the EII components of PTS
gut
. This organization is conserved in the phylum 
Firmicutes, with a few exceptions like C. beijerinckii that lacks the gene gutF and the 
genus Listeria which lacks the gene gutR (Tangney et al., 1998). 
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The role of GutM and GutR proteins has been studied in E. coli, where a complex and 
not entirely clear mechanism has been proposed in which GutM is an activator and 
GutR a repressor (Yamada and Saier, 1988). In the Firmicutes group, the analysed gut 
operons contain homologues to the gutM gene, but the GutR regulator is different from 
that of E. coli. 
It has been demonstrated that the GutR protein of L. casei is a regulator that acts as a 
transcriptional activator by binding to its operator upstream of the gut operon (Stülke et 
al., 1998; Alcántara et al., 2008). GutR has a PTS regulation domain (PRD) 
phosphorylatable by the components of the PTS system, and both the GutR operator and 
the PDR are conserved in Firmicutes. The gutM gene encodes for a conserved protein of 
unknown function in this group of bacteria, but studies performed with L. casei indicate 
that GutM plays a regulatory role (Alcántara et al., 2008). 
2.3. Exopolysaccharides produced by LAB 
Some LAB as well as other bacteria, fungi or algae are able to produce different types 
of exopolysaccharides (EPS). Generally, bacterial EPS are heterogeneous long-chain 
polymers of high molecular weight, which are released into the environment 
(Sutherland, 1972). They can be excreted outside the cell wall or be attached to it, 
forming a capsular layer (Ruas-Madiedo and de los Reyes-Gavilan, 2005; Chapot-
Chartier et al., 2011). In general, EPS-producing bacteria do not use these polymers as 
an energy source. The functional role of these EPS is not completely understood, but 
organisms invest a great deal of energy in their production, so presumably they must 
play an important role for bacteria. Indeed, it has been shown that EPS influence the 
way in which microorganisms interact with their external environment (Donot et al., 
2012). EPS are capable of retaining water, protecting bacteria from desiccation. They 
also act as a physical barrier and can protect bacteria from bacteriophage attack, 
predation by protozoans, penetration of toxic compounds, surfactants and antibiotics, as 
well as a defence against osmotic stress (Donot et al., 2012; Ruas-Madiedo, 2014). In 
addition, when EPS are secreted they are able to aggregate forming complex structures, 
as well as to interact with other biomolecules, participating in interactomic processes 
such as bacteria-eukaryotic cell and bacteria-bacteria (Ruas-Madiedo et al., 2008). Thus, 
they play an important role in the colonization of different ecosystems through adhesion 
to surfaces and the formation of biofilms, which in turn, help them to adapt to different 
physico-chemical conditions of the environment (Donot et al., 2012). Apart from its 
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adhesive and protective functions, the formation of a biofilm promotes the association 
of different microbial species, and these in turn can create attachment sites for other 
species, becoming a symbiotic ecosystem where the metabolic products of one species 
can act as substrates for metabolic processes of another species (Sutherland, 2001; 
Dunne, 2002; Tytgat et al., 2018). 
2.3.1. Classification 
EPS produced by LAB are linear or branched biopolymers with repeating units of sugar 
or sugar derivatives, which are linked by glycosidic bonds. These compounds reach a 
very high molecular mass, even exceeding 10
8
 Da (Zarour et al., 2017), depending on 
the number of residues that constitute their structure. Thus, LAB are able to produce a 
wide range of EPS that can differ in: (i) monosaccharide composition and type of 
linkages; (ii) primary structure with or without different degrees and type of branching; 
(iii) molecular weight and (iv) overall structural conformation (Ruas-Madiedo and de 
los Reyes-Gavilan, 2005; Finore et al., 2014). Therefore, EPS are commonly classified, 
based on their monosaccharide composition and biosynthetic pathway, in 
homopolysaccharides (HoPS) and heteropolysaccharides (HePS). 
2.3.1.1. Heteropolysaccharides 
HePS are composed of repeating units of at least two or more different 
monosaccharides, mainly glucose, galactose and rhamnose, but also can contain with 
less frequency N-acetylated monosaccharides (N-acetyl-glucosamine and N-acetyl-
galactosamine), other monosaccharides like fucose, mannose or ribose, as well as 
organic and inorganic (glucuronic acid, acetyl groups, glycerol, phosphate, etc.) 
substituents (Torino et al., 2015; Salazar et al., 2016). In addition, the repeating unit 
backbone can present side groups, and all the monomers can be linked by many 
different types of ‘-osidic’ bonds. The use of nuclear magnetic resonance (NMR) has 
shown the great variety of repeating units, ranging from three to eight monomers, 
present in HePS synthesized by LAB, which has resulted in the description of up to 45 
NMR structures (De Vuyst et al., 2001; Laws et al., 2001; Broadbent et al., 2003; Ruas-
Madiedo et al., 2009). This high complexity is also detected in the biosynthesis and 
secretion pathways, which require the joint action of several proteins usually encoded 
by genes located in operons. Often, these operons harbour genes encoding proteins 
predicted to be involved in regulation, glycosyltransferases for the synthesis of the 
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repeating units, as well as proteins for chain length determination, polymerization, and 
export (Ruas-Madiedo, 2014). 
Among the variety of HePS, three of them are notable for their industrial application, 
kefiran, gellan gum and xanthan gum. Kefiran is a HePS produced by LAB, mainly by 
Lactobacillus kefiranofaciens, although other species of Lactobacillus (L. kefirgranum, 
L. parakefir, L. kefir and L. delbrueckii ssp. bulgaricus) are able to produce it (Patel et 
al., 2012). Kefiran consists of almost equal amounts of glucose and galactose, forming a 
repeating pentasaccharide unit that displays one to two monosaccharide branches in 
random positions (Exarhopoulos et al., 2018). The other two HePS are anionic and 
produced by non-LAB bacterial strains. Gellan gum is produced by the bacteria 
Spingomonas paucimobilis and Azotobacter chroococcum (Sutherland and Kennedy, 
1996). This HePS is composed of repeating tetrasaccharide units of two residues of β-
D-glucose, one of β-D-glucuronate and one of α-L-rhamnose (Zhu et al., 2013). 
Xanthan gum is synthesised by Xanthomonas campestris (Vorholter et al., 2008). This 
HePS is made up of pentasaccharide subunits, forming a cellulose backbone with 
trisaccharide side chains composed of mannose β-(1,4)-glucuronic-acid, β-(1,2)-
mannose attached to alternate glucose residues in the backbone by α-(1,3) linkages 
(Jansson et al., 1975). 
2.3.1.2. Homopolysaccharides 
HoPS are composed of only one type of monosaccharide sub-unit: glucose (glucans), 
fructose (fructans) or galactose (polygalactans) and only one protein is responsible for 
the synthesis and the extracellular location of the HoPS. These glucans, fructans and 
polygalactans are subdivided based on the glycosidic linkage of the repeating unit 
backbone and the position of the carbon involved in the bond. Thus, glucans are sub-
classified into α-glucans (dextran, mutan, alternan and reuteran) and β-glucans; 
whereas, fructans are sub-classified into levan-type and inulin-type, both being β-
fructans (Torino et al., 2015; Zannini et al., 2016).  
Dextran is a α-glucan with a main backbone chain linked by α-(1,6) glycosidic bonds, 
and may also be branched through various secondary linkages such as α-(1,2), α-(1,3) or 
α-(1,4). Dextran was first described in Leuconotoc mesenteroides, and the dextran 
synthesized by the dextransucrase from the NRRL B-512F strain, which consists of a 
dextran with 5 % of branching in α-(1,3), was one of the first biopolymers produced at 
industrial scale for medical and biotechnological applications (Barker et al., 1993; 
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Monchois et al., 1997). Furthermore, this HoPS is widely produced among LAB and it 
has been reported in dextran-producing species from Weissella, Streptococcus, 
Pediococcus, Oenococcus, Lactobacillus and Leuconostoc genera (Katina et al., 2009; 
Komatsu et al., 2010; Patel et al., 2010; Dimopoulou et al., 2016; Nácher-Vázquez et 
al., 2017b; Zarour et al., 2018). 
Mutan is a α-glucan with a main backbone chain linked by α-(1, 3) glycosidic bonds, 
and can be branched with α-(1, 6)-linked side chains. This HoPS is produced by a 
mutansucrase and that of S. mutans forms the main constituent of the dental plaque 
conditioning layer, being this bacterium the essential virulence factor associated with 
biofilm development in dental caries (Hamada and Slade, 1980; Koo et al., 2013). Also, 
other strains belonging to Leuconostoc, Streptococcus and Lactobacillus genera are able 
to produce mutan (Côté and Skory, 2012; Côté et al., 2013). 
Alternan is an α-glucan whose backbone chain consists of alternating α-(1,6) and α-
(1,3) glycosidic linkages that can have some degree of α-(1,3) branching (Argüello-
Morales et al., 2000). This unique structure confers to this HoPS physical characteristic 
such as high solubility, low viscosity and resistance to bacterial and enzymatic 
hydrolysis (Smith et al., 1994; Leathers et al., 2003). The first instance of alternan was 
its production by L. mesenteroides NRRL B-1355 strain (Côté and Robyt, 1982), 
synthesised by the glucansucrase ASR (also known as alternansucrase) that is unable to 
synthesize two consecutive α-(1,3) linkages (Côté and Sheng, 2006).  
Reuteran, as the name suggests, is a specific α-glucan synthesised by L. reuteri. 
Reuteran-producing L. reuteri 121 was the first know strain that synthesised the HoPS 
by action of the glucansucrase GTFA (reuteransucrase), and contains in large amount α-
(1,4) linkages (58%) and α-(1,6) linkages (42%) with apparently no repeating units 
(Kralj et al., 2002). The structure of the reuteran produced by GTFA was elucidated in 
alternating α-(1, 4) and α-(1, 6) linkages with no consecutive α-(1, 6) detected (Kralj et 
al., 2002; Kralj et al., 2004). However, another reuteransucrase from L. reuteri ATCC 
55730, named GTFO, was found to produce a higher proportion of α-(1,4) linkages 
(80%) and less α-(1,6) linkages (20%) in its polymer, with no alternating structure 
(Kralj et al., 2005). 
The β-glucan produced by LAB has a backbone of β-(1, 3)-linked units, branched with 
β-(1, 2)-linked side chains of varying distribution. The production of β-glucan by LAB 
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is uncommon, and it has been described for only some LAB isolated from alcoholic 
fermented beverages: Pediococcus parvulus IOEB8801 and Oenococcus oeni 
IOEB0205 (Llaubères et al., 1990; Dols-Lafargue et al., 2008) strains isolated from 
wine; P. parvulus 2.6, CUPV1 and CUPV22, Lactobacillus suebicus CUPV221, 
Lactobacillus diolivorans G77 and O. oeni I4 (Dueñas-Chasco et al., 1997; Dueñas-
Chasco et al., 1998; Ibarburu et al., 2007; Garai-Ibabe et al., 2010). Also it has been 
reported that several strains of the non-LAB probiotic bacteria Propionibacterium 
freundenreichii are able to produce this kind of β-glucan (Nordmark et al., 2005; 
Deutsch et al., 2010). β-glucans are synthesised by a glycosyltransferase, a 
transmembrane enzyme that utilizes UDP-glucose as donor substrate (Werning et al., 
2006). Finally, the pathogen LAB Streptococcus pneumoniae serotype 37 forms a 
capsule with a β-glucan similar to that of the other LAB (Adeyeye et al., 1988), 
Fructans are HoPS made of β-D-fructosyl molecules that can be linked by β-(2, 1) or β-
(2, 6) bonds, forming inulins or levans respectively. Inulin-type EPS are synthesised 
from sucrose by an inulosucrase enzyme, and they have been describe in LAB such as 
Lactobacillus johnsonii NCC 533, S. mutans JC2 and L. reuteri 121 (Anwar et al., 2008; 
Patel et al., 2012). In turn, levan EPS are produced by a levansucrase and have been 
described in LAB such as Lactobacillus sanfranciscencis LTH 2590, L. reuteri LB121 
and L. mesenteroides NRRL B-512 F (Patel et al., 2012). All of them are considered 
prebiotic compounds. 
Polygalactans are uncommon HoPS composed of a pentameric repeating unit of 
galactose, whose main chain consists of three galactose molecules linked by β-(1,3) and 
β-(1,4) bonds and has a side chain of two galactoses linked by β-(1,3) bonds. They were 
described for the strain L. lactis sbsp. cremoris H414 (Gruter et al., 1992). 
2.4 Pediococcus parvulus 2.6 
This bacterium was isolated from natural Basque cider, in which it is responsible for an 
unwanted alteration called ‘ropiness’ or ‘oiliness’ which is due to the production of an 
EPS (Fernández et al., 1995). The presence of EPS provided a raised phenotype in the 
bacterial colonies when grown on solid media, as well as a viscous aspect in the growth 
in liquid medium. At first, the strain was described as Pediococcus damnosus 2.6, but 
later using 16s rDNA sequencing techniques it was definitively given the name P. 
parvulus 2.6 (Werning et al., 2006). As previously mentioned, this strain produces a β-
glucan and its physical-chemical characterization showed that the structure was formed 
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by a main chain of glucopyranose molecules linked by β-(1,3) bounds, which branches 
in the O-2 position of one of every two residues, formed by a single molecule of β-
glucopyranose (Dueñas-Chasco et al., 1997). The gene gtf encodes the GTF 
glycosyltransferase that belongs to the COG1215 membrane-bound glycosyltransferase 
family and consists in a cytosolic glycosyltransferase domain flanked by two and four 
transmembrane segments (Werning et al., 2006). This is the only enzyme involved in 
the synthesis of this β-glucan (Werning et al., 2008). The gene gtf is located in the 
natural plasmid pPP2, and an isogenic EPS non-producing 2.6NR strain was obtained 
by curing this plasmid (Fernández et al., 1995). P. parvulus 2.6, was able to resist in 
vitro simulated gastrointestinal stress and adhered to enterocytes in an in vitro Caco-2 
cell model (Fernández de Palencia et al., 2009). Also, the capacity of its EPS to 
modulate human macrophages cytokine profile has been investigated (Notararigo et al., 
2014). 
In this work, I have extended the study of the probiotic properties and 
immunomodulatory capacities of this bacterium and its β-glucan. I have investigated the 
bacterium’s metabolic capacities with emphasis on its sorbitol utilisation and its 
relationship with the EPS production, I have used zebrafish as in vivo model to evaluate 
their properties and I have investigated the use of the bacterium to produce functional 
foods enriched with the bacterial β-glucan. 
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The eukaryotic (1, 3)-β-glucans are well-known immunomodulators, and the bacterial 
2-substituted (1, 3)-β-glucan produced by LAB has been suggested as a potential 
immunomodulator. P. parvulus 2.6 is the most characterized bacterium, which produces 
this bacterial β-glucan. 
Thus, the aim of this thesis was to obtain in depth knowledge of the genetic and 
functional characteristics of P. parvulus 2.6 and the production of its β-glucan, as well 
as to gain knowledge in the immunomodulatory properties of this biopolymer. To 
achieve these goals, the next objectives were proposed: 
1. The development and/or usage of tools for: 
1.1. The detection and quantification of the β-glucan produced by P. parvulus 2.6. 
1.2. The detection of lactic acid bacteria and the study of gene expression by the 
usage of the mCherry fluorescent protein. 
2. To investigate the sorbitol metabolism and its relationship with the β-glucan 
biosynthesis in P. parvulus 2.6. Furthermore, the sorbitol utilization will be studied 
at the molecular level. 
3. The fluorescent labelling of P. parvulus 2.6 for the detection of its presence during 
the evaluation of its probiotic properties. 
4. The evaluation of the probiotic properties of P. parvulus 2.6 using an in vitro Caco-
2 cells model and an in vivo gnotobiotic zebrafish larvae model. 
5. The in vivo evaluation of the immunomodulation properties of the pediococcal β-
glucan using a gnotobiotic and an inflammation induced zebrafish models. 
6. The development and evaluation of new cereal-based foods by fermentation with P. 
parvulus. 
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Resumen 
Los exopolisacáridos (EPS) de las bacterias del ácido láctico (BAL) han sido y están 
siendo ampliamente estudiados debido a su gran interés, tanto a nivel industrial, al ser 
utilizados para la mejora de las propiedades organolépticas de los alimentos, como por 
sus efectos beneficiosos para la salud al actuar como compuestos prebióticos sobre la 
microbiota del tracto digestivo y como moduladores del sistema inmune (Pérez-Ramos 
et al., 2016). Así, durante los últimos años se han ido describiendo nuevas bacterias 
productoras de EPS, entre ellas Pediococcus parvulus 2.6 aislada de sidra y objeto de 
estudio de este trabajo. Su EPS es un homopolisacárido con una cadena principal, 
constituida por moléculas de glucopiranosa unidas por enlaces β-(1,3), que se ramifica 
en la posición O-2 de uno de cada dos residuos, con cadenas laterales formadas por una 
única molécula de β-glucopiranosa. Este EPS (β-glucano) ha sido descrito en un número 
reducido de BAL aisladas de bebidas alcohólicas. Nuestro grupo ha mostrado que este 
β-glucano posee propiedades prebióticas e inmunomoduladoras (Russo et al, 2012; 
Notararigo et al., 2014) y por tanto la detección de nuevas bacterias productoras de este 
tipo de EPS es de gran interés dentro del campo de la alimentación funcional. Sin 
embargo, los métodos habitualmente utilizados para la detección y cuantificación de los 
EPS, como el método colorimétrico del fenol-sulfúrico (DuBois et al., 1956), requieren 
la purificación previa de los polímeros para eliminar los posibles carbohidratos 
contaminantes presentes en las muestras, y una posterior caracterización fisicoquímica 
para obtener su estructura. Así, el desarrollo de un método específico para la detección 
del β-glucano en el sobrenadante de los cultivos bacterianos permitiría una rápida 
identificación de las BAL productoras y una cuantificación directa de los niveles de 
producción. 
La enzima responsable de sintetizar el β-glucano es la GTF glicosiltransferasa (GTF). 
Este hecho fue demostrado por nuestro grupo al clonar el gen gtf, que codifica la GTF 
de P. parvulus 2.6, en el plásmido pNGTF y expresar la enzima en forma activa en 
Lactococcus lactis NZ9000, con una síntesis concomitante de un β-glucano con la 
misma estructura que el EPS pediocócico (Werning et al., 2008). La GTF de P. 
parvulus 2.6 posee una similitud del 33% a nivel de aminoácidos con la Tts 
glicosiltransferasa de Streptococcus pneumoniae serotipo 37, responsable de la síntesis 
de un polisacárido capsular muy similar en estructura al EPS de Pediococcus. Además, 
nuestro grupo de investigación demostró previamente, que un anticuerpo desarrollado 
frente a la cápsula de S. pneumoniae serotipo 37 (Ac anti-37) era capaz de aglutinar a la 
bacteria P. parvulus 2.6 y no a la cepa isogénica P. parvulus 2.6NR, que no produce el 
β-glucano (Fernández de Palencia et al., 2009). Con estos antecedentes, en este trabajo 
nos planteamos diseñar y validar un ensayo de inmunoabsorción ligado a enzimas 
(ELISA) de inhibición basado en la utilización del Ac anti-37 como anticuerpo primario 
para la detección y cuantificación rápida del β-glucano, así como para el estudio 
bioquímico de la actividad enzimática de las GTF glicosiltransferasas que lo producen. 
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Así, el β-glucano producido por L. lactis NZ9000[pNGTF] y posteriormente purificado, 
fue utilizado para el desarrollo del método ELISA de inhibición. Esquemáticamente, el 
inmunoensayo consiste en inmovilizar el β-glucano purificado (62,5 ng mL-1) en los 
pocillos de una placa de microtítulo a 4 ºC durante 16 h. Independientemente, las 
muestras a analizar se exponen al Ac anti-37 (diluido 1:800) durante 30 min a 
temperatura ambiente y posteriormente las mezclas se adicionan a los pocillos de la 
placa y se incuban durante 1 h y 30 min a temperatura ambiente. Después de lavar los 
pocillos, el Ac anti-37 unido al β-glucano inmovilizado en los pocillos se conjuga con 
un anticuerpo policlonal (diluido 1:25.000) ligado a la fosfatasa alcalina, durante 2 h a 
temperatura ambiente. Por último, se adiciona una solución que contiene p-
nitrofenilfosfato y se incuba la placa en oscuridad durante 30 min a 37 ºC. La actividad 
de la fosfatasa alcalina hidroliza el p-nitrofenilfosfato liberando fosfato inorgánico y la 
base conjugada p-nitrofenol que es un compuesto de color amarillo, que se detecta por 
absorbancia a 415 nm en un espectrofotómetro. Para correlacionar los valores de 
absorbancia con la concentración del β-glucano se genera una recta patrón utilizando, 
como EPS competidor unido al Ac anti-37, concentraciones conocidas del β-glucano 
purificado. Los resultados obtenidos revelaron que existe una relación lineal entre los 
incrementos de absorbancia y los de concentración del EPS en un rango entre 20 ng mL
-
1 
y 2500 ng mL
-1
. Para determinar la especificidad del método se utilizaron soluciones 
de otros polímeros: un (1,3)-β-glucano lineal (curdlano), un (1,3)-β-glucano ramificado 
en posición O-6 (laminarina) y un heteropolisacarido ramificado (xantano). Ni el 
xantano ni el curdlano fueron capaces de competir con el β-glucano inmovilizado por su 
unión al Ac anti-37. Sin embargo, la laminarina si fue capaz de competir, pero a unas 
concentraciones muy elevadas, mostrando una correlación lineal entre 10 µg mL
-1 
y 250 
µg mL
-1
. 
Otra de las aportaciones de este trabajo fue la estandarización de la detección y 
cuantificación del β-glucano directamente en los sobrenadantes de cultivos bacterianos 
mediante el inmunoensayo. El método fue validado con sobrenadantes de cultivos de 
bacterias productoras del β-glucano aisladas de sidra (P. parvulus 2.6, Oenococcus oeni 
I4, Lactobacillus diolivorans G-77) y de la estirpe recombinante L. lactis 
NZ9000[pNGTF], crecidos en medios complejos (MRS y M17), que contienen 
polisacáridos. Además, la utilización de este método reveló valores basales muy bajos 
en las muestras controles, correspondientes a los medios de cultivo y los sobrenadantes 
de estirpes no productoras. 
Por otra parte, se evaluó comparativamente la eficacia del inmunoensayo, que cuantifica 
el β-glucano directamente en el sobrenadante de los cultivos bacterianos, con el método 
clásico colorimétrico del fenol-sulfúrico, que valora el contenido total de carbohidratos 
neutros en la muestra y requiere una precipitación previa de los EPS con etanol. Se 
crecieron las bacterias productoras anteriormente citadas en medios definidos que no 
contienen otros polisacáridos, y se analizaron sus sobrenadantes utilizando ambos 
métodos. La cuantificación por el método ELISA de inhibición reveló valores de 
concentración de β-glucano entorno a un 36-61 % superior a los detectados con el 
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método del fenol-sulfúrico en los sobrenadantes de todas las estirpes analizadas. Estas 
diferencias podrían deberse a que moléculas del EPS de bajo peso molecular no 
precipitaran con etanol. Para probar esta hipótesis, se cuantificó la concentración de β-
glucano antes y después de su purificación por precipitación con etanol utilizando el 
método ELISA, y como se esperaba se comprobó que en este proceso de purificación se 
produce una reducción de los niveles iniciales, en torno al 20-38 %. 
Independientemente, cabe destacar que durante el desarrollo de esta tesis hemos 
utilizado el imunoensayo para valorar el β-glucano en los sobrenadantes de cultivos 
bacterianos (ver detalles en el Capítulo 4), así como unido a P. parvulus 2.6 (ver 
detalles en el Capítulo 5) y validado su utilización para realizar una cuantificación 
específica de este EPS en matrices alimentarias (ver detalles en el Capítulo 6). 
Finalmente, el método ELISA de inhibición fue utilizado para caracterizar 
bioquímicamente la actividad enzimática de la GTF, en lugar de emplear el método 
estándar que requiere el uso del sustrato radioactivo UDP-[
14
C]glucosa. Para los 
ensayos se utilizaron vesículas membranosas de L. lactis NZ9000[pNGTF], que 
contenían la enzima GTF y como sustrato la UDP-glucosa. Se determinó que la 
constante de afinidad (Km) de la enzima era 123 ± 3 µM y la velocidad máxima (Vmax) 
de catálisis era 18 ± 0,8 ng de EPS por mg de proteína total por minuto. La Km obtenida 
in vitro para la GTF glicosiltransferasa fue similar a las reportadas para otras enzimas de 
su misma familia (Werning et al., 2006; Werning et al., 2008). 
Mi aportación a este trabajo 
Para lograr la consecución de este trabajo científico, mi aportación fue la siguiente. 
Contribuí al desarrollo y validación del método ELISA de inhibición, así como a la 
detección y cuantificación del β-glucano en los sobrenadantes de los cultivos de las 
estirpes productoras. Finalmente, también participé en la elaboración de la Tabla 1 y de 
la Figura 4 del trabajo. 
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Exopolysaccharides  synthesized  by lactic  acid bacteria  have  prebiotic  properties  and  contribute  to the
rheology  and  texture  of  fermented  foods.  Here,  we have  standardized  an  immunological  method  for  the
speciﬁc  detection  of 2-substituted  (1,3)--d-glucans.  The  method  allows  direct detection  and  quantiﬁ-
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Thus,  this  method  allows  the  fast  identiﬁcation  of  producing  bacteria,  as  well  as biochemical  characteri-
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1. Introduction
Most commercialized probiotic microorganisms are lactic acid
bacteria (LAB) and some produce exopolysaccharides (EPS) (Ruas-
Madiedo, Abraham, Mozzi, & de los Reyes-Gavilán, 2008; Salminen
et al., 1998; Ventura, Canchaya, Fitzgerald, Gupta, & van Sinderen,
2007). In addition, some LAB strains belonging to the Pediococcus,
Lactobacillus and Oenococcus genera, isolated from cider and wine,
are able to produce a 2-substituted (1,3)--d-glucan EPS (Dols-
Lafargue et al., 2008; Duen˜as-Chasco et al., 1997, 1998; Ibarburu
et al., 2007; Llaubères, Richard, Lonvaud, Dubourdieu, & Fournet,
1990). Analysis of the rheological properties of the 2-substituted
(1,3)--d-glucan synthesized by Pediococcus parvulus 2.6R showed
that it has potential utility as a biothickener (Lambo-Fodje et al.,
2007; Velasco et al., 2009). Pediococcus (Fernández de Palencia
et al., 2009) and Lactobacillus (Garai-Ibabe et al., 2010) strains
that produce this EPS have increased adherence to Caco-2 cells.
Abbreviations: DM,  deﬁned medium; ELISA, enzyme linked immuno-
sorbent assay; EPS, exopolysaccharide; GLC, gas–liquid chromatography; GLC–MS,
gas–liquid chromatography–mass spectrometry; HP-SEC, high-performance size
exclusion chromatography; LAB, lactic acid bacteria; PBS, Phosphate buffered saline;
SDM, semi-deﬁned medium.
∗ Corresponding author. Tel.: +34 918373112; fax: +34 915360432.
E-mail address: plg@cib.csic.es (P. López).
P. parvulus 2.6R is able to immunomodulate macrophages
(Fernández de Palencia et al., 2009) and production of the 2-
substituted (1,3)--d-glucan confers to the intestinal Lactobacillus
paracasei NFBC 338 higher resistance to gastrointestinal and
technological stresses (Stack et al., 2010). In addition, human con-
sumption of oat-based food prepared with P. parvulus 2.6R resulted
in a decrease of serum cholesterol levels, boosting the effect
previously demonstrated for (1,3)(1,4)--d-glucans of oat-based
products (Mårtensson et al., 2005). Moreover, the production of
yogurt and various beverages with 2-substituted (1,3)--d-glucan
producing LAB indicates the advantageous techno-functional prop-
erties of these strains (Elizaquível et al., 2011; Kearney et al., 2011).
Furthermore, the puriﬁed EPS from P. parvulus 2.6R increased the
growth, viability and adherence capability of probiotic LAB (Russo
et al., 2012). Therefore, LAB producing this EPS could have poten-
tial as probiotic strains and the 2-substituted (1,3)--d-glucan itself
appears to have prebiotic properties.
The speciﬁc detection and quantiﬁcation of EPS produced
by LAB, especially in a background that contains other car-
bohydrates, is laborious and time-consuming. The colorimetric
phenol–sulphuric method (Dubois, Gilles, Hamilton, Rebers, &
Smith, 1956) to quantify the total polysaccharide content of sam-
ples, requires the removal of any disaccharides or monosaccharides
present in the media by ultraﬁltration, dialysis or ethanol precip-
itation (Ruas-Madiedo & de los Reyes-Gavilán, 2005; Notararigo
et al., 2013). A complete characterization of the polysaccharide
http://dx.doi.org/10.1016/j.carbpol.2014.06.072
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Fig. 1. Analysis of puriﬁed EPS produced by L. lactis NZ9000[pNGTF] (A) and P. parvulus 2.6R (B) by high-performance size exclusion chromatography using as molecular
weight  standards dextrans of 104, 4 × 104, 7 × 104, 1.5 × 105, 2.7 × 105, 4.1 × 105, 6.7 × 105, 1.4 × 106 and 2 × 106 Da (Fluka).
then usually requires further puriﬁcation, followed by relatively
sophisticated, derivatization, degradation and analytical tech-
niques. Therefore a simple direct method for the speciﬁc and
quantitative detection of 2-substituted (1,3)--d-glucan synthe-
sized by bacteria would facilitate the identiﬁcation of new potential
probiotic strains, and the quantiﬁcation of 2-substituted (1,3)--d-
glucan production.
LAB 2-substituted (1,3)--d-glucans are synthesized by GTF gly-
cosyltransferase (Werning et al., 2006, 2008), which has signiﬁcant
identity (33%) only with the Tts glycosyltransferase of Streptococcus
pneumoniae serotype 37 (Llull, Mun˜oz, López, & García, 1999). This
latter enzyme synthesizes this organism’s capsule (Llull, García, &
López, 2001), which is a -d-glucan similar to that synthesized by
Pediococcus and Lactobacillus strains. Anti-serotype 37 antibodies
also agglutinate Lactococcus lactis and Lb. paracasei NFBC 338 strains
that over-produce GTF glycosyltransferase (Dols-Lafargue et al.,
2008; Stack et al., 2010; Werning et al., 2008) as well as LAB strains
naturally carrying this gene (Dols-Lafargue et al., 2008; Werning
et al., 2006). Therefore, in this work, we report on the design and
validation of a competition enzyme linked immuno-sorbent assay
(ELISA) method for the speciﬁc detection of 2-substituted (1,3)--
glucans, based on S. pneumoniae serotype 37 antibodies.
2. Materials and methods
2.1. Bacterial strains and growth conditions
The following bacteria were used in this work. The 2-substituted
(1,3)--d-glucan-producer strains isolated from Basque natu-
ral cider: Lactobacillus diolivorans G-77 (Duen˜as-Chasco et al.,
1998), Oenococcus oeni I4 (Ibarburu et al., 2007), P. parvulus 2.6R,
and its isogenic non-producing strain (2.6NR) (Duen˜as-Chasco
et al., 1997). The 2-substituted (1,3)--d-glucan-producing L. lac-
tis NZ9000[pNGTF] recombinant strain, which carries in the pNGTF
plasmid, based on the pNZ8048 vector, the P. parvulus 2.6R gft gene
under control of the PnisA promoter, and its isogenic -d-glucan
non-producing strain L. lactis NZ9000[pNZ8048] (Werning et al.,
2008).
The Pediococcus strains were routinely grown at 30 ◦C in Man
Rogosa Sharpe (MRS) broth (De Man, Rogosa, & Sharpe, 1960) sup-
plemented with 0.5% glucose and 0.1% Tween 80. O. oeni I4 was
routinely grown at 30 ◦C under anaerobic conditions in MRS  supple-
mented with 0.5% fructose and 1% glucose. Lb. diolivorans G-77 was
routinely grown at 30 ◦C in MRS  supplemented with 0.5% glucose.
The Lactococcus strains were routinely grown at 30 ◦C in M17 broth
(Terzaghi & Sandine, 1975) supplemented with chloramphenicol
(5 g ml−1).
For EPS production, batch fermentations without pH control
were carried out in a semi-deﬁned medium (SDM) supplemented
with glucose (2%) (Duen˜as-Chasco et al., 1997) or MRS  for P. parvu-
lus 2.6R and Lb. diolivorans G-77 as well as in the same media
supplemented with fructose (1%) for O. oeni I4 or in a deﬁned
medium (DM) (Sánchez et al., 2008) or M17, both supplemented
with glucose (0.5%) and chloramphenicol (5 g ml−1) for L. lactis
NZ9000[pNGTF]. Pediococcus, Lactobacillus and Oenococus strains
were grown to stationary phase to increase production of the
EPS. L. lactis strains were grown in the indicated media until
OD600 = 0.6. Then, for L. lactis NZ9000[pNGTF] only, expression of
the gtf gene encoding the GTF glycosyltransferase was induced with
nisin (0.25 ng ml−1) 24 h prior to testing. The strains were stored at
−80 ◦C in either MRS  or M17  media supplemented with 20% (v/v)
glycerol.
2.2. Isolation, puriﬁcation and characterization of EPS
synthesized by LAB
The 2-substituted (1,3)--glucan samples from P. parvulus 2.6R
and L. lactis NZ9000[pNGTF] were isolated and puriﬁed from culture
supernatants by ethanol precipitation and dialysis as previously
described (Notararigo et al., 2013). Stock solutions of both puriﬁed
EPS were prepared at 1 mg  ml−1 in phosphate buffered saline (PBS)
pH 7.0 and stored at −20 ◦C. For ELISA assays, EPS stock solutions
were diluted in PBS pH 7.0 prior to analysis. The molecular masses of
the EPS were determined by high-performance size exclusion chro-
matography (HP-SEC, GPCV 2000, Waters), as previously described
(Velasco et al., 2009).
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Fig. 2. Range of detection of puriﬁed 2-substituted (1,3)--d-glucan by the
immunological method. EPS produced by L. lactis NZ9000[pNGTF] (A) and P.
parvulus 2.6R (B) immobilized in microtitre plates and puriﬁed EPS from L. lactis
NZ9000[pNGTF] () and P. parvulus 2.6R (©) were tested as competitors. The values
are  the mean of three independent experiments. Standard deviations are indicated
as vertical bars over dots.
2.3. ELISA assays
ELISA assays were carried out in 96-well Nunc Maxisorp
microtitre plates (Thermo Fisher Scientiﬁc, USA). The samples
(cultures supernatants or puriﬁed polysaccharides) and a negative
control without biopolymers were tested in duplicate in each assay.
In the standard assay the 2-substituted (1,3)--d-glucan synthe-
sized by L. lactis NZ9000[pNGTF] or by P. parvulus 2.6R was  used at
62.5 ng ml−1 as immobilized EPS as well as at various concentra-
tions as competitor for binding to the primary antibody (dilution
1:800 of anti-serotype 37, Statens Serum Institut, Denmark). In
addition, to test speciﬁcity of the method, laminarin from Laminaria
digitata; curdlan from Alcaligenes faecalis and xanthan from Xan-
thomonas campestris (all from Sigma-Aldrich, Germany) were used
as competitors at concentrations from 3.9 g ml−1 to 2.5 mg  ml−1.
To optimize the ELISA assay, various 2-substituted (1,3)--
glucan solutions (31.25, 62.5, 125, 250 and 500 ng ml−1) were used
to coat the wells of microtitre plates (200 l/well) by incubation
for 16 h at 4 ◦C. The wells were washed twice with 200 l of solu-
tion I (PBS pH 7.0 and 0.05% Tween 20), and then 300 l of blocking
solution (solution I plus 0.5% gelatin) were added, followed by 3 h
of incubation at 21 ◦C. To perform the competition assay 150 l
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Fig. 3. Speciﬁcity of the immunological method. Laminarin (A), curdlan (B) and xan-
than (C) were tested as competitors. The values are the mean of three independent
experiments. Standard deviations are indicated as vertical bars over dots.
of each dilution of the primary antibody (1:200, 1:400, 1:800 or
1:1600) was  incubated for 30 min  at 21 ◦C with 150 l of each EPS
dilution (from 2.4 ng ml−1 to 5.0 g ml−1). Then, 200 l of the mix-
ture were added to each activated well of the microtitre plates and
after 1.5 h of incubation at 21 ◦C (to allow binding of free anti-
body to the immobilized 2-substituted (1,3)--glucan) the wells
were washed three times with solution I. The amount of primary
antibody bound to the wells was detected by addition of 200 l of
the secondary antibody (polyclonal Anti-IgG against rabbit alkaline
phosphatase, Sigma-Aldrich, Germany) diluted 1:25,000 in block-
ing solution, incubation for 2 h at 21 ◦C, four washes of the wells
with solution I followed by the addition of 200 l of developing
solution (p-nitrophenylphosphate at 1 mg  ml−1) in diethanolamine
buffer (0.2 M diethanolamine pH 9.8 and 5 mM MgCl2, Sigma) and
a ﬁnal incubation for 30 min  at 37 ◦C. Then, the reactions were
stopped by addition of 2 N NaOH (50 l) and the absorbance at
415 nm was  measured in a microtitre plate reader (BioRad model
680).
2.4. Phenol–sulphuric method
To determine the 2-substituted (1,3)--d-glucan concentra-
tion by this method, two replicates of 0.5 ml  culture supernatants
were precipitated overnight with 1 ml of ethanol at −20 ◦C
and sedimented by centrifugation (13,600 × g, 20 min  4 ◦C). The
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Table 1
Comparative analysis of exopolysaccharide production by ELISA and phenol–sulphuric methods.
Bacteria Method
ELISA Phenol–sulphuric Phenol–sulfuric/ELISA
EPS concentration
Totala (g ml−1) Precipitatedb (g ml−1) Precipitatedb/totala (%) Precipitatedb (g ml−1) Precipitatedb/precipitatedb (%)
P. parvulus 2.6R 322 ± 15 200 ± 35 62 117 ± 21 58
L.  lactis NZ9000/pNGTF 235 ± 35 183 ± 19 78 117 ± 8 64
O.  oeni I4 118 ± 7 94 ± 9 80 59 ± 5 63
L.  diolivorans G-77 211 ± 40 166 ± 24 79 64 ± 6 39
a Total: concentration of the EPS was determined directly in culture supernatants.
b Precipitated: concentration of the EPS present in culture supernatants was determined after ethanol precipitation.
precipitates were twice resuspended in 0.5 ml  of distilled water
and ethanol reprecipitated and resedimented as described above.
Finally, after resuspension in distilled water, the concentration
of the biopolymer present in the precipitates was determined
by the phenol–sulphuric method as reported by Dubois et al.
(1956).
2.5. Analysis of GTF glycosyltransferase activity
Membrane vesicles displaying GTF glycosyltransferase activ-
ity, were prepared from L. lactis NZ9000[pNGTF] as previously
described (Werning et al., 2008) and the enzymatic reactions were
carried out as follows. Duplicate 100 l reactions were prepared
containing 12.5, 25 or 50 g of membrane proteins as well as a
range of UDP-glucose (Sigma) concentrations (from 0.04 to 25 mM),
1 mM CaCl2, 9 mM MgCl2 and 50 mM NaCl. These were incubated
for 30 min  at 30 ◦C then the reactions were stopped by addition
of 900 l of 100% ethanol. After 2 h incubation at 4 ◦C, samples
were centrifuged at 13,226 × g at 4 ◦C for 20 min, the precipitates
were air dried, and resuspended in 500 l of PBS buffer pH 8.0. The
reaction product was quantiﬁed by the ELISA method. The kinetic
parameter, apparent Km and apparent Vmax were determined from
Lineweaver Burk plots.
2.6. Chemical analysis of the enzymatic reaction product
The neutral sugar composition and linkage type was determined
using polysaccharide synthesized in duplicate 1 ml  reactions con-
taining membrane vesicles (50 mg  of total proteins) with or without
25 mM UDP-glucose. The ethanol precipitates, after air drying, were
resuspended in 1 ml  of distilled H2O plus 5 l of 10% SDS, incubated
for 15 min  at 37 ◦C and dialyzed (molecular mass cut-off 3.5 kDa)
against distilled H2O for 24 h. Then, 100 l aliquots containing
the membrane vesicles and the reaction product were hydrolyzed,
acetylated and analyzed for the presence of neutral sugars by
gas–liquid chromatography (GLC) or after methylation, hydrolysis,
reduction and acetylation for the determination of the structural
unit of the polysaccharide by gas–liquid chromatography–mass
spectrometry (GLC–MS) as previously described (Werning et al.,
2008).
3. Results
3.1. Sensitivity of the ELISA assay
To determine the sensitivity of the method two samples
of 2-substituted (1,3)--glucans synthesized by either L. lactis
NZ9000[pNGTF] or P. parvulus 2.6R were puriﬁed and their molecu-
lar masses determined by HP-SEC. The average molecular masses of
the two main fractions were 6.6 × 106 and 1.8 × 104 Da for L. lactis
(Fig. 1A) and of 9.6 × 106 and 3.4 × 104 Da for P. parvulus (Fig. 1B).
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Fig. 4. Detection of 2-substituted (1,3)--d-glucan in culture supernatants. (A) The
indicated L. lactis strains were grown and expression of the EPS induced in either
M17  medium. P. parvulus 2.6R and 2.6NR, Lb. diolivorans G-77 and O. oeni I4 were
grown in MRS medium. Triplicates of these cultures were then centrifuged and the
supernatants were directly used for quantiﬁcation of the -d-glucan present by the
ELISA assay. The values are the mean of three independent experiments. Standard
deviations are indicated as vertical bars over bars.
The higher molecular mass fraction was the most abundant for
both strains constituting, respectively, 96% and 92% of the total
polymer population. Both EPS preparations were used for testing as
immobilized -glucans and as competitors for binding to the pri-
mary antibody. Both EPS preparations were immobilized efﬁciently
(Fig. 2A versus B) and both puriﬁed -d-glucans could be quantiﬁed
within a range of 20 to 2500 ng ml−1, independently of the origin
of the immobilized polymer (Fig. 2).
3.2. Speciﬁcity of the assay
Using the puriﬁed -d-glucan from L. lactis (described above)
as the immobilized substrate, we tested the speciﬁcity of the
method using three polysaccharides as competitors: (i) laminarin,
a 6-substituted (1,3)--d-glucan (Fig. 3A); (ii) curdlan, a linear
(1–3)--d-glucan (Fig. 3B) and (iii) xanthan, a branched het-
eropolysaccharide (Fig. 3C). Xanthan was unable to bind to the
primary antibody even at very high concentration (500 g ml−1)
and curdlan also showed a very low afﬁnity for the antibody at
250 g ml−1. Laminarin was able to compete with the immobilized
2-substituted (1,3)--d-glucan in a linear mode, when tested in the
range 10 to 250 g ml−1.
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Fig. 5. Analysis by GLC of monosaccharides (A and B) and by GLC–MS (C and D) of linkage types between glucose units of the EPS synthesized in vitro by GTF glycosyltransferase.
Analysis of reactions containing (A and C) or lacking (B and D) UDP-glucose.
3.3. Quantiﬁcation of EPS in growth media by using the ELISA
assay or the phenol–sulphuric method
The suitability of the immunological method for directly quanti-
fying (1–3)--d-glucan in LAB growth media was  tested as follows.
The -d-glucan puriﬁed from L. lactis NZ9000[pNGTF] was dis-
solved in either the DM (deﬁned) or SDM (semi-deﬁned) medium
or in M17  and MRS  complex media, and the EPS concentration
was determined by the competition ELISA assay. In all cases the
method was able to quantify EPS in the range of 30 to 500 ng ml−1
(Supplemental material S1). However, examination of the differ-
ent slopes of the curves (see panels A; B, C and D of Supplemental
material S1) in comparison with Fig. 2, indicated that for correct
quantiﬁcation of 2-substituted (1,3)--d-glucan in different buffers
or growth media, the corresponding standard curve should be
prepared using the corresponding solvent. Therefore, the method
used to quantify -d-glucan present in culture supernatants of LAB
grown in the above mentioned media always used the appropri-
ate standard curve. Thus, L. lactis NZ9000[pNGTF] and the isogenic
-d-glucan non-producing L. lactis NZ9000[pNZ8048] were grown
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in M17  medium as described previously (Werning et al., 2008). P.
parvulus 2.6R and the isogenic -d-glucan non-producing strain
(2.6NR) as well as O. oeni I4 and Lb. diolivorans G-77, and two
other 2-substituted (1,3)--d-glucan producers, were grown in
MRS  medium to stationary phase as described above. The cultures
were then centrifuged and, after removal of the supernatants, the
EPS still bound to the cells were released by resuspension into one
volume of PBS and the bacterial cells were removed by centrifu-
gation. Then, the supernatants, after appropriate dilution in PBS,
were directly used in the ELISA assay. The results revealed that the
2-substituted (1,3)--d-glucan secreted by the four producing-LAB
could be detected in the media used, whereas only background lev-
els were observed in the supernatants of the non-producing strains
(Fig. 4).
To compare the inhibition enzyme immunoassay and the
phenol–sulphuric method, culture supernatants of L. lactis
NZ9000[pNGTF] grown in DM medium and P. parvulus 2.6R, Lb. dio-
livorans G-77 and O. oeni I4 grown in SDM medium were analyzed
using both methods. Only these media were tested for detec-
tion of the 2-substituted (1,3)--d-glucan, because the presence of
other polysaccharides in M17  and MRS  media impairs the usage of
the phenol–sulphuric method. The concentration of 2-substituted
(1,3)--d-glucan was determined directly in the supernatants by
the ELISA test or in their ethanol precipitates by the ELISA and
phenol–sulphuric methods (Table 1). Determination of the EPS con-
centration in the precipitates showed that for all the strains tested
the ELISA assay revealed a higher level of production (from 61% for
Lb. diolivorans G-77 to 36% for L. lactis NZ9000[pNGTF]). In addi-
tion, comparison of EPS detection by the ELISA method prior to, or
after, precipitation demonstrated that indeed precipitation results
in a moderate loss of 2-substituted (1,3)--d-glucan in a range from
38% to 20% for P. parvulus 2.6R and O. oeni I4 biopolymers. These
differences were probably due to low molecular weight EPS that
was not precipitated by ethanol. Therefore, these results indicate
that the ELISA method allows a more reliable determination of the
biopolymer after its synthesis by bacteria.
3.4. Detection of 2-substituted (1,3)-ˇ-d-glucan produced in an
enzymatic reaction
Membrane vesicles containing the GTF glycosyltransferase,
were prepared from L. lactis NZ9000[pNGTF] and the enzymatic
activity was analyzed in vitro using UDP-glucose as substrate.
The reaction product was detected and quantiﬁed by the ELISA
method. Kinetic analysis of the results (Supplemental material S2)
indicated that the GTF glycosyltransferase has an afﬁnity for UDP-
glucose of Km = 123 ± 3 M and a Vmax = 18 ± 0.8 ng of EPS/mg of
total protein/min. This Km is almost identical to that reported for
the cellulose synthase BscA (125 M)  (Ross, Mayer, & Benziman,
1991) which, like GTF, belongs to the GT-2 family of glycosyltrans-
ferases.
To conﬁrm the nature of the enzymatic reaction product,
reactions performed with membrane vesicles and containing UDP-
glucose (test) or lacking the substrate (control) were analyzed.
In the presence or absence of the substrate, the GLC analysis
detected rhamnose, glucose and galactose, in the ratios 1:2.9:0.4
and 1:1.4:0.5 for the test (Fig. 5A) and control (Fig. 5B) reactions,
respectively. Thus, the L. lactis membrane vesicle preparations
contained three monosaccharides, whose origin could be due to
polysaccharides bound to them and as expected only glucose was
highest in the test reaction. The GLC–MS analysis (Fig. 5C and D)
detected, in the test reaction only (Fig. 5C), the three peaks that are
characteristic of 2-substitute d-(1,3)--glucan, corresponding to
terminal glucopyranose, 3-O-substituted glucopyranose, and 2-di-
O-substituted glucopyranose. Thus, the product synthesized in vitro
by the GTF glycosyltransferase was  indeed 2-substituted (1,3)--
d-glucan, conﬁrming the ELISA detection of the product.
4. Discussion
ELISA tests have been developed previously for the detec-
tion of both linear and 6-substituted (1,3)--d-glucans (Douwes,
Doekes, Montijn, Heederik, & Brunekreef, 1996; Sander, Fleischer,
Borowitzki, Brüning, & Raulf-Heimsoth, 2008) as well as for the spe-
ciﬁc detection of 6-substituted (1,3)--d-glucans (Milton, Udeni
Alwis, Fisette, & Muilemberg, 2001; Rao et al., 2007; Sander et al.,
2008). However, as far as we know, this is the ﬁrst instance of
an ELISA test developed for the detection of 2-substituted (1,3)-
-d-glucan. In the inhibition enzyme immunoassay developed in
this work the commercially available antibody (anti-S. pneumoniae
serotype 37) has been used. Our results show that this primary anti-
body speciﬁcally detects 2-substituted (1,3)--d-glucan, has very
low binding afﬁnity for 6-substituted (1,3)--d-glucan and does
not bind linear (1,3)--d-glucan even at a concentration as high
as 500 g ml−1. The ELISA method allows detection of 30 ng ml−1
of the biopolymer in growth medium, a level of sensitivity simi-
lar to that observed for other -d-glucan, such us (1,6)--d-glucan
(Vink et al., 2004) or (1,3)--d-glucan (Douwes et al., 1996), when
polyclonal antibodies were used for their detection. This method is
less sensitive than that obtained for the detection of other polysac-
charides with monoclonal antibodies (in the range of pg ml−1) or
than the amoebocyte lysate assays for which commercial kits, such
as Glucatell® (Associates of Cape Cod, USA) or Fungitic-G (Seika-
gaku, Japan) are available. However, the ﬁrst mentioned type of
assay cannot be applied to the detection of 2-substituted (1,3)-
-d-glucan and the second type does not discriminate between
different types of (1,3)--d-glucans. In addition, our results show
that the sensitivity of our ELISA test permits the detection of novel
2-substituted (1,3)--d-glucan-producing bacteria by direct anal-
ysis of culture supernatants even after growth in complex media.
Moreover, the method can be used for the biochemical characteri-
zation of the glycosyltransferases involved in their synthesis. These
ﬁndings will facilitate the identiﬁcation of new probiotic strains and
the optimization of the production of this EPS.
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Resumen 
Pediococcus parvulus 2.6, una bacteria ácido láctica (BAL) aislada de sidra del País 
Vasco, considerada como prototipo de bacteria productora de un exopolisacárido tipo 
(1,3)-β-D-glucano ramificado en posición O-2 (β-glucano). El β-glucano es sintetizado 
por la GTF glicosiltransferasa utilizando como sustrato UDP-glucosa. Tanto la cepa 2.6 
como su β-glucano han sido ampliamente estudiados y caracterizados. Se ha analizado 
el metabolismo de la bacteria y los factores que influyen en la síntesis de su EPS 
(Velasco et al., 2007), además de analizar las propiedades físico-químicas del EPS 
mediante resonancia magnética nuclear (Velasco et al., 2009). También, se ha estimado 
su masa molecular en más de 10
6
 Da, y ensayos de reología mostraron que este β-
glucano tenía potencial como bioespesante. Este β-glucano es producido solamente por 
un número reducido de BAL, cuyo nicho ecológico son las bebidas alcohólicas como el 
vino o la sidra. Así, su estructura y enlaces difieren de otros β-glucanos producidos por 
plantas, hongos o algas. 
Por otra parte, se han caracterizado ciertas propiedades probióticas de P. parvulus 2.6, 
como su resistencia a un estrés gastrointestinal o la capacidad de adhesión in vitro a 
células humanas Caco-2 (Fernández de Palencia et al., 2009). Se ha mostrado que su 
EPS favorece la adhesión a las células epiteliales, mejora el crecimiento y viabilidad de 
algunos microorganismos probióticos (Russo et al., 2012) y favorece la proporción 
antiinflamatoria IL10/TNFα en un modelo in vitro de macrófagos humanos (Notararigo 
et al., 2014). 
Teniendo en cuenta estos antecedentes, la secuenciación del genoma de P. parvulus 2.6 
supone un paso más en la consecución de una visión global de su potencial metabólico, 
así como valorar la presencia de determinantes incompatibles con su potencial 
utilización como bacteria probiótica. Además, ha supuesto la caracterización del primer 
genoma de una estirpe de P. parvulus. 
La secuenciación del genoma se llevó a cabo a partir de una muestra de 2 µg de ADN 
genómico. Una librería del genoma completo se obtuvo mediante la técnica TruSeq 
ADN y utilizando el sistema Genome AnalyzerIIx de Illumina. El análisis de la librería 
permitió ensamblar el genoma en 115 cóntigos, el menor de 206 pb y el mayor de 171 
kpb. También permitió estimar el tamaño del genoma en 2.236 kpb. Se anotaron un total 
de 2.241 genes de los cuales 2.069 codifican proteínas, 3 ARNs ribosomales, 60 ARNs 
transferentes, 4 ARNs no codificantes y 105 pseudogenes. El genoma completo de P. 
parvulus 2.6 fue depositado en el GenBank bajo el número de acceso LXND00000000. 
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Mi aportación a este trabajo 
Para lograr la consecución de este trabajo científico, mi aportación fue la siguiente. 
Contribuí a la extracción del ADN genómico bacteriano que fue objeto de la 
secuenciación y posteriormente contribuí al análisis de la secuencia obtenida detectando 
el operón de utilización y transporte de sorbitol, que fue estudiado en el Capítulo 4 de 
esta tesis. Además, realicé el borrador del manuscrito. 
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We report here the draft genome sequence of Pediococcus par-vulus 2.6 (formerly Pediococcus damnosus), a lactic acid
bacterium isolated from ropy cider (1). This is the first strain of
P. parvulus whose genome has been characterized. The 2.6
strain produces the immunomodulatory exopolysaccharide
2-substituted (1,3)--D-glucan (2), which is synthesized by a lim-
ited number of bacteria and confers probiotic properties to the
producing strains. This polysaccharide differs from the -glucans
produced by plants and other microorganisms. The synthesis of
2-substituted (1,3)--D-glucan by P. parvulus 2.6 is controlled by
a single heterotransmembrane glucosyltransferase (GTF), which
polymerizes glucosyl residues from UDP glucose (3–5). Some of
the conditions that influence the homopolysaccharide (HoPS)
synthesis by P. parvulus 2.6, as well as the enzymatic activities
involved in sugar metabolism in this strain, have been examined
(6, 7). The physicochemical properties of theHoPS have also been
determined, and nuclear magnetic resonance (NMR) analysis
showed that the same HoPS was synthesized, irrespective of the
sugar source used for growth (8). The molecular masses of these
-glucans are high (106 Da), and their rheological properties
showed that they have potential utility as biothickeners (8). An
oat-based product fermented by P. parvulus 2.6 showed improved
rheology (9), thereby decreasing the need for added stabilizers and
texturizers.
The potential of P. parvulus 2.6 as a probiotic strain has also
been examined; it resists gastrointestinal stress, adheres to Caco-2
cells, and its HoPS reduces the production of inflammatory cyto-
kines by polarized macrophages (10). We have also shown that
P. parvulus HoPS improves the growth and viability of probiotic
microorganisms, as well as their adhesion to human enterocytes
(11). The 2-substituted (1,3)--D-glucan increases in vitro the ra-
tio of interleukin 10 (IL10) (anti-inflammatory) to tumor necrosis
factor alpha (TNF) (inflammatory) in humanmacrophages and
decreases the levels of the proinflammatory IL8 in human intes-
tine organ cultures (reference 12 and Notararigo S., Antolin M.,
Guarner F., López P., unpublished data).
An oat-based product fermented by P. parvulus 2.6 had a bifi-
dogenic effect and decreased serum cholesterol levels in humans
(13). Possibly, the 2-substituted (1,3)--D-glucan has a synergistic
effect with the hypocholesterolemic action of oat -glucans. Fi-
nally, P. parvulus 2.6 displays antibacterial activity against several
bacterial species (14), including natural contaminants in oats, a
property that reduces the need for chemical preservatives and im-
proves the functionality of the final product.
Two micrograms of genomic DNA was subjected to library
preparation using the TruSeq DNA sample perp kit FC-121-1001,
according to the manufacturer’s instructions. Whole-genome se-
quencing used the IlluminaGAIIx at the Genomics Research Cen-
tre (Fiorenzuolad’Arda, Italy). A total of 26,018,224 paired-end
reads (2  110-bp length) were assembled into 115 contigs. The
genome was calculated to be 2,236,754 long. The size of the short-
est contig was 206 bp, while the length of the longest contig was
171,226 bp. The genome sequence was annotated by the NCBI
Prokaryotic Genomes Annotation Pipeline. A total of 2,241 genes
were predicted to encode 2,069 proteins, three rRNAs, 60 tRNAs,
and four noncoding RNAs (ncRNAs), and 105 are pseudogenes.
Accession number(s).The complete genome ofP. parvulus 2.6
has been deposited at DDBJ/EMBL/GenBank under accession
number LXND00000000.
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Resumen 
El género Lactobacillus es uno de los más abundantes dentro del grupo de las bacterias 
del ácido láctico (BAL), y también de los más importantes debido a su interés 
biotecnológico, así como por sus características probióticas que promueven efectos 
beneficiosos para la salud. Así, para realizar su evaluación es útil el desarrollo de 
nuevas herramientas genéticas que permitan estudiar la expresión de genes que 
codifiquen enzimas y otras proteínas de interés. Entre dichas herramientas, cabe 
destacar los vectores plasmídicos para evaluar promotores transcripcionales, que 
contienen genes codificantes de proteínas fluorescentes. Además, cuando los vectores 
contienen fusiones transcripcionales, son responsables de la expresión de dichas 
proteínas y pueden ser utilizados, una vez transferidos, para la detección y localización 
de bacterias en procesos interactivos como la formación de biopelículas o la 
colonización del tracto gastrointestinal. En un trabajo previo de nuestro grupo, se diseñó 
un gen mrfp sintético, que codifica la proteína mCherry, una variante monomérica de la 
proteína fluorescente roja de Dicosoma sp. Los codones del gen mrfp fueron 
optimizaron para su expresión en bacterias Gram-positivas, y la proteína mCherry 
codificada por él, a partir de plásmidos recombinantes, fue validada como marcador en 
Lactococcus lactis y Enterococcus faecalis (Garcia-Cayuela et al., 2012). 
Sin embargo, los plásmidos construidos en el trabajo antedicho, que contenían dos 
replicones distintos, no fueron funcionales ni en lactobacilos ni en neumococos. Por ese 
motivo, en este trabajo, se construyó el plásmido denominado pRCR, que permite la 
evaluación de promotores en cepas pertenecientes a especies del género Lactobacillus y 
en Streptococcus pneumoniae. Este plásmido, que replica mediante el mecanismo de 
circulo rodante, contiene el replicón pSH71 de L. lactis y presenta un amplio espectro 
de hospedador. El plásmido pRCR porta, además del gen cat que codifica la 
cloranfenicol acetil transferasa, el gen mrfp precedido por un sitio para clonación 
múltiple. Fue generado in vitro y establecido en S. pneumoniae 708 mediante 
electrotransformación. Los transformantes fueron seleccionados por resistencia a 
cloranfenicol, y posteriormente fue transferido a Escherichia coli DH5α. También, los 
resultados presentados en el Capítulo 4 de esta tesis han demostrado la validez del 
vector para estudios de expresión génica en Lactobacillus plantarum y Lactobacillus 
casei. 
En este trabajo, para validar la mCherry como proteína marcadora de la expresión 
génica en los lactobacilos, se clonó la posible región promotora PlbaB de Lactobacillus 
acidophilus en el vector pRCR generando el plásmido pRCR11. Este plásmido fue 
establecido en E. coli DH5α, y transferido posteriormente a L. acidophilus CECT903. 
El gen lbaB de L. acidophilus codifica la bacteriocina lactacina B y se ha demostrado 
previamente que su expresión es inducible por el co-cultivo con otras bacterias vivas, 
como Streptococcus thermophilus (Tabasco et al., 2009). Así, en este trabajo se evaluó 
la expresión de la proteína mCherry tanto en cultivo simple, como en co-cultivo con S. 
thermophilus STY-31, mediante medidas espectrofotométricas de la fluorescencia 
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emitida por la bacteria portadora. El crecimiento de la cepa CECT903 fue similar en 
ambas condiciones. Sin embargo, solamente se obtuvo señal fluorescente en la 
condición de co-cultivo, donde el incremento de la señal apareció ligado al crecimiento 
y alcanzó su valor máximo durante la fase estacionaria. Los resultados obtenidos 
mostraron que la regulación de la expresión de la lactacina B se inicia desde el 
comienzo de la fase exponencial. Además, revelaron la existencia de un promotor 
funcional en el fragmento de ADN clonado en pRCR11. En este trabajo, también nos 
propusimos caracterizar este promotor, analizando el inicio de la transcripción mediante 
la técnica de extensión del cebador. Los resultados revelaron dos fragmentos extendidos 
de 185 (el más abundante en co-cultivo) y 187 nucleótidos, correspondientes 
respectivamente a dos posibles sitios de inicio de la transcripción, una citosina y una 
adenina. Con las muestras en co-cultivo con S. thermophilus, se detectaron en la 
posición 185 niveles del fragmento extendido 5 veces superiores a los obtenidos con los 
monocultivos de L. acidophilus. Aguas arriba del sitio de inicio de la transcripción se 
localizaron las cajas -35 (TTGtAa) y -10 (aATAAT) características de promotores 
bacterianos. Además, los dos sitios de inicio de la transcripción están incluidos en uno 
de los brazos de una repetición invertida situada aguas abajo del promotor, característica 
del sitio de unión de un regulador transcripcional y por su localización, característica de 
un represor. La expresión del operón de la lactacina B está controlada por el regulador 
de respuesta RR_1798 (RR) de un sistema de tres componentes (Altermann et al., 2005; 
Tabasco et al., 2009). Así, en condiciones de monocultivo, el RR actuaría como un 
represor impidiendo la unión de la ARN polimerasa al promotor por competición, 
produciéndose bajos niveles de transcripción. Por el contrario, la presencia de otra 
bacteria sería detectada por la histidina kinasa HK_1799 del sistema, que modificaría al 
RR fosforilándolo, inhibiendo la represión transcripcional y provocando un incremento 
en la expresión de lbaB. 
Mi aportación a este trabajo 
Para lograr la consecución de este trabajo científico, mi aportación fue la siguiente. 
Contribuí al estudio de la expresión génica a partir del promotor PlbaB, a la realización 
de las inducciones en co-cultivo y a la extracción de las muestras de ARN para los 
estudios de extensión del cebador. 
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Introduction
Lactobacilli belong to the lactic acid bacteria (LAB) group, 
and traditionally they have been used for fermented food 
production. They are widespread in natural environments 
including niches such as the human and animal gastrointes-
tinal tracts, where they can play important roles as health 
modulators [2, 23]. Thus, they are increasingly used as 
functional food ingredients (probiotics), and as vectors for 
live oral vaccines and drugs [3, 24, 25]. Several Lactoba-
cillus species have been identified to produce bacteriocins, 
some of them have a dual role, acting as inhibitors at high 
concentrations and participating in interspecies communi-
cation or bacterial crosstalk [8].
Due to the increased interest in lactobacilli health 
effects, it is relevant to develop genetic tools that can 
detect regulation in living cells of gene expression such 
as the production of proteins, including enzymes, from 
these bacteria [9, 15]. One strategy is the construction of 
fluorescent proteins to study the effect of lactobacilli in 
the immune system and their localization within the gas-
trointestinal tract [2, 6]. Fluorescent proteins could also 
facilitate the monitoring of these bacteria in biofilm for-
mation and interaction with the host. In addition, fluo-
rescent proteins are used as reporters for transcriptional 
gene expression and regulation. In our previous work, we 
designed a mrfp gene codon, optimized for expression in 
Gram-positive bacteria, from the monomeric variant of 
the ‘mCherry’ red fluorescent protein (RFP) from Dico-
soma sp. [11]. Its use as a reporter in Lactococcus lactis 
and Enterococcus faecalis was validated by the construc-
tion and testing of shuttle vectors based on the pAK80 
plasmid [11]. Additional applications of the mCherry-
derived vectors in these LAB species have been recently 
reported [4, 5].
Abstract Lactobacilli are widespread in natural environ-
ments and are increasingly being investigated as poten-
tial health modulators. In this study, we have adapted the 
broad-host-range vector pNZ8048 to express the mCherry 
protein (pRCR) to expand the usage of the mCherry pro-
tein for analysis of gene expression in Lactobacillus. This 
vector is also able to replicate in Streptococcus pneumo-
niae and Escherichia coli. The usage of pRCR as a pro-
moter probe was validated in Lactobacillus acidophilus by 
characterizing the regulation of lactacin B expression. The 
results show that the regulation is exerted at the transcrip-
tional level, with lbaB gene expression being specifically 
induced by co-culture of the L. acidophilus bacteriocin pro-
ducer and the S. thermophilus STY-31 inducer bacterium.
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In this study, we have constructed a vector based on the 
pSH71 replicon [7, 12], to expand the usage of mCherry for 
analysis of gene expression in Lactobacillus and its usage 
as a promoter probe validated in L. acidophilus.
Materials and methods
Bacterial strains and culture conditions
Lactobacillus acidophilus CECT 903 from the Colección 
Española de Cultivos Tipo (Paterna, Spain) and L. acido-
philus La5 (Chr. Hansen, Hørsholm, Denmark) strains were 
grown in MRS broth (Pronadisa, Madrid, Spain) supple-
mented with 0.05 % l-cysteine hydrochloride (Calbiochem, 
Merck KGaA, Darmstadt, Germany) and 0.2 % Tween 80 
(Oxoid, Hampshire, UK) (MRSCT) at 37 °C. Streptococ-
cus thermophilus STY-31 (Chr. Hansen) was grown in 
ESTY broth (Pronadisa) supplemented with 0.5 % glu-
cose at 37 °C. Escherichia coli DH-5α [21] was grown 
in Luria–Bertani broth at 37 °C with vigorous shaking. 
Streptococcus pneumoniae 708 [18] was grown in AGCH 
medium [17] supplemented with 0.25 % yeast extract and 
0.8 % sucrose at 37 °C without shaking. When necessary, 
chloramphenicol (Sigma-Aldrich, St. Louis, MO, USA) 
was added to the culture medium at a final concentration of 
10 µg mL−1 for E. coli and 5 µg mL−1 for S. pneumoniae 
and L. acidophilus. Plate media were prepared by adding 
agar (Pronadisa) to liquid broth at a final concentration of 
1.5 %.
General DNA manipulation and transformation
The promoter-probe vector and the expression plasmid 
constructed in this work were based on the pSH71 repli-
con [7, 12]. Plasmid pRCR was constructed as follows 
(Fig. 1). Plasmid pNZ8048 [16] was digested with BglII 
and SacI to remove the nisin promoter. The resultant 
3,168 bp DNA fragment, containing the rolling-circle repli-
con of the pSH71 plasmid and the chloramphenicol resist-
ance cat gene, was purified from a 0.8 % agarose gel using 
the QIAquick Gel Extraction Kit (Qiagen Iberia, Madrid, 
Spain). The mrfp gene encoding the mCherry protein [11] 
was amplified from plasmid pTVCherry (National Col-
lections of Industrial and Marine Bacteria, Aberdeen, 
UK) by using the specific primers mCherryF (5′-GGA 
AGATCTTCCCGAATTCCCCGGGGATCCTCTAGAGG 
GATACGCACG AGTTTCAACT-3′) and mCherryR 
(5′-CGCGAGCTCATTTATATAATTCGTCCATGCCAC 
CTGT-3′) to obtain a 801 pb amplicon containing the mrfp 
gene preceded by the multicloning site BglII, EcoRI SmaI, 
XmaI BamHI, XbaI. The PCR product was then digested 
with BglII and SacI restriction enzymes and ligated, with 
T4 DNA ligase (Thermo Fisher Scientific, Waltham, USA), 
to the 3,168 bp fragment from pNZ8048. The resulting 
plasmid, named pRCR (3,960 bp), was established in S. 
pneumoniae 708 by transformation as previously described 
[19]. Transformants were selected for chlorampheni-
col resistance, and the correct nucleotide sequence of the 
insert, containing a multicloning site and the mrfp gene in 
pRCR, was confirmed by DNA sequencing at Secugen S.L. 
(Centro de Investigaciones Biológicas, Madrid, Spain).
The promoter (PlbaB) of the L. acidophilus La5 lactacin 
B gene [22] was cloned upstream of mrfp in pRCR, gen-
erating the transcriptional fusion PlbaB-mrfp in pRCR11. 
To this end, an amplicon was generated using the chro-
mosomal DNA of L. acidophilus La5 as template and the 
primers LBA1797F (5′-AGGAGATCTGCGTACAAAGAT 
GTGGTTAA-3′) and LBA1797R (5′-AGGTCTAGATGAG 
ATTTTTATCTCATTTCAAC-3′) to obtain a 221 pb frag-
ment containing the PlbaB sequence. After digestion with 
BglII and XbaI, the amplicon was introduced into the multi-
cloning site of pRCR, after digestion with the same restric-
tion enzymes. The resulting plasmid pRCR11 (4,166 bp) 
was established in E. coli DH5α by transformation as 
described previously by Hanahan [13]. The presence of the 
transcriptional fusion in pRCR11 was confirmed by DNA 
sequencing with primers LBA1797F and LBA1797R.
Plasmid pRCR11 was transferred to L. acidophilus 
CECT903 cells by electrotransformation as follows. The 
CECT903 strain was grown under aerobic conditions at 
37 °C, without shaking, during 15 h in MRSCT broth sup-
plemented with 1 % glycine. Subsequently, 4 mL of the 
culture were used to inoculate 200 mL of the same fresh 
medium, and grown until it reached an OD600 of 0.3–0.4. 
Cells were collected by centrifugation at 0 °C and 8,600×g 
for 10 min and washed four times with ice-cold electropo-
ration buffer (HEPES 0.1 mM, sucrose 0.5 M, pH 7.5). 
Finally, cells were resuspended in 1.6 mL of ice-cold elec-
troporation buffer. 750 µL of cells and 0.5 µg of plasmid 
DNA were used for electrotransformation. The electropora-
tion conditions were 25 μF, 200 Ω and 2.5 kV in a 0.4-cm 
cuvette, using a Gene Pulser and a Pulse Controller appara-
tus (Bio-Rad, Richmond, CA, USA). After electroporation, 
cells were resuspended in 8 mL of MRSCT broth supple-
mented with 10 mM CaCl2 and 0.5 M sucrose, incubated 
aerobically at 37 °C for 3 h, without agitation, and then 
plated onto MRSCT medium supplemented with 1 % agar 
and chloramphenicol.
Induction assay and determination of fluorescence
Induction of expression of mCherry from the PlbaB promoter 
in L. acidophilus CECT903[pRCR11] cells was assayed by 
co-culturing L. acidophilus CECT903[pRCR11] with the 
inducer Streptococcus thermophilus STY-31 strain [22]. 
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Co-cultures were carried out in MRSCT medium inocu-
lated with 2 % each of L. acidophilus CECT903 [pRCR11] 
and S. thermophilus STY-31 overnight cultures.
The levels of fluorescence of the mCherry encoded by 
pRCR11 and bacterial growth were tested simultaneously 
with the Varioskan Flash system (Thermo Fisher Scientific, 
Waltham, MA, USA), which provides quantitative data 
of cell density via measuring OD at 600 nm and in vivo 
mCherry expression at an excitation wavelength of 587 nm 
and an emission wavelength of 612 nm. Background fluo-
rescence of the control strain (L. acidophilus CECT903 
[pRCR11] without S. thermophilus STY-31 grown under 
the same conditions) was used to normalize the fluores-
cence signals during cultivation. All measurements were 
performed in sterile 96-well optical bottomed microplates 
(Nunc, Rochester, NY, USA) with a final assay volume of 
300 µL per well by using the microtiter plate assay system 
Varioskan Flash. The microplates were incubated for 24 h 
at 37 °C. Measurements were made at 1 h intervals.
Preparation of nucleic acids
For cloning and sequencing experiments, plasmidic DNA 
was purified from E. coli DH-5α by usage of QIAprep Spin 
Miniprep and Midiprep kits (Qiagen, Hilden, Germany) 
or from S. pneumoniae 708 as previously described [21]. 
For primer extension analysis, a culture of L. acidophilus 
CECT903[pRCR11] and the co-culture of L. acidophilus 
CECT903 [pRCR11] and S. thermophilus STY-31 were 
grown to an OD600 of 1.2 and then used for analysis of 
mrfp mRNA. Total RNA was isolated with a Ribolyser and 
Recovery kit from Hybaid (Middlesex, UK) as specified by 
the supplier. The RNAs were checked for the integrity and 
yield of the rRNAs by Qubit™ fluorometer (Invitrogen, 
Fig. 1  Schematic diagram 
showing the construction of 
pRCR and pRCR11. For details, 
see “Materials and methods”. 
Relevant restriction sites are 
shown. Specific genes are: mrfp 
and cat that encode mCherry 
and the protein responsible 
for the resistance to chloram-
phenicol, respectively. PlbaB, 
promoter of the lactacin B 
structural gene of Lactobacillus 
acidophilus La5
pRCR
(3960 bp)
SacI
BglII
EcoRI
SmaI
XmaI
BamHI
XbaI
mrfp SacI
BglII
EcoRI
SmaI
XmaI
BamHI
XbaI
XbaIBglII
PlbaB
BglII SacI
pNZ8048
(3349 bp)
pRCR11
(4166 bp)
SacI
BglII XbaI
PlbaB
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Madrid, Spain) and by Gel Doc 1000 (Bio-Rad). The pat-
terns of rRNAs were similar in all preparations.
Primer extension analysis
Primer extension analysis was performed by a modifica-
tion of the method described by Fekete et al. [10]. The start 
site of lbaB mRNA was detected using the LBABP primer 
(5′-TGAGTTGAAACTCGGTGCGTATCCTCT-3′) labeled 
with 6-FAM at its 5′-end (Sigma-Aldrich). Two hundred 
picomoles of primer were annealed to 40 μg of total RNA. 
Primer extension reactions were performed by incuba-
tion of the annealing mixture with 20 nmol each of dNTP 
(dATP, dGTP, dCTP and dTTP), 200 U of Maxima Reverse 
Transcriptase (Thermo Fisher Scientific, Madrid, Spain) in 
1× reverse transcriptase buffer (Thermo Fisher) in a final 
volume of 50 µL at 50 °C for 60 min. Then, the reactions 
were supplemented with 50 µL of TE (10 mM Tris HCl pH 
8.0, 1 mM EDTA) and purified by treatment with phenol 
(vol:vol) for 5 min at room temperature and ethanol precip-
itation with three volumes of 100 % ethanol in the presence 
of 0.3 mM Na acetate. After overnight storage at −20 °C, 
samples were sedimented by centrifugation at 12,000×g 
for 30 min at −10 °C and resuspended in TE (12 µL).
Detection and quantification of the reaction products 
were carried out in a 8 % polyacrylamide gel containing 
7 M urea. Bands labeled with 6-FAM were detected and 
directly quantified with a FujiFilm Fluorescent Image Ana-
lyzer FLA-3000 (Fujifilm, Düsseldorf, Germany).
For determination of the length of the extended prod-
ucts, the primer extension reactions were further purified 
using Agencourt Clean Seq (Beckam Coulter, Alcoben-
das, Madrid, Spain) and kept frozen at −20 °C until use. 
Samples were separated on an Abi 3730 DNA Analyzer 
(Applied Biosystems, Tres Cantos, Madrid, Spain) cap-
illary electrophoresis instrument using techniques and 
parameters recommended by the manufacturer. A DNA 
sequence of pRCR11 determined by the dideoxynucleotide 
method with unlabeled LBABP primer was included in the 
same capillary in each run to determine fragment length. 
The Peak Scanner version v1.0 (Applied Biosystems) was 
used to screen the data and identify major peaks.
Results and discussion
Plasmids containing the mCherry coding gene
Following the construction and analysis of the pTL family 
of plasmids designed for using mCherry as a reporter in 
LAB [11], we were unable to transfer any of these plas-
mids neither to L. casei and L. acidophilus strains nor to 
S. pneumoniae strains. These pTL plasmids were derived 
from pAK80, which carries, in addition to the erythromy-
cin resistance marker, two origins of replication, one from 
the lactococcal plasmid pCT1138 and the other from the 
E. coli p15A plasmid, and replicates in Gram-positive bac-
teria by the theta mode mechanism [14]. As an alternative, 
and with the aim of developing new tools for gene expres-
sion analysis in lactobacilli, the use of the replicon of the 
L. lactis pSH71 plasmid [7, 12] was investigated. This 
plasmid uses the rolling-circle-type mechanism for repli-
cation, and is characterized by a broad host-range, which 
includes Gram-positive bacteria and E. coli. Therefore, a 
promoter-probe vector (pRCR) and an expression plasmid 
(pRCR11) carrying the synthetic mrfp gene optimized for 
LAB [11] and the chloramphenicol resistance marker were 
constructed (Fig. 1). pRCR was generated by changing a 
DNA fragment of pNZ4048 containing the nisA promoter, 
located between the restriction sites BglII and SacI, by a 
DNA fragment containing the mrfp gene preceded by a 
polylinker to facilitate further cloning of transcriptional 
promoters upstream of the mCherry coding gene. The 
pRCR plasmid was established in S. pneumoniae 708 by 
transformation and selection for chloramphenicol resist-
ance. In addition, as predicted, the plasmid was also able 
to replicate in L. sakei MN1, L. plantarum WCFS1 and E. 
coli DH5α (personal communications by M. Nacher, A. 
Pérez-Ramos and M.L. Mohedano, respectively). Conse-
quently, the resulting vector had kept its broad-host-range 
attribute and had the potential to be used in various LAB 
species.
To evaluate the functional expression of mCherry in lac-
tobacilli, the region located upstream of the lbaB bacteri-
ocin structural gene from L. acidophilus [22] and carrying 
the putative promoter PlbaB was cloned upstream of mrfp in 
pRCR to generate pRCR11. The expression of lactacin B 
in L. acidophilus has been demonstrated to be inducible by 
the co-culture with live target bacteria [22]. The mrfp gene 
was used as reporter to monitor the PlbaB activity during 
the induction of lactacin B production by the transforma-
tion of L. acidophilus CECT 903 with pRCR11. The induc-
tion of bacteriocin expression was assayed by co-cultur-
ing this strain with S. thermophilus STY-31, a previously 
identified inducer strain [22]. The functional expression 
of mCherry under the control of PlbaB and the increase of 
biomass during cell growth were monitored (Fig. 2). The 
results revealed that the growth of L. acidophilus CECT 
903[pRCR11] was very similar in both single and co-cul-
tures. However, the mCherry activity was detected only in 
the presence of S. thermophilus STY-31. Moreover, under 
co-culture conditions the increase of mCherry fluorescence 
correlated with the growth pattern. These results indicated 
that up-regulation of lactacin B expression initiates dur-
ing exponential growth as previously demonstrated [22]. 
The maximum fluorescence levels were detected at the 
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stationary phase (OD600 = 1.3), consequently growth to 
this phase was used for further experiments.
Transcriptional analysis of the influence of co-culture 
with S. thermophilus on lactacin B expression  
in L. acidophilus
Our previous quantitative RT-PCR studies of L. acidophi-
lus La5 lbaB gene expression had shown that in the pres-
ence of S. thermophilus STY-31 an increase of the lbaB 
transcript takes place [22]. Thus, total RNA was extracted 
from L. acidophilus CECT603[pRCR11] cells grown in 
the presence or absence of S. thermophilus STY-31 to sta-
tionary phase and samples were used for primer extension 
analysis performed with a 5-end 6-FAM labeled LBABP 
primer. Analysis of the same volume (6 µL) of both reac-
tions in a polyacrylamide gel detected the extended prod-
ucts encoded by pRCR11 complementary to the lbaB tran-
script in L. acidophilus CECT603[pRCR11] grown in the 
presence or absence of S. thermophilus STY-31 (Fig. 3b). 
In the absence of the inducer two bands with similar inten-
sity were observed, whereas in the co-cultures one more 
prominent and two minor longer extended products were 
observed. The fluorescence of the bands was quantified 
with a fluorescent image analyzer, and the results revealed 
a fivefold induction due to the presence of S. thermophilus 
STY-31 (Fig. 3b).
To determine the length of the extended products and 
the 5-end of the lbaB transcript, the primer extension 
reactions were also analyzed by capillary electrophoresis 
in conjunction with a DNA sequence of pRCR11 gener-
ated with unlabeled LBABP primer (Fig. 3a). Since we 
expected low transcript levels of PlbaB in cells grown 
in mono-culture, we processed 250 nL for the capillary 
electrophoresis experiments compared to 40 nL derived 
from cells grown in co-culture. The pattern of the peaks 
observed (Fig. 3b) correlated with that obtained for 
the labeled bands in the polyacrylamide gel (Fig. 3a). 
The two bands detected in cultures of L. acidophilus 
CECT603[pRCR11] corresponded to extended products 
of 185 and 187 nt, the first being the major band present 
in the co-cultures (Fig. 3b). This result located the 5′-end 
of the lbaB mRNA at a C and A (Fig. 3c), since 6-FAM 
labeled DNA extended products run as if they were, on 
an average, three nucleotides shorter than the dideoxy 
sequencing products [10]. Upstream of the start sites, a 
putative promoter was detected composed of a −35 (TTG-
tAa) and a −10 (aATAAT), these sequences being char-
acteristic for the binding of the vegetative σ factor of the 
bacterial RNA polymerases with an anomalous (too long) 
spacing of 24 nt (Fig. 3c). Moreover, the two start sites for 
transcription are included in one of the arms of the inverted 
repeat characteristic for binding of transcriptional regula-
tors. This location predicts that the binding of a protein 
to the inverted repeat will impair initiation of transcrip-
tion catalyzed by the RNA polymerase. The expression of 
the lactacin B operon is regulated by the response regula-
tor RR_1798 which is part of a three-component regula-
tory system composed of the inducing peptide IP_1800, 
the HK_1799 histidine kinase and the RR_1798 response 
regulator [1, 22]. Thus, it seems that under uninduced 
conditions competition between the RNA polymerase and 
RR_1798 for binding to the upstream region of lbaB gene 
will result in low levels of the transcript starting at the two 
nucleotides G and C. Then, in the presence of bacteria that 
compete for the environmental niche, HK_1799 would 
sense its presence and, by modification of the RR_1798, 
would impair the repression of transcription of lbaB and 
result in an increase of lactacin B levels. We have previ-
ously demonstrated that the production of lactacin B by L. 
acidophilus is controlled by an autoinduction mechanism 
involving a secreted peptide and by co-culture with live 
inducer cells [22]. These characteristics of induction of 
bacteriocin production through autoinduction and co-cul-
ture have been recently described to be widespread among 
bacteriocinogenic L. plantarum strains [20]. The use of 
mCherry as a promoter probe in pRCR11 has allowed us 
to locate the region where the lbaB transcriptional regula-
tion is specifically induced by co-culture of the lactacin B 
producer with the inducing bacteria.
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Fig. 2  Detection of induction of expression of mCherry encoded 
by pRCR11. Fluorescence (relative fluorescence units; triangles) 
and growth (OD600; circles) of cultures of L. acidophilus CECT 
903[pRCR11] (open symbols) and co-cultures of L. acidophi-
lus CECT 903[pRCR11] and Streptococcus thermophilus STY-31 
(closed symbols) grown in MRSCT are depicted. The growth of cul-
tures was monitored at a wavelength of 600 nm. Fluorescence emis-
sion of mCherry was recorded at 612 nm after excitation at a wave-
length of 587 nm
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In conclusion, the rolling-circle-type mechanism for rep-
lication of pRCR has broadened the host-range in LAB of 
the mCherry-based vectors pTLR. Indeed, the promoter-
probe vector pRCR has demonstrated to be suitable for 
characterization of complex promoter induction mecha-
nisms such as those related to bacteriocin production by L. 
acidophilus.
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Resumen 
Las bacterias del ácido láctico (BAL) presentan un amplio metabolismo fermentativo y 
entre sus sustratos se encuentra el sorbitol. Este polialcohol está presente en plantas, 
principalmente en las hojas y frutos de la familia Rosaceae. Es un compuesto de bajo 
contenido calórico y una alta hidrofilia, por ello es altamente utilizado en la industria 
alimentaria y farmacéutica como edulcorante, humectante y estabilizante. Su 
producción a nivel industrial se lleva a cabo principalmente mediante la reducción 
química de la glucosa, aunque en los últimos años ha habido trabajos de ingeniería 
metabólica donde se han utilizado BAL como factorías celulares para la producción de 
sorbitol a partir de otras fuentes de carbono. Además, la absorción del sorbitol en el 
intestino es lenta, por lo que la ingesta de altas dosis puede provocar diarreas. También, 
pueden darse procesos de intolerancia que se ven agravados en pacientes con 
enfermedades intestinales como gastroenteritis, celiaquía o enfermedades inflamatorias 
intestinales. Por ello, el uso de bacterias que sean capaces de metabolizar el sorbitol 
puede tener utilidad probiótica. 
En bacterias, el sorbitol es transportado y fosforilado a sorbitol-6-P mediante un sistema 
de transporte dependiente de fosfoenolpiruvato (PTS), específico para el sorbitol 
denominado PTS
gut
. Los genes que codifican los componentes de este sistema, así como 
los genes involucrados en el metabolismo del sorbitol y su regulación constituyen el 
operón gut. El análisis del genoma de la bacteria Pediococcus parvulus 2.6 productora 
de un (1,3)-β-D-glucano ramificado en posición O-2 (β-glucano) (Capítulo 2 de esta 
tesis) mostró la presencia de este operón en su genoma. El operón gut está compuesto 
de seis genes (gutFRMCBA) que se encuentran bajo el control de una única posible 
región promotora. El gen gutF codifica una sorbitol-6-P deshidrogenasa, capaz de 
transformar el sorbitol-6-P en frutosa-6-P. Los genes gutR y gutM codifican sendas 
proteínas reguladoras. Y los genes gutC, gutB y gutA codifican los componentes EIIC, 
EIIBC y EIIA del sistema de transporte PTS
gut
. Así, en este trabajo se abordó el estudio 
del metabolismo del sorbitol por P. parvulus 2.6, su influencia en la síntesis del β-
glucano, la localización génica del operón y su regulación molecular mediada por las 
proteínas GutR y GutM. 
El estudio metabólico realizado tanto en P. parvulus 2.6 como en su estirpe isogénica 
no productora de β-glucano 2.6NR revelo que: (i) la estirpe 2.6 es capaz de transportar y 
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metabolizar el sorbitol, de manera más eficiente en co-metabolismo con la glucosa, en 
un ambiente ácido y en condición de aireación, donde la acción de una NADH oxidasa 
puede favorecer la formación de NAD
+
, cofactor necesario para la conversión de 
sorbitol-6-P a fructosa-6-P; (ii) posiblemente la glucosa ejerce una represión catabólica 
del metabolismo del sorbitol, iniciando la estirpe 2.6 el transporte y metabolismo del 
sorbitol cuando ha consumido toda la glucosa del medio y (iii) la estirpe 2.6NR es 
incapaz de transportar y metabolizar el sorbitol. 
La utilización del método inmunológico, desarrollado en nuestro laboratorio para la 
detección específica y cuantificación del β-glucano producido por P. parvulus 2.6 
(Capítulo 1 de esta tesis), mostró que esta bacteria es capaz de utilizar el sorbitol como 
precursor para la síntesis del β-glucano, con una eficacia similar a la obtenida a partir de 
la glucosa. En P. parvulus 2.6 se ha descrito la existencia de una enzima glucosa-6-P 
isomerasa que cataliza la reacción reversible de conversión de fructosa-6-P y glucosa-6-
P (Velasco et al., 2007), lo que relaciona la ruta catabólica del sorbitol con la ruta 
biosintética del β-glucano a partir de UDP-glucosa. 
P. parvulus 2.6 contiene tres plásmidos naturales denominados pPP1 (39,1 kpb), pPP2 
(24,5 kpb) y pPP3 (12,7 kpb). P. parvulus 2.6NR fue generada a partir de la cepa 2.6 
por tratamiento con bromuro de etidio y novobiocina (Fernández et al., 1995), que 
produjo la pérdida del plásmido pPP2, portador del gen gtf que codifica la GTF 
glicosiltransferasa responsable de la síntesis del β-glucano. Un análisis de hibridación 
Southern permitió determinar que el operón gut está localizado en el plásmido pPP1 de 
la cepa 2.6, pero no en el plásmido pPP1* de la cepa 2.6NR. El análisis de las 
secuencias de ambos plásmidos mostró que una región de 9.473 pb, que contiene el 
operón gut, no está presente en el plásmido pPP1* de 2.6NR. Flanqueando esta 
secuencia se detectaron genes codificantes de una transposasa y una serin-recombinasa 
que podrían haber estado involucradas en la pérdida del operón gut. En consecuencia, 
nuestra hipótesis actual de trabajo es que durante el proceso de curación del plásmido 
pPP2 también sucedieron procesos de recombinación e intercambio génico entre los 
plásmidos generando la cepa 2.6NR portadora de pPP1*. Sin embargo, para validar esta 
hipótesis es necesario realizar más trabajos. 
Finalmente, nos propusimos estudiar la regulación de la expresión del operón gut de P. 
parvulus 2.6 e inferir la función de las dos proteínas reguladoras GutR y GutM. 
Previamente, la regulación del operón gut fue estudiada en Lactobacillus casei BL23 
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por Alcántara y cols. (2008). Los resultados obtenidos por estos autores demostraron 
que GutR actúa como un activador transcripcional, mientras que la función de GutM era 
incierta, aunque sí se observó que la proteína era necesaria para la expresión del operón. 
La baja homología de los operones gut de P. parvulus 2.6 y L. casei BL23 y de sus 
secuencias operadoras localizadas en las regiones de los promotores transcripcionales, 
nos hizo asumir que no debería existir complementación entre los sistemas de 
utilización del polialcohol en estas BAL. Además, detectamos un operón gut en la 
estirpe Lactobacillus plantarum 90, cuyos productos proteicos presentaban una 
homología del 95-100 % con las proteínas codificadas por el operón de P. parvulus 2.6, 
y los promotores transcripcionales con un 99% de identidad. De este modo, nos 
planteamos realizar el estudio de la regulación del operón gut de P. parvulus 2.6 tanto 
en L. casei BL23 como en L. plantarum 90, clonando distintas regiones de ADN en el 
vector pRCR (construido en el Capítulo 3 de esta tesis) y analizando la expresión de la 
proteína fluorescente mCherry. En primer lugar, se clonó la posible región promotora 
Pgut obteniéndose el vector pRCR16, y a partir de esta construcción se clonó bajo su 
control el gen gutR, el gen gutM o ambos genes obteniéndose, respectivamente, los 
plásmidos recombinantes pRCR17, pRCR18, pRCR19. Las 4 construcciones fueron 
clonadas en Lactococcus lactis MG1363 y posteriormente transferidas tanto a L. casei 
BL23 como a L. plantarum 90. Los resultados obtenidos en L. casei BL23 mostraron 
que no existe complementación entre ambos sistemas, ya que las proteínas reguladoras 
de BL23 no fueron capaces de activar la expresión de la proteína mCherry codificada 
por pRCR16, a partir del promotor Pgut de P. parvulus 2.6. Los estudios de expresión 
génica en las bacterias portadoras de las otras dos construcciones determinaron que, en 
presencia del gen gutR de la cepa 2.6, la expresión a partir de Pgut se activaba, mientras 
que si el gen gutM se encontraba solo no existía activación. Por otro lado, los resultados 
obtenidos con las cepas derivadas de L. plantarum 90 mostraron la complementación 
entre ambos sistemas, y como se inducía en mayor medida la expresión de la proteína 
mCherry en presencia del regulador GutR de P. parvulus 2.6 en multicopia. En este 
sistema, la sobreexpresión de GutM en solitario produjo un efecto deletéreo del 
crecimiento de L. plantarum 90 en las primeras fases de inducción. Sin embargo, en la 
fase tardía de la inducción (a partir de las 5 h) se detectó una mayor expresión de 
mCherry en presencia de GutM que la producida en presencia de GutR. Por otra parte, 
tanto en L. casei BL23 como en L. plantarum 90, la sobreexpresión conjunta de GutR y 
GutM produjo una inducción más moderada de la expresión de mCherry. Todos estos 
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resultados junto con la predicción de la existencia de una posible proteína fusionada 
GutR-M, indican que ambas proteínas interactúan entre sí y son necesarias para la 
regulación de la expresión del operón gut. Sin embargo, para probar esta hipótesis será 
necesaria la realización, en un futuro, de trabajos complementarios. 
Mi aportación a este trabajo 
Para lograr la consecución de este trabajo científico, mi aportación fue la siguiente. 
Contribuí a la realización de todo el trabajo experimental, salvo a la secuenciación 
mediante la técnica de “primer walking” de la región de 11.746 pb en la estirpe 2.6 que 
contiene el operón gut. También realicé el borrador del manuscrito, así como las figuras 
y tablas que contiene. 
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Pediococcus parvulus 2.6 secretes a 2-substituted (1,3)-β-D-glucan with prebiotic and
immunomodulatory properties. It is synthesized by the GTF glycosyltransferase using
UDP-glucose as substrate. Analysis of the P. parvulus 2.6 draft genome revealed the
existence of a sorbitol utilization cluster of six genes (gutFRMCBA), whose products
should be involved in sorbitol utilization and could generate substrates for UDP-glucose
synthesis. Southern blot hybridization analysis showed that the cluster is located in a
plasmid. Analysis of metabolic fluxes and production of the exopolysaccharide revealed
that: (i) P. parvulus 2.6 is able to metabolize sorbitol, (ii) sorbitol utilization is repressed
in the presence of glucose and (iii) sorbitol supports the synthesis of 2-substituted (1,3)-
β-D-glucan. The sorbitol cluster encodes two putative regulators, GutR and GutM, in
addition to a phosphoenolpyruvate-dependent phosphotransferase transport system
and sorbitol-6-phosphate dehydrogenase. Therefore, we investigated the involvement
of GutR and GutM in the expression of gutFRMCBA. The promoter-probe vector pRCR
based on the mrfp gene, which encodes the fluorescence protein mCherry, was used to
test the potential promoter of the cluster (Pgut) and the genes encoding the regulators.
This was performed by transferring by electrotransformation the recombinant plasmids
into two hosts, which metabolize sorbitol: Lactobacillus plantarum and Lactobacillus
casei. Upon growth in the presence of sorbitol, but not of glucose, only the presence of
Pgut was required to support expression of mrfp in L. plantarum. In L. casei the presence
of sorbitol in the growth medium and the pediococcal gutR or gutR plus gutM in the
genome was required for Pgut functionality. This demonstrates that: (i) Pgut is required for
expression of the gut cluster, (ii) Pgut is subjected to catabolic repression in lactobacilli,
(iii) GutR is an activator, and (iv) in the presence of sorbitol, trans-complementation for
activation of Pgut exists in L. plantarum but not in L. casei.
Keywords: Pediococcus parvulus, exopolysaccharides, β-glucans, sorbitol, lactic acid bacteria, probiotic
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INTRODUCTION
Sorbitol, also named D-glucitol, is a six-carbon sugar polyol
widespread in plants, particularly in fruits, such as berries,
cherries, plums, pears and apples. However, sorbitol is
obtained industrially, by catalytic hydrogenation of glucose
or glucose/fructose mixtures. This polyol has a relative sweetness
of about 60% compared to that of sucrose, high-water solubility
and is largely used as a low calorie sweetener, humectant,
texturizer and softener (Zumbé et al., 2001). In addition, sorbitol
is used in the production of pharmaceutical compounds, such as
sorbose and ascorbic acid, and as a vehicle for drug-suspension
(Silveira and Jonas, 2002). Sorbitol has also a potential prebiotic
effect in vivo, since it does not contribute to the formation of
dental caries, is slowly and only partially absorbed in the small
intestine and can reach the colon where it can act as substrate
for bacterial fermentation. Supplementation with sorbitol
resulted in enrichment of lactobacilli in rat colon and cecum
(Sarmiento-Rubiano et al., 2007).
Sorbitol absorption is mediated by dose and concentration.
Doses greater than 30 g can cause water retention, resulting in
osmotic diarrhea, bloating, flatulence, cramping and abdominal
pain (Fernández-Bañares et al., 2009). These doses vary
depending on the condition of the intestinal absorption surface.
In patients with malabsorption, the ingestion of 5–20 g, provoked
diarrhea and gastrointestinal complications (Montalto et al.,
2013). In the colon, this sugar alcohol is metabolized by some
species of Lactobacillus and is also a preferred carbon source for
human intestinal bifidobacteria (Sarmiento-Rubiano et al., 2007).
Furthermore, utilization of sorbitol as a carbon source
has been described in a variety of bacteria within the fila
proteobacteria (Yamada and Saier, 1988; Aldridge et al., 1997)
and firmicutes (Tangney et al., 1998; Boyd et al., 2000; Yebra
and Pérez-Martínez, 2002). Among the firmicutes, there are some
lactic acid bacteria (LAB) with catabolic pathways for sorbitol
metabolism (Rhodes and Kator, 1999; Sarmiento-Rubiano et al.,
2007). These pathways are encoded by genes organized in gut
operons, and include the sorbitol transport system, sorbitol-6-
phosphate dehydrogenase (S6PD) as well as regulatory protein(s),
and those of Lactobacillus casei and Lactobacillus plantarum
have been characterized (Nissen et al., 2005; Ladero et al., 2007;
Alcantara et al., 2008).
Sorbitol is transported into the cells and phosphorylated
to sorbitol-6-phosphate by a phosphopyruvate-dependent
phosphotransferase (PTS) sorbitol system (PTSgut). Each PTS
is composed of two cytoplasmic enzymes, common to the
transport of different compounds (EI and HPr) and of different
membrane-associated enzyme complexes (EII), specific for one,
or several substrates. The genes gutC, gutB and gutA encode the
EII domain of a sorbitol PTS (Alcantara et al., 2008). The gutF
gene encodes a sorbitol-6-P dehydrogenase, which catalyzes the
conversion of sorbitol-6-phosphate to fructose-6-phosphate, a
compound that is introduced into the glycolytic pathway with
NADH regeneration (Nissen et al., 2005). The gutR and gutM
genes encode two regulatory proteins. The role of the GutM and
GutR proteins has been studied in Escherichia coli, operating
GutM as an activator and GutR as a repressor (Yamada and
Saier, 1988). In the firmicutes group, the analyzed gut operons
contain homologs to the gutM and gutR genes, but the role
of GutR regulator is different from that of E. coli. The GutR
of L. casei has been functionally characterized and it has been
shown to be a PTS-controlled transcriptional activator, via a PTS
regulation binding domain (PRD) (Stülke et al., 1998). Also, both
the GutR binding sequence and the PRD domain are conserved
in firmicutes. GutM encodes a highly conserved protein in
firmicutes and in L. casei plays a regulatory role (Alcantara et al.,
2008).
Pediococcus parvulus 2.6 (Werning et al., 2006) (previously
named Pediococcus damnosus) is a lactic acid bacteria isolated
from a ropy cider (Fernández et al., 1995). This LAB
produces a 2-substituted (1,3)-β-D-glucan exopolysaccharide
(EPS) (Dueñas-Chasco et al., 1997), with high molecular mass
(>106 Da), and whose rheological properties showed its potential
utility as a biothickening agent (Velasco et al., 2009). The
presence of this EPS improves some probiotic features of
P. parvulus 2.6, including tolerance to simulated gastrointestinal
conditions and adherence to Caco-2 cell lines and reduces
inflammation-related cytokine levels produced by polarized
macrophages (Fernández de Palencia et al., 2009; Immerstrand
et al., 2010). Moreover, the purified EPS improves the growth,
viability and adhesion capability of probiotic microorganisms
(Russo et al., 2012), also it activates macrophages with anti-
inflammatory effects (Notararigo et al., 2014), and decreases the
levels of the proinflammatory IL8 in human intestine cultures
(Notararigo et al., unpublished data). The draft genome of
P. parvulus 2.6 has been determined (Pérez-Ramos et al., 2016),
and its analysis showed the existence of a putative sorbitol
utilization gut operon in this bacterium. Thus, this current
work focuses on the genomic location, expression and metabolic
involvement of the gut operon of P. parvulus 2.6 in sorbitol
catabolism, as well as its interplay with EPS production by this
bacterium.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The bacteria used in this work are listed in Table 1. Pediococcus
and Lactobacillus strains were routinely grown in de Man
Rogosa Sharpe (MRS) broth (Pronadisa, Madrid, Spain) at
30◦C and 37◦C, respectively. Lactococcus lactis strains were
grown in ESTY broth (Pronadisa) supplemented with 0.5%
glucose at 30◦C. When bacteria carried the pRCR plasmid or its
derivatives the medium was supplemented with chloramphenicol
(Cm) at 5µg mL−1 for L. lactis and at 10µg mL−1 for lactobacilli.
E. coli V517 was grown in LB broth and incubated at 37◦C.
For evaluation of sorbitol utilization, P. parvulus strains were
grown in a MRS broth made by components (de Man et al.,
1960) without glucose, pH was adjusted to 5.2 and the medium
supplemented with 10 mM glucose (MRSG), 30 mM sorbitol
(MRSS) or 10 mM glucose plus 30 mM sorbitol (MRSGS) at 30◦C.
Prior selection of conditions for growth in presence of sorbitol
several tests were performed. First various carbon sources were
tested (10 mM glucose, 10 mM fructose or 10 mM maltose) and
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TABLE 1 | Bacteria used in this work.
Bacteria Plasmid Resistance Characteristics Reference
Pediococcus parvulus 2.6 pPP1, pPP2, and
pPP3
– 2-substituted (1,3)-β-D-glucan producer Pérez-Ramos et al., 2016
P. parvulus 2.6NR pPP1 and pPP3 – Non-EPS-producing strain. Derivative of 2.6
strain by pPP2 plasmid curing
Fernández et al., 1995
Lactococcus lactis subsp. cremoris MG1363 – – Plasmid free type strain used for plasmid cloning Wegmann et al., 2007
L. lactis subsp. cremoris MG1363[pRCR] pRCR CmR Source of promoter probe pRCR containing the
mrfp gene, which encodes the fluorescent
mCherry protein
Mohedano et al., 2015
Escherichia coli V517 8 plasmids
pVA517A through
pVA517H
ND Source of plasmids used as references in agarose
gel analysis
Macrina et al., 1978
Lactobacillus casei BL23 – – Bacteria used for heterologous gene expression Mazé et al., 2010
L. casei BL23[pRCR16] [pRCR16] CmR Derivative of pRCR by cloning of Pgut upstream of
mrfp
This study
L. casei BL23[pRCR17] [pRCR17] CmR Derivative of pRCR16 by cloning of gutR
upstream of mrfp
This study
L. casei BL23[pRCR18] [pRCR18] CmR Derivative of pRCR16 by cloning of gutM
upstream of mrfp
This study
L. casei BL23[pRCR19] [pRCR19] CmR Derivative of pRCR16 by cloning of gutMR
upstream of mrfp
This study
Lactobacillus plantarum 90 1 uncharacterized
plasmid
ND Bacteria used for heterologous gene expression Lamontanara et al., 2015
L. plantarum 90[pRCR16] [pRCR16] CmR Derivative of pRCR by cloning of Pgut upstream of
mrfp
This study
L. plantarum 90[pRCR17] [pRCR17] CmR Derivative of pRCR16 by cloning of gutR
upstream of mrfp
This study
L. plantarum 90[pRCR18] [pRCR18] CmR Derivative of pRCR16 by cloning of gutM
upstream of mrfp
This study
L. plantarum 90[pRCR19] [pRCR19] CmR Derivative of pRCR16 by cloning of gutMR
upstream of mrfp
This study
ND, no determined; CmR, resistance to chloramphenicol.
pH at 6.8, 5.2 or 4.0 and then influence of aeration was evaluated
in presence of 10 mM glucose at either pH 6.8 and 5.2 (results not
show).
For evaluation of mCherry expression, Lactobacillus strains
were grown in a MRSG containing 55 mM (1% w/v) glucose or
in a MRSS containing 55 mM (1% w/v) sorbitol at 37◦C.
Plasmidic DNA Preparations
Total plasmidic DNA preparations of P. parvulus 2.6 and
2.6NR strains were prepared as follows. Bacterial cultures were
grown to an optical density at 600 nm (OD600 nm) of 2.5, and
100 mL of each culture were sedimented by centrifugation at
10,000 × g for 20 min at 4◦C. The cells were resuspended
in 4 mL of a solution containing 50 mM Tris/HCl pH 8.0,
10 mM EDTA, lysozyme (30 mg mL−1) and RNasa A (10 µg
mL−1), and incubated for 30 min at 37◦C. Then, 4 mL of a
solution containing 220 mM NaOH and 1.33% sodium dodecyl
sulfate) were added and samples were incubated for 5 min at
room temperature. Upon addition of 5 M potassium acetate
pH 5.0 (4 mL), samples were centrifugated at 10,000 × g for
15 min at 21◦C. The DNA present in the supernatants was
precipitated, concentrated by addition of 8.7 mL of isopropanol,
sedimented by centrifugation at 10,000 × g for 15 min at 4◦C,
and resuspended in 10 mM Tris, 1 mM EDTA buffer (4.3 mL).
The DNA preparation was deproteinated by treatment with 7.5 M
ammonium acetate (2.7 mL) and phenol (4.3 mL) during 5 min at
room temperature and then sedimented at 10,000 × g for 5 min
at 21◦C. The aqueous phase containing total plasmidic DNA was
further purified by isopycnic CsCl density gradient centrifugation
and dialysis as previously described (López et al., 1989). The
final recovery was 54 µg and 58 µg for 2.6 and 2.6NR DNA
preparations, respectively.
The recombinant plasmids from the lactococcal and
lactobacilli strains were isolated using the High pure plasmid
isolation kit (Roche) as follows. Bacteria were grown until
stationary phase (109 colony forming units mL−1) and 1 mL of
each culture were sedimented by centrifugation at 10,000× g for
10 min at 4◦C. Cells were resuspended in solution I of the kit
supplemented with lysozyme (30 mg mL−1) and were incubated
for 30 min at 37◦C. Then, plasmid isolation were performed
as described in the kit protocol, eluting the plasmidic DNA in
100 µL at approximately 100 ng µL−1.
Sequencing
DNA sequencing was performed by the dideoxy method
at Secugen (Madrid, Spain). The sequencing of the sorbitol
utilization cluster and the flanking regions of pPP1 of P. parvulus
2.6 was performed using total plasmidic DNA preparations
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of the bacterium (see above) with the walking strategy and
the sequence has been deposited in GenBank (accession No
MF766019). The lack of sorbitol cluster in the 2.6NR strain
was confirmed by sequencing of its pPP1 plasmid by using as
substrates a total plasmidic preparation of 2.6NR strain and
either pPP1∗F or pPP1∗R primers (see Table 2) In addition,
in the case of sequencing with pPP1∗F, it was also used as
substrate the product of a polymerization reaction catalyzed
by the bacteriophage 829 DNA polymerase with plasmidic
DNA of P. parvulus 2.6NR and hexamers containing random
sequences.
Construction of pRCR16, pRCR17,
pRCR18, and pRCR19
A region located upstream of the P. parvulus 2.6 gut operon
carrying the putative Pgut promoter and the gutR and gutM
genes was cloned into the promoter probe pRCR vector.
To this end, three DNA regions of pPP1 plasmid were
amplified with Phusion High Fidelity Polymerase (PHFP,
ThermoFisher Scientific) by using a plasmidic DNA preparation
of P. parvulus 2.6 and the primers depicted in Table 2,
which have homology with pPP1 DNA and carry restriction
sites suitable for cloning. Plasmid pRCR16 (Figure 1) was
generated by ligation of the Pgut promoter to the pRCR
promoter probe vector (Mohedano et al., 2015), after double
digestion of both DNAs with BglII and XmaI (New England
Biolabs, Ipswich, MA, United States), with the T4 DNA ligase
(New England Biolabs). Then, between the XmaI and XbaI
restriction sites of pRCR16 three amplicons were independently
cloned, containing gutR, gutM or gutRM, generating plasmids
pRCR17, pRCR18 and pRCR19, respectively. The clonings were
performed in L. lactis MG1363, the ligations mixtures were
used to transform the bacteria by electroporation (25 µF,
2.5 kV and 200  in 0.2 cm cuvettes), as previously described
(Dornan and Collins, 1987) and transformants were selected
in ESTY-agar plates supplemented with Cm at 5 µg mL−1.
The inserts present in the new four recombinant plasmids were
confirmed by automated sequencing. Then, DNA preparations
of pRCR17, pRCR18 and pRCR19 obtained from L. lactis
MG1363 (0.5 µg) were used for transfer to lactobacilli by
electroporation (25 µF, 1.3 kV and 200  in 0.1 cm cuvettes)
as previously described (Berthier et al., 1996) and transformants
were selected in MRSG-agar plates supplemented with Cm at
10 µg mL−1.
Southern Hybridization
Plasmid samples were fractionated by electrophoresis in a 0.7%
agarose gel and DNA molecules were revealed by staining
with ethidium bromide at 0.5 µg mL−1. The image of
the gels was obtained with GelDoc 200 (BioRad) and the
bands were quantitated with the Quantity One 4.5.2 software
(BioRad). The DNA fragments were transferred to a nylon
membrane Biodyne A (PALL Gelman Laboratory, AnnArbor,
MI, United States) by 5 inches Hg of vacuum for 2 h
using the Vacuum Blotter model 785 (Bio-Rad). Internal
regions of gutF, gutR and gutB genes were amplified by PCR
generating amplicons 1, 2, and 3, respectively, in reactions
catalyzed by PHFP, and by using as substrate total plasmidic
DNA preparation of P. parvulus 2.6 and the primer pairs
shown in Table 2. Then, the amplicons were labeled with
digoxigenin-dUTP by using the DIG high prime DNA labeling
and detection starter kit II (Roche, Mannheim, Germany).
Each DIG-labeled DNA probe (25 ng mL−1) was used for
hybridization at 45◦C following the specifications of the kit’s
supplier. The hybridization bands were revealed with the
chemiluminescent substrate CSPD, and the signals were detected
TABLE 2 | Oligonucleotides used in this work.
Primers Sequence (5′- 3′) Utilization Amplicon size (bp)
pts1F TGCGGAAGCGGTTAATCGGCT gutF DNA probea 618
pts1R CCACGACTCTTGCCTCCCGCA
ptsRF CGAACTGGAAGCAACCTGGGA gutR DNA probea 652
ptsRR CCGATGAATAATTGGCGCTGC
ptsBF GGAATGGAAGCTGTTGATGGC gutB DNA probea 643
ptsBR CAACGCCAATCAAGGTCCCGA
pgutBglIIF GAAGATCTACCATATGGCGATAATGAAAA Cloning of Pgut in pRCRa 186
pgutXmaIR TCGCTCCCGGGTCATTTCTTTTC
gutRXmaIF CGTGGTTAACCCGGGAATTTTAGTTG Cloning of gutR in pRCR16a 1952
gutRXbaIR GCTCTAGAAACGCACTGACTAGGATCA
gutMXmaIF TCCCCCCGGGTTAAATCAGTTGATGGA Cloning of gutM in pRCR16a 597
gutMXbaIR GCTCTAGAACAGCCCATAAAGCCC
gutRXmaIF CGTGGTTAACCCGGGAATTTTAGTTG Cloning of gutRM in pRCR16a 2472
gutMXbaIR GCTCTAGAACAGCCCATAAAGCCC
pPP1∗F CATAGTTCACTGGGCTACCA Sequencing of pPP1∗b –
pPP1∗R TAGCGGTGCCTCCCTTTAAT –
aPlasmidic DNA preparations of P. parvulus 2.6 was used as substrate for the PCR reactions. bPlasmidic DNA preparations of P. parvulus 2.6NR was used as substrate
for the DNA sequencing.
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FIGURE 1 | Scheme of construction of plasmids pRCR16, pRCR17, pRCR18, and pRCR19. Maps of these plasmids and of the parental pRCR are depicted. The
pertinent restriction sites are shown, as well as the putative promoter of the gut operon (Pgut ) and the following genes: mrfp, cat, gutR and gutM encoding the
mCherry, a chloramphenicol acetyltransferase, GutR and GutM, respectively.
with the LAS-3000 imaging system (Fujifilm, Stamford, CT,
United States).
Analysis of the Metabolic Fluxes of
P. parvulus and Its EPS Production
P. parvulus 2.6 and 2.6NR strains were grown in either MRSG
or MRSGS under aerobic conditions (shaking at 180 rpm),
at 30◦C during 66 h, and samples were taken at the times
indicated in Figure 2 to monitor growth by determination of
optical density at 600 nm and of acidification of the media by
measuring pH. Also, samples were centrifuged at 16,000 × g for
30 min at 4◦C, and the levels of glucose, sorbitol, lactic acid and
EPS in the supernatants were analyzed. The experiments were
performed in triplicate for each strain and in each condition of
growth.
Analysis of Culture Supernatants by Gas
Chromatography-Mass Spectrometry (GC-MS)
The concentration of glucose, sorbitol and lactic acid was
determined by GC–MS using myo-inositol as internal standard.
For this analysis, myo-inositol (100 µg) was first added to aliquots
of the bacterial culture supernatants. The mixture was lyophilized
and derivatized with 2.5% hydroxylamine chloride in pyridine
for 30 min at 70◦C, to form the sugar oximes. Afterward,
bis-trimethylsilyl trifluoroacetamide (BSTFA) was added and
samples were incubated for 45 min at 80◦C, to form the
trimethylsilylated derivatives. Identification and quantification of
the compounds were performed by GC–MS on a 7980A-5975C
instrument (Agilent, Santa Clara, CA, United States) equipped
with a HP-5MS column (30 m × 0.25 mm I.D. × 0.2 µm
film thickness) with helium as the carrier gas. Injector and
detector were set at 275◦C. Samples (1 µL) were injected
with a split ratio of 1:50 with a temperature program: 80◦C
for 4 min, then 15◦C min−1 to 270◦C and finally 30◦C
min−1 to 310◦C (2 min). The peaks in the chromatograms
corresponding to sugars and lactic acid were identified by
their retention times. Quantifications were calculated using
the peak areas and the calibration standard curve for each
compound.
Quantification of the 2-Substituted (1,3)-β-D-Glucan
Produced by P. parvulus
A competition (ELISA) method for the specific detection
of the EPS synthesized by P. parvulus 2.6, based on
Streptococcus pneumoniae serotype 37 antibodies, was performed
as previously described (Werning et al., 2014). Briefly, the ELISA
assay was carried out in 96-Well Nunc-Immuno MicroWell
MaxiSorp plates (Thermo Fisher Scientific), and the EPS of
P. parvulus 2.6, purified as previously described (Notararigo
et al., 2013), was immobilized in each well (62.5 ng per well).
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FIGURE 2 | Analysis of metabolism of P. parvulus 2.6 (A,B) and 2.6NR (C)
strains. Bacteria were grown in the indicated media. Symbols: OD600 nm (N),
glucose ( ), sorbitol (4), lactic acid (#) and pH (). The experiments were
performed in triplicate and the mean value and standard deviation is depicted.
Culture supernatants [diluted with phosphate-buffered saline
(PBS) pH 7.2 when necessary] were used as competitor for
binding to the primary antibody (dilution 1:800 of anti-
serotype 37, Statens Serum Institut, Copenhagen, Denmark).
Then, primary antibody was conjugated with a secondary
antibody, polyclonal Anti-Rabbit IgG alkaline phosphatase
(Sigma–Aldrich, Saint Louis, MO, United States) diluted
1:25,000, and finally was revealed with p-nitrophenylphosphate
in diethanolamine buffer (Sigma–Aldrich). Reaction signals
were detected with a microtiter plate reader model 680
(Bio-Rad, Hercules, CA, United States), measuring the OD
at 415 nm. Quantification was performed using a standard
curve generated by the competition for the primary antibody
of serial dilutions of the purified P. parvulus 2.6 EPS dissolved
in PBS.
Detection of mCherry Fluorescence in
LAB Carrying pRCR16, pRCR17,
pRCR18, or pRCR19
To detect the expression levels of the mCherry fluorescent
protein, L. plantarum Lp90 strains carrying the pRCR derivatives
were diluted 1:100 and grown in MRS supplemented with
1% glucose in static mode at 37◦C, until mid-exponential
phase. Then the cultures were centrifuged at 9,000 × g for
10 min at room temperature, and the cells were washed with
one volume of PBS pH 7.2 prewarmed at 37◦C. Then, the
bacteria were resuspended in the same volume of MRS broth
supplemented with 1% sorbitol or 1% glucose prewarmed
at 37◦C. Cultures were incubated at 37◦C with agitation of
180 rpm, and samples were taken each hour. Two hundred
microliter of all chilled samples were centrifuged at 9,000 × g
for 10 min at 4 ◦C and cells were washed once with
chilled PBS buffer pH 7.2. Samples were resuspended in
200 µL of PBS buffer pH 7.2 and used to measure the
fluorescence levels of mCherry protein in a 96-Well Nunc
U96 MicroWell plate (Thermo Fisher Scientific) in a Varioskan
Flash equipment (Thermo Fisher Scientific), using 587 and
610 nm wavelengths for excitation and detection of emission,
respectively. In addition, appropriate dilutions were prepared
to estimate culture biomass by measuring the OD600 nm.
Three independent trials were performed and the same fresh
suspensions, without fixing, were used for phase contrast and
fluorescent microscopy analysis with a Leica DM1000 model
microscope (Leica Microsystems, Mannheim, Germany) with a
light source EL6000 and a filter system TX2 ET for detection of
red fluorescence. The microscope was connected to a DFC3000G
camera (Leica Microsystems) with a CCD sensor. Image analysis
was performed using Leica Application Suite X Software (Leica
Microsystems).
To detect the expression of the mCherry fluorescent protein,
L. casei BL23 strains carrying the pRCR derivatives were
grown and processed in the same manner as the L. plantarum
cultures, except that preinoculum cultures were diluted in
MRS supplemented with 1% glucose or 1% sorbitol to an
OD600 nm = 0.1 and then were incubated at 37◦C with agitation
of 180 rpm for 16 h, until they reached early stationary phase.
Then, 1 mL of each culture was centrifuged and washed with
PBS as above. Samples were concentrated five-fold and used to
measure the fluorescence levels and to take fluorescence images
as described above.
Bioinformatic Analysis
The DNA sequence of plasmid pPP1 was analyzed with the
programs included in the DNASTAR Lasergene 12 (DNAstar
Inc. Madison, WI, United States). Homologies of pPP1 DNA
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FIGURE 3 | Analysis of EPS production by P. parvulus 2.6 in MRSGS ( ), (N)
and () and in MRSG (#), (4) and (). (A) Concentration of EPS present in
cultures supernatants is depicted. The results were expressed in mg of EPS
per L or in mmol of glucose per L. (B) The OD600 nm of the cultures is
depicted. (C) Specific EPS concentration is shown and it was calculated as
the ratio EPS concentration/OD600 nm. The experiments were performed in
triplicate and the mean value and standard deviation is depicted
sequences and of its inferred translated products with the NCBI
data bases of the National Center for Biotechnology Information
(NCBI) were analyzed with the Basic Local Alignment Search
Tool (BLAST)1. Multiple sequence alignment of genes and
proteins were performed with Clustalx 2.12 programs.
Transmembrane helices in GutM were predicted using
TMHMM 2.03 (TMpred4) programs. Prediction of secondary
structures in the gut mRNA was accomplished with the mfold 2.3
program5.
RESULTS
Analysis of P. parvulus Sorbitol
Metabolism
Sorbitol could be a substrate for the synthesis of P. parvulus
2.6 EPS and analysis of the DNA sequence of the draft genome
of this bacterium (Pérez-Ramos et al., 2016) with the BLAST
program revealed a putative gut operon, that could be involved
in transport and catabolism of this compound. Therefore, growth
of P. parvulus 2.6 and its isogenic EPS-non-producing (non-
ropy) 2.6NR strain in MRS (without glucose) and MRSS (medium
containing sorbitol) was tested. The 2.6NR strain showed the
same poor growth in both media (Supplementary Figure S1).
However, the presence of sorbitol in the medium significantly
improved the growth of the 2.6 strain (Supplementary Figure S1),
reaching a final OD600 nm of 3.0 in MRSS versus 0.45 in
MRS, indicating that this bacterium was able to utilize sorbitol.
Nevertheless, the growth of P. parvulus 2.6 in MRSS was very
slow and took more than 12 days to reach the final optical density
(Supplementary Figure S1). Therefore, in order to improve the
growth rate of 2.6 strain, the influence of modifying various
parameters in bacterial growth in MRSS was investigated. The
best inferred conditions were the usage of a MRSGS containing
as carbon sources 10 mM glucose plus 30 mM sorbitol, pH= 5.2,
and growth with aeration at 30◦C. Thus, these conditions
were used to investigate a potential interplay between sorbitol
utilization and EPS production by P. parvulus 2.6.
A comparative study of the metabolic fluxes of P. parvulus
strains by analysis of culture supernatants during growth in
MRSG or MRSGS corroborated that 2.6, but not 2.6NR, was
able to ferment sorbitol (Figure 2). Co-metabolism of sorbitol
and glucose by the 2.6 strain resulted in an increase of
2.5-fold in the final biomass estimated by the OD600 nm of the
cultures. Values of 4.48 ± 0.18 in MRGS (Figure 2A) compared
to 1.77 ± 0.06 reached in MRSG (Figure 2B), the latter being
similar to 1.36 ± 0.05 observed for the 2.6NR strain in MRGS
(Figure 2C). In addition, a prolonged exponential growth phase
of the 2.6 strain was observed in the MRSGS medium (50 h
versus 20 h, Figures 2A,B). In the 2.6NR culture supernatants,
the initial sorbitol levels (30 mM) remained constant during the
entire time period of the assays, revealing that this bacterium was
unable to transport sorbitol to the cytosol (Figure 2C). Moreover,
the analysis of the carbon source consumption by the 2.6 strain
1https://blast.ncbi.nlm.nih.gov/Blast.cgi
2http://www.ebi.ac.uk/Tools/msa/clustalw2/
3http://www.cbs.dtu.dk/services/TMHMM-2.0/
4http://embnet.vital-it.ch/software/TMPRED_form.html
5http://unafold.rna.albany.edu/?q=mfold/RNA-Folding-Form
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FIGURE 4 | Detection of plasmids of P. parvulus 2.6 and 2.6NR strains.
Plasmids preparations of P. parvulus strains and of E. coli V517 were analyzed
in a 0.7% agarose gel. (A) The image of the gel. The three samples were run
in the same gel. In (B) the calibration curve for plasmid size determination is
depicted. Symbols: plasmids from E. coli V517 (), plasmids from P. parvulus
strains ().
showed that glucose started to be transported to the cytosol after
2 h of growth, and upon 26 h of incubation the monosaccharide
was undetectable in the culture supernatants (Figures 2A,B).
Furthermore, only after 20 h of incubation did the 2.6 strain
start to internalize the sorbitol and presumably to metabolize it,
because the bacterium did not enter into the stationary phase
until the sorbitol was consumed (Figure 2A). The metabolic
activity of the two strains was monitored by detecting the lactic
acid production, since it is the main metabolic end-product
because pediococci are homofermentative bacteria. The results
showed that the 2.6 strain grown in MRSG (Figure 2B) and the
2.6NR strain grown in MRSGS (Figure 2C) released to the culture
media similar amounts of lactic acid, the maximum levels being
18.45± 0.45 mM and 20.19± 0.42 mM, respectively. By contrast,
the 2.6 strain grown in the presence of both carbon sources
showed a higher lactic acid production, up to 76.03 ± 0.43 mM
(Figure 2A). Correlating with these results, the final pH of the
2.6 cultures in MRSG and of the 2.6NR cultures in MRSGS was
similar (4.81 ± 0.02 versus 4.78 ± 0.02), and higher than that of
the 2.6 cultures in MRSGS (4.23± 0.02).
Furthermore, the EPS production by P. parvulus 2.6 in the
presence or absence of sorbitol was investigated. Significant EPS
levels were detected after 14 h of growth in MRSG and MRSGS
media. Therefore, the data depicted in Figure 3 correspond to
those obtained within the 14–62 h incubation period. The results
revealed that the bacterium produced EPS during the growth
in MRSGS and synthesized higher levels of the polymer in this
medium than in MRSG (Figure 3A). Thus, after 62 h of growth
in MRSG, the 2.6 strain produced 78.6 ± 3.7 mg L−1 of EPS,
while in MRSGS synthesized 180.5 ± 11.8 mg L−1. Additionally,
in order to evaluate the specific efficiency of the EPS production
depending on the carbon source used, the ratio between EPS
concentration and the biomass estimated from the OD600 nm
(Figure 3B) was calculated (Figure 3C). The results showed
that irrespectively of the carbon source, the bacteria had almost
identical efficiency of EPS production, which increased during
the exponential and stationary phases of growth (Figure 3C).
Determination of Genomic Location of
the gut Operon
P. parvulus 2.6 probably carries three natural plasmids, which
were previously named pPP1, pPP2 and pPP3 (Werning et al.,
2006), and we have identified only three plasmid replication
machineries in the P. parvulus draft genome (Pérez-Ramos et al.,
2016). In addition, the P. parvulus 2.6 EPS is synthesized by
the GTF glycosyltransferase encoded by the gtf gene, which is
located in the pPP2 plasmid (Werning et al., 2006). Thus, the
2.6NR strain was generated from 2.6 by pPP2 plasmid curing after
treatment with the DNA intercalating agent ethidium bromide
and the gyrase inhibitor novobiocin (Fernández et al., 1995).
Consequently, given that 2.6NR does not utilize sorbitol, it
was feasible that the gut operon was encoded by pPP2 and
this hypothesis was investigated. First, total plasmidic DNA
preparations of the two Pediococcus strains were purified by
fractionation in a CsCl gradient to eliminate non-supercoiled
(open circles and linear) forms of the plasmids. Then, the purified
plasmidic DNA preparations were analyzed in an agarose gel
(Figure 4). Four and three bands were detected, respectively,
in preparations of the 2.6 and 2.6NR strains. The sizes of the
bands were inferred from their migration using a calibration
curve (Figure 4B) generated with the plasmids of the E. coli V517
strain and are shown in Figure 4A. Two of the bands apparently
were shared by 2.6 and 2.6NR, and were initially ascribed to
the monomeric forms of pPP1 (39.1 kpb in 2.6 and 40.0 kpb in
2.6NR) and pPP3 (12.7 kpb). As expected, pPP2 (24.5 kpb) was
not detected in 2.6NR DNA preparations. Moreover, we could
not ascribe to any plasmid the band with less mobility and a
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FIGURE 5 | Detection of the P. parvulus 2.6 gut operon by Southern blot hybridization. Plasmids preparations of the P. parvulus strains were fractionated by
electrophoresis in agarose gel, transferred to membranes and hybridized for detection of gutF, gutR and gutB with the probes 1, 2, and 3, respectively. (A) Physical
map of the gut operon, including the putative promoter of the gut operon (Pgut ), the operon genes (gutF, gutR, gutM gutC, gutB and gutA), a secondary structure
including the 3′-end of gutR and the 5′-end of gutM (coordinates 3483-3512 in GenBank accession No MF766019) as well as a transcriptional terminator
(coordinates 6103-6027 in GenBank accession No MF766019) downstream of gutA. In addition, location of probes 1, 2, and 3 is indicated. (B) Images of the
corresponding gels and hybridized membranes. The double headed arrows indicate the position of the hybridized bands in the corresponding gel.
theoretical molecular weight of 56.8 kbp that was present in DNA
preparations of both strains. Quantification of the bands from
agarose gels (Figures 5, 6) revealed different proportions of the
plasmidic forms in 2.6 (0.3:5.9:2.5:1.0) and 2.6NR (0.8:1.0:0.0:1.0)
samples.
The gut operon of P. parvulus 2.6 (Figures 5A, 6A) is
composed of six genes, of which gutF encodes a sorbitol-
6-phosphate dehydrogenase; gutRM encodes two putative
regulators; and gutCBA encodes the proteins EIIC, EIIBC
and EIIA which are components of a phosphoenolpyruvate-
dependent sorbitol phosphotransferase system (PTSgut). Thus, to
detect the location of the gut operon, Southern blot hybridization
of total plasmidic DNA preparations was performed using as a
probe internal regions of gutF, gutR or gutB. One hybridization
signal was observed with the three probes at the position of
the 39.1 kb pPP1 plasmid in the 2.6 DNA sample (Figure 5B).
Surprisingly, this plasmid was apparently present in both
P. parvulus strains, but in the 2.6NR DNA sample no signal
was observed. Nevertheless, the results demonstrated that the
gut operon was not located in the pPP2 plasmid, but rather was
carried by the pPP1 plasmid of the 2.6 strain and not of the newly
designated pPP1∗ plasmid of 2.6NR strain.
Analysis of Plasmids pPP1 of P. parvulus
2.6 and pPP1∗ of P. parvulus 2.6NR
The results obtained by Southern blot analysis prompted us
to obtain further information of pPP1 and pPP1∗ plasmids.
Thus, the total plasmidic DNA preparation of the 2.6 strain
was used as a substrate to confirm the sequence of the gut
operon and to determine the unknown nucleotide sequence
of the flanking regions (undetected in the draft genome of
the bacterium) by the dideoxynucleotide method and with the
walking strategy. The sequence of a DNA segment of 11,746 bp
(Figure 6A and GenBank accession No MF766019) was obtained
and its analysis revealed the existence of nine open reading
frames (ORF), in addition to the 6 genes (gutFRMCBA) of
the gut operon (Figure 6A and Supplementary Table S1).
One open reading frame was detected upstream of the gut
operon and was designated tnp, since its product has 100%
identity with a multispecies transposase (Genbank accession
No WP_003606336.1) widely distributed in the Lactobacillaceae
family. Downstream of the gut operon were detected four
ORF named orf1, orf2, orf3 and orf4, which could encode
hypothetical proteins conserved in other LAB. In addition,
the product of the named res gene belongs to the Ser-
recombinase superfamily (cl02788) and specifically to the PinE
conserved protein domain family (COG1961), showing more
than 90% amino acid identity with proteins from oenococci,
lactobacilli and pediococci annotated as Pin-related site-specific
recombinases/DNA invertases. Also, two divergent genes named
tauE and tetR seem to encode a TauE sulfite exporter which
belongs to the TauE conserved domain family (pfam01925) and a
transcriptional regulator belonging to the TetR family (domain
architecture ID 11442015), and both proteins have more than
95% amino acid identity with their homologues in Oenoccocus
oeni and lactobacilli.
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FIGURE 6 | The sorbitol operon and flanking DNA regions of P. parvulus 2.6. (A) Sequenced regions of pPP1 and pPP1∗ plasmids are shown. Genes and ORF are
depicted and homologies at the nucleotide level are indicated (see details in the text). ? Indicates unknown sequence. Homology of regulatory genetic regions (B)
and proteins (C) involved in sorbitol utilization between P. parvulus 2.6, L. plantarum 90 and L. casei BL23 is shown. (B) DNA sequences of: the putative Pgut
promoters (–10 boxes) and the GutR operator of L. casei are underlined; the putative cre sequences for catabolic repression are overlined; also the start codon (ATG)
of gutF gene and the nucleotides between this and the –10 boxes are depicted. Red letters indicate mismatches with the P. parvulus 2.6 DNA sequence. ∗Means
identity of nucleotides. (C) Identity of the amino acid sequence of the Gut proteins from L. plantarum 90 and L. casei BL23 with those of P. parvulus 2.6 is depicted.
Based on the DNA sequence of the gut operon flanking regions
in pPP1, and on the lack of the gut operon in 2.6NR, primers
were designed and used to try to detect if there exists any
identity between pPP1 and pPP1∗ by DNA sequencing. Two
of these, pPP1∗F and pPP1∗R, located respectively upstream
and downstream of the gut operon, provided the desired
information (Figure 6A). A good chromatogram of the DNA
sequencing of pPP1∗ using the 2.6NR plasmidic preparation
and pPP1∗F primer with 100% identity with pPP1 was obtained
until nucleotide 156 in the chromatogram (548 nt in Genbank
accession No WP_003606336.1), then at least two overlapping
sequences were observed (Supplementary Figure S2A), and
it was not possible from this point to deduce a further
correct DNA sequence. This was not the case when DNA
from the 2.6 strain was used as substrate, since a good
chromatogram of the pPP1 DNA sequencing was obtained
(Supplementary Figure S2B). However, the usage of pPP1∗R
allowed not only to determine that the homology between
pPP1 and pPP1∗ starts again at nucleotide 10,021 (in Genbank
accession No WP_003606336.1), but also that upstream of
this position in pPP1∗ there exists a region including a uvrX
putative gene identical to those of other pediococci (i.e., in
pPC892-2 plasmid, Genbank accession No CP021472.1) and
Lactobacilli (i.e., in pH10 plasmid, Genbank accession No
CP002430.1) plasmids, which do not carry orf2, orf3 and
orf4.
With regard to the gut operon of P. parvulus 2.6, the
identity of the region including the genes and the upstream
regulatory regions with the homologues of L. plantarum strains
was 99% (Figures 6A,B) and nucleotides from 694-to 60020
in GenBank accession No MF766019), consequently the amino
acid sequence of the Gut proteins of P. parvulus showed an
identity ranging from 95 to 100%, with those of L. plantarum 90
(Figure 6C). No significant homology at the DNA sequence level
was detected between the characterized operons of L. casei and
those of P. parvulus (Figure 6B and results not shown). However,
presumably due to convergent evolution, homology ranging from
68 to 24% amino acid identity was detected between the Gut
proteins of P. parvulus 2.6 and of L. casei BL23 (Figure 6C).
Analysis of the Gut Operon Regulation
GutR and GutM of P. parvulus could be involved in regulation
of the gut operon expression and upstream of the start codon of
P. parvulus 2.6 gutF gene, a TATAtT sequence was detected that
only deviates one nucleotide from the consensus −10 promoter
region (Figure 6B). Thus, to gain insight into this potential
regulation, complementation studies in heterologous LAB hosts
able to utilize sorbitol were carried out. First, we cloned
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FIGURE 7 | Detection of fluorescence in L. casei BL23 strains at stationary phase. Cultures of the indicated strains in MRSS (sorbitol) or MRSG (glucose) were
analyzed by phase contrast (left panels) or fluorescence (right panels) microscopy.
independently the putative promoter sequence (designated Pgut)
and its upstream region (Figure 6B), as well as the transcriptional
fusions Pgut-gutR, Pgut-gutM and Pgut-gutRM into the pRCR
promoter probe vector (Mohedano et al., 2015) upstream of the
mrfp, generating the pRCR16, pRCR17, pRCR18 and pRCR19
plasmids, respectively (Figure 1). Thus, functionality of the
promoter and influence of GutR and GutM could be detected
by measuring the levels of fluorescence of the mCherry encoded
by the mrfp gene. As hosts to perform the studies, we chose: (i)
the plasmid free L. casei BL23, because its sorbitol utilization
and the regulation of its gut operon is known (Yebra and Pérez-
Martínez, 2002; Nissen et al., 2005; Alcantara et al., 2008) and,
(ii) L. plantarum 90, because we have previously detected in
this bacterium efficient functional expression of mCherry from
a pRCR derivative, without problems of plasmid incompatibility
and that the copy number of the plasmid was 62 ± 2 molecules
per bacterial genome (Russo et al., 2015).
The well characterized transcriptional activator GutR of
L. casei BL23 controls expression of the gut operon of this bacteria
and its operator site upstream of the Pgut has been identified as
well as a catabolite repression element (cre) overlapping the −10
region of the promoter (Alcantara et al., 2008) (Figure 6B). The
P. parvulus 2.6 GutR has only a low homology of amino acids
(24%) with its homologue of L. casei, but like its counterpart
belongs to the BglG transcriptional antiterminators family,
possesses the PRD domain and the DNA helix turn helix binding
domain. Therefore, both proteins could have a similar role.
Alignment of the L. casei and P. parvulus -10 regions revealed
that the upstream regulatory regions of BL23 strain has no clear
homologs in the 2.6 strain (Figure 6B). Consequently, cross
talk between transcriptional signals of P. parvulus and L. casei
regulators should not take place, and influence of the pediococcal
GutR and GutM in expression of Pgut from the 2.6 strain
could be investigated in the BL23 strain without interferences.
Thus, the pRCR derivatives were transferred independently to
the BL23 strain and the recombinant bacteria were grown in
MRS supplemented with either 1% glucose or 1% sorbitol until
stationary phase prior to analysis. Examination of the cultures
by fluorescent and phase contrast optical microscopy revealed
that only bacteria carrying pRCR17 and pRCR19 and grown in
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TABLE 3 | Heterologous expression of components of the P. parvulus 2.6 gut
operon in L. casei BL23 carrying pRCR derivatives plasmids grown in either MRSS
or MRSG.
L. casei strains DNA insert in
pRCR derivatives
Specific fluorescencea
MRSS MRSG
BL23[pRCR16] Pgut 0.14 ± 0.07 0.14 ± 0.01
BL23[pRCR17] Pgut-gutR 5.69 ± 0.44 0.07 ± 0.09
BL23[pRCR18] Pgut-gutM 0.19 ± 0.06 0.11 ± 0.02
BL23[pRCR19] Pgut-gutRM 3.58 ± 0.06 0.05 ± 0.02
aThe specific fluorescence is depicted and it was calculated as the ratio of the
detected fluorescence (5×) and the bacterial biomass estimated from the OD600 nm
of the culture.
presence of sorbitol have fluorescence (Figure 7). In addition,
fluorescence as well as the optical density of the cultures was
measured and the specific fluorescence, referred to the biomass,
was calculated. The fluorescence quantification confirmed that
the Pgut-gutRmrfp, and Pgut-gutRMmrfp transcriptional fusions
are activated upon growth in the presence of sorbitol (Table 3).
Thus, these results revealed that expression from the Pgut
required the activation by GutR and the presence of sorbitol in
the growth medium. Moreover, they indicated that activation by
GutR decreased, when GutM was present (5.69 ± 0.44 versus
3.58± 0.06).
Concerning the L. plantarum 90 host, its GutR has 98%
homology to that of P. parvulus 2.6 (Figure 6C) and the
DNA sequence of the region located upstream of the two
Pgut promoters only differs in one nucleotide (Figure 6B).
Consequently, both operons must have the same regulatory
gene system, which implies that both systems could recognize
each other. Thus, a trans-complementation process was expected
between the regulatory proteins of Lp90 and the promoter
region of 2.6. Therefore, the pRCR derivatives were transferred
independently to the 90 strain and, since a cross talk is more
complex situation, its comprehension required a more detailed
analysis. For this reason, the recombinant bacteria, after growth
in MRS supplemented with 1% glucose, were transferred to
MRS fresh medium supplemented with either 1% sorbitol or
1% glucose and a time course assay of fluorescence and growth
of the cultures was performed. The results revealed that all
recombinant strains became fluorescent, when grown in the
presence of sorbitol and, with the time of incubation the
fluorescence increased (Figure 8 and Table 4). In addition,
analysis of the bacterial growth showed that all cultures in
MRSG have very similar exponential growth rates (ranging
from 0.889 ± 0.059 to 0.803 ± 0.049) and all entered slowly
into stationary phase after 2 h of incubation (Figure 8F and
Table 4). Initial transfer of the cultures to MRSS resulted in
a similar decrease (around 50%) of the growth rate (values
from 0.416 ± 0.045 to 0.495 ± 0.011) during the first 2 h of
induction. Then, probably after consumption of the residual
intracellular glucose or due to the induction process, bacteria
decreased their growth rate to levels ranging from 0.259 ± 0.020
to 0.251± 0.034, besides the 90[pRCR18] (GutM overexpressor),
that after stalling its growth from 2 h to 3 h incubation time
decreased its growth rate to 0.239 ± 0.048, indicating that
overexpression of GutM in absence of high levels of GutR has a
negative impact for the cells. Furthermore, analysis of the specific
levels of fluorescence of the cultures referred to their biomass
(Table 4) showed different levels for the different fusions (Pgut-
mrfp < Pgut-gutRMmrfp < Pgut-gutRmrfp < Pgut-gutMmrfp),
showing that overexpression of GutM provokes the highest
induction of expression from Pgut . In addition, the highest levels
were observed after 4 h of induction for cells carrying either
pRCR17 (22.38± 2.02) or pRCR19 (19.26± 2.10) versus the end
of the incubation (6 h) for cells carrying pRCR16 (14.81 ± 0.66)
and pRCR18 (26.83± 1.83).
Thus, the results revealed a trans-complementation of
the L. plantarum regulatory proteins on expression driven from
the P. parvulus Pgut promoter. Moreover, the results confirmed
the role of inducer of GutR as well as requirement of sorbitol for
expression from Pgut and support that co-expression of GutR and
GutM decrease the activation mediated by GutR.
DISCUSSION
The overall metabolic results obtained here support that
P. parvulus is able to synthesize EPS in MRS medium
using either glucose or sorbitol as carbon sources. We have
previously demonstrated that the 2-substituted (1,3)-β-D-glucan
of P. parvulus 2.6 is synthesized by the GTF glycosyltransferase
utilizing UDP-glucose as substrate (Werning et al., 2014). In
addition, Velasco et al. (2007) determined that the 2.6 strain
transport the glucose by a PMF-permease and possesses the
α-phosphoglucomutase and the UDP-glucose pyrophosphorylase
activities responsible for the conversion of glucose-6-P to
glucose-1-P and further conversion of this compound to UDP-
glucose. Thus, Velasco et al. (2007) showed how the 2.6 strain
uses the glucose, not only for the central metabolism, via
the glycolytic pathway, but also for the secondary metabolism
involving a biosynthetic pathway for its EPS synthesis. In
addition, the detection of the genetic determinants of sorbitol
utilization by the 2.6 strain obtained in this work supports
that the bacterium transports sorbitol by a PTSgut system and
converts sorbitol-6-P into fructose-6-P by the action of sorbitol-
6-P dehydrogenase. Fructose-6-P can be converted to glucose-6-P
by a reaction catalyzed by phosphoglucose isomerase, enzymatic
activity that was also previously detected in the 2.6 strain
(Velasco et al., 2007). Therefore, the 2.6 strain possesses the
transport and enzymatic machineries for synthesis of the EPS
from sorbitol. In addition, we have detected that aeration of
the cultures during the growth improves sorbitol consumption
(results not shown). Accordingly, the conversion of sorbitol-6-
P into fructose-6-P requires NAD+ as an oxidative co-factor
to produce NADH (Zarour et al., 2017). Analysis of the draft
genome of the 2.6 strain showed the existence of a putative
NADH oxidase coding gene. If this enzyme exists, it could
unbalance the NAD+/NADH equilibrium toward the oxidized
form NAD+.
The P. parvulus 2.6 2-substituted (1,3)-β-D-glucan is
composed of molecules of glucose and consequently the
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FIGURE 8 | Trans complementation of the sorbitol utilization regulatory machinery in L. plantarum 90. Bacteria carrying (A,E,F) pRCR16 (,), (B,E,F) pRCR17 (#, ), (C,E,F) pRCR18 (♦, ) or (D,E,F) pRCR19 (4, N) were grown in MRSG and at time 0 were transferred to fresh MRSS (open symbols) or to MRSG (closed
symbols). OD600nm and fluorescence of the cultures were monitored every hour. Overlays of images of the cultures taken at time 0 and after 2, 4, and 6 h incubation
by phase contrast and fluorescent microscopy are depicted. The experiments were performed in triplicate and the mean value and standard deviation is depicted.
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EPS concentration can be calculated as molarity of this
monosaccharide (see secondary Y axis in Figure 3A). This
calculation revealed that in both media this bacterium only
used a small percentage of the substrate molecules (10 mM
glucose plus 30 mM sorbitol in MRSGS or 10 mM glucose in
MRSG) for synthesis of EPS (0.99 or 0.45 mM, respectively),
whereas more than 90% was utilized in the glycolytic pathway to
synthesize pyruvic acid (2 molecules per 1 molecule of substrate)
and by action of the lactate dehydrogenase to finally generate
lactic acid (1 molecule per 1 molecule of pyruvate, 79 mM
or 18 mM). Moreover, the specific quantification method for
2-substituted (1,3)-β-D-glucan used here and the estimation
of the specific concentration of EPS synthesized (Figure 3C)
showed that, using as substrate either glucose or sorbitol, the
bacterium synthesizes the same polymer and suggests that with
the same efficiency. This was not the case when synthesis of
this EPS utilizing fructose was tested, since levels were low
compared with that obtained from glucose (Velasco et al.,
2007). We have also observed a temporal delay of 2.6 to start
to consume sorbitol in MRSGS (Figure 3A). This could be
due to the existence of a catabolite repression of sorbitol
utilization by glucose. Supporting this hypothesis, we have
detected a potential cre operator (Figure 6) for the CcpA, which
mediates with HPR this regulation in firmicutes (Deutscher,
2008).
In P. parvulus 2.6, the gut operon, as in other LAB, constitutes
the genetic determinant for sorbitol transport and conversion
into fructose-6-P. In addition, we have established here that
it is located in a plasmid named pPP1 (Figure 6) which is
unusual, since the almost identical operon of L. plantarum and
that of Lactobacillus pentosus strain SLC13 (82% homologous,
Genbank accession No CP022130.1) as well as the unrelated
one from L. casei are located in the chromosome. As far
as we know, only the location of an unrelated gut operon
in the megaplasmid pMP118 from L. salivarius UCC118 has
been previously described (Claesson et al., 2006). A search of
the protein data banks revealed that L. salivarius 5713 and
JCM1046 strains possess, respectively, the pHN3 and pMP1046A
megaplasmids which carry gut operons homologous to that of
pMP118 (Jiménez et al., 2010; Raftis et al., 2014). Flanking
the operon two inverted repeat sequences (nucleotides 604-
627 and 6612-6635 of Genbank accession No WP_003606336.1)
were identified, which are also present at the same relative
location in L. plantarum strains and at various locations in
lactobacilli chromosomes and plasmids (even more than one
copy per genome). The upstream region is preceded by a tnp gene
encoding a putative transposase, which could be responsible for
mobilization of the gut operon from plasmid to chromosome or
vice versa.
Lactic acid bacteria are prone to carry more than one
compatible plasmid and this facilitates exchange of different
regions with physiological significance, that later on can
be transferred to other bacteria by plasmid conjugation or
mobilization (Cui et al., 2015). Thus, downstream of the gut
operon of pPP1 there are DNA regions almost identical to that
present in plasmids of lactobacilli, which along with P. parvulus
can be contaminants of alcoholic beverages. Furthermore, the
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FIGURE 9 | Predicted folding of the gut mRNA region including the 3′-end of
gutR and the 5′-end of gutM. (A) Secondary structure of the wild-type
P. parvulus 2.6 and L. plantarum 90 gut operons. The arrow and the G
indicate that in the insert of pRCR18 G substitute to the A in the indicated
position. (B) Secondary structure of the L. casei BL23 gut operon.
Oenococcus oeni pOENI-1 and pOENI-1v2 plasmids (Favier
et al., 2012) and pPP1 carry a region containing among
others the res, tauE and tetR genes. The putative TauE sulfite
exporter is possibly involved in adaptation to stress conditions
during alcoholic beverage production (Favier et al., 2012).
Thus, the recombinase or invertase site specific Res could be
responsible for a mobilization of an element composed of a
truncated res, tauE and tetR to a stable location, since at
the 3′-end region of res and downstream of tetR unit exist
inverted complementary sequences 5′-TTTTAAAGC-3′ and 5′-
GCTTTAAAA-3′ (nucleotides 7774–7778 and 10021–10029 of
Genbank accession No WP_003606336.1).
Another instance of plasmids rearrangement in P. parvulus is
that which generated the profile and DNA sequence of 2.6NR
strain plasmids (Figure 6). The initial isolate of 2.6NR strain
generated in the Basque country University (BCU, Spain) and
described in Fernández et al. (1995), kindly provided by Dr.
Maria Teresa Dueñas (BCU) was studied in this work. Thus, the
changes in plasmid cassettes were not produced in our laboratory,
and presumably they took place upon treatment of 2.6 strain with
ethidium bromide and novobiocin and was selected for the loss
of the ropy phenotype. Thus, it is feasible that a formation of
a co-integrate of pPP1 with other plasmid, may be pPP2, took
place and convergent replication from two origins prompted to a
deletion of one of the replicons, may be the pPP2, since its loss
was envisaged, to generate pPP1∗.
Concerning the regulation of expression of the gut operon,
the overall results showed that it is repressed in the absence
of sorbitol in the growth medium and that the P. parvulus
GutR is an activator like the L. casei BL23 regulator (Alcantara
et al., 2008). In this system, it has been proposed that GutM
is involved in the activation, since a decreased expression
of the gut operon was detected in a GutM deficient mutant
(Alcantara et al., 2008). Furthermore, the complementation
studies in L. plantarum 90 performed here showed a heterologous
regulation of gene expression from the pediococcal Pgut promoter
by the GutR from Lactobacillus, and a positive effect when
only the pediococcal GutM was overexpressed (Figure 8 and
Table 4). Thus, these results suggest that a protein-protein
interaction between the P. parvulus GutM and the L. plantarum
GutR could potentiate the activation of the Pgut promoter, since,
P. parvulus 2.6 GutR and GutM have 98% identity with their
homologues of L. plantarum 90. In addition, either in L. casei
BL23 and in L. plantarum a decrease of expression from Pgut was
observed when GutM was overexpressed in combination with
GutR (Figure 8 and Tables 3, 4). This prompted us to analyze
the genetic environment of gutR and gutM. An overlapping of
the last nucleotide of the termination codon (TAA) of gutR
and the first nucleotide of the start codon (ATG) of gutM was
detected in P. parvulus 2.6 and L. plantarum 90 genomes. This
indicated that post-transcriptional regulation of the gut operon
could exist in this bacterium. For this reason, the secondary
structure of the region surrounding the overlapping in the
gut mRNA was folded with the Mfol program (Figure 9A).
A secondary stem-loop structure was predicted with a 1G =
−5.6 kcal mol−1, the ribosomal binding site (RBS) of gutM
(5′-GGAGG-3′) was located at the loop and partially blocked
in the stem of the structure. Thus, even though the sequence
of the RBS of gutM indicates a high efficiency of utilization
for the ribosome, the initiation of translation of gutM could be
partially impaired by the partial RBS blockage, which would be
released by the opening provoked by the passage of the ribosomes
translating gutR. In addition, the overlapping of gutR and gutM
is located at the end of the stem of the structure. Thus, two
post-transcriptional regulations could take place: (i) translation
of gutR can act by favoring translation of gutM by exposition
of its RBS and (ii) a -1 frameshift (Atkins et al., 2016) could
happen at the TAA termination codon of gutR and ribosomes
translating this could step back one nucleotide and upon charging
the corresponding tRNA read the Leu (TTA) codon and continue
translating gutM. In this way a fused peptide GutR-M could
be synthesized. The same structure could be formed in the
transcript encoded by the plasmid pRCR19 with a 1G = −5.9
kcal mol−1, containing gutRM and which could be a substrate for
the two proposed post-transcriptional regulations. Furthermore,
the DNA fragment cloned in pRCR18, lacks most of the gutR
gene but still retains some of the 3′-end region of this gene
and the encoded mRNA can form a secondary structure almost
identical to the wild-type structure (with only a change of A-U by
G-U pairing at the end of the stem, Figure 9). Thus in bacteria
carrying pRCR18 partial blockage of the RBS could take place,
but synthesis of GutR-M could not occur. This could explain
the antagonistic effect of overexpression of gutM from pRCR18
(increase of expression from Pgut) and pRCR19 (decrease of
expression from Pgut), if GutR-M exists and has a role.
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Prediction of transmembrane regions in the regulatory
proteins with the TM-Pred revealed that GutR is a soluble protein
and that the first amino acids from 1 to 21 of GutM constituted
a transmembrane region also predicted for the GutR-M fused
polypeptide. This fused polypeptide could provide an efficient
anchoring of the regulator to the membrane bringing it close
to the PTSgut system facilitating the phosphorylation of GutR
and resulting in the physiological optimal expression of the
operon. This generation of a fused polypeptide could also take
place in L. plantarum but does not seems to occur in L. casei,
since in this bacterium the TAA translational stop codon of
GutR and the ATG start codon of GutM are adjacent and not
overlapped (Figure 9). However, the L. casei gut transcript can
form a secondary structure with a 1G = −9.8 kcal mol−1
which could block the RBS of gutM gene, couple translation of
GutR and GutM could take place, and protein-protein interaction
could be responsible for higher activation of the system at the
beginning of the induction process. Our results indicate that
high levels of GutM synthesized from a multicopy plasmid have
a deleterious effect for the bacteria (Figure 8) and probably
the proposed models of posttranscriptional regulation are
designed to have the right concentration of regulatory proteins.
Nevertheless, further experiments are required to pinpoint the
role of GutM and of the putative GutR-M polypeptide of
P. parvulus.
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Resumen 
En el sector de la acuicultura, los β-glucanos de origen fúngico son ampliamente 
utilizados para la prevención de brotes infectivos de origen bacteriano y vírico. Sin 
embargo, el uso de antibióticos sigue siendo la práctica más habitual, provocando la 
aparición de cepas resistentes y debilitando tanto la microbiota como el sistema inmune 
de estos animales. 
Muchas bacterias del ácido láctico (BAL) forman parte de la microbiota de humanos y 
otros animales, ejerciendo importantes beneficios para su salud y por este y otros 
motivos, a muchas de estas bacterias se las consideran organismos probióticos. Así, a 
nivel del sistema digestivo contribuyen a reestablecer y mantener la homeostasis 
microbiana, a fortalecer de la barrera intestinal, a combatir a los patógenos y a estimular 
el sistema inmune. Además, ciertos biopolímeros como los EPS producidos por BAL, 
son considerados como importantes agentes inmunoestimulantes. De este modo, la 
implementación del uso de probióticos que a su vez produzcan EPS inmunoestimulantes 
puede ser una práctica muy beneficiosa en este campo. Por este motivo, en este trabajo 
se han estudiado las propiedades probióticas de la bacteria P. parvulus 2.6, así como las 
propiedades inmunoestimulantes de su (1,3)-β-D-glucano ramificado en posición O-2 
(β-glucano). Para ello se utilizaron modelos embrionarios de Danio rerio (pez cebra). 
Este modelo ha emergido, por sus numerosas ventajas frente a los modelos in vivo 
tradicionales, como una interesante alternativa para la evaluación de las propiedades 
probióticas de bacterias. Así, en trabajos previos nuestro grupo ya ha utilizado este 
modelo para la evaluación de BAL de las especies Lactobacillus fermentum, 
Lactobacillus plantarum, Lactobacillus sakei y Leuconostoc mesenteroides (Russo et 
al., 2015; Nácher-Vázquez et al., 2017a; Zarour et al., 2018). 
En este trabajo, P. parvulus 2.6 y su cepa isogénica 2.6NR no productora de β-glucano 
fueron marcadas fluorescentemente mediante la transferencia del plásmido pRCR12, lo 
que permitió su detección in vivo en el modelo del pez cebra. El plásmido pRCR12 fue 
desarrollado en nuestro laboratorio a partir del vector pRCR (generado en el Capítulo 3 
de esta tesis), mediante la clonación del promotor neumocócico Px (Russo et al., 2015). 
En las cepas de P. parvulus la presencia de pRCR12 conllevó a la expresión constitutiva 
de la proteína fluorescente mCherry, emitiendo altos niveles de fluorescencia y 
otorgando una coloración rosada intensa a sus colonias. Además, la presencia del 
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plásmido no afectó el crecimiento bacteriano. En este trabajo, también se valoró 
mediante el uso de un modelo in vitro la capacidad de adhesión de las bacterias 
recombinantes a la línea celular humana Caco-2. En un trabajo previo realizado con las 
estirpes parentales, ya se mostró que la cepa 2.6 presenta una mayor capacidad de 
adhesión a los enterocitos, que la cepa 2.6NR (Fernández de Palencia et al., 2009). En 
este trabajo, hemos demostrado que la presencia del plásmido pRCR12 no afecta a la 
capacidad de adhesión de las bacterias. La cepa 2.6[pRCR12] mostró mayor adhesión 
que 2.6NR[pRCR12] a las células eucarióticas intestinales. Para valorar la influencia del 
β-glucano en la adhesión, se cuantificó la cantidad de biopolimero que está presente 
durante los ensayos de adhesión utilizando el método inmunológico desarrollado en el 
Capítulo 1 de esta tesis, y se añadió esa cantidad a los cultivos de la cepa 2.6NR. De 
este modo, la unión a las células Caco-2 de la cepa 2.6NR[pRCR12] aumentó 
significativamente al realizarse el ensayo de adhesión en presencia del β-glucano 
purificado. De igual modo, al eliminar el EPS de los cultivos de 2.6, esta vio disminuida 
su capacidad de adhesión. Estos resultados confirmaron que el β-glucano influye 
favorablemente en la capacidad de adhesión de P. parvulus. 
También, en este trabajo se han utilizado dos modelos embrionarios de pez cebra: (i) un 
modelo gnotobiótico para analizar la capacidad de colonización de las cepas 
recombinantes de P. parvulus, la competición de estas BAL frente a la infección 
producida por Vibrio anguillarum NB10[pOT11], y para la evaluación de la capacidad 
inmunomoduladora de su β-glucano; y (ii) un modelo donde la línea transgénica de pez 
cebra Tg(mpx:GFP) fue sometida a un proceso de inflamación inducida para analizar en 
ella la capacidad anti-inflamatoria del β-glucano. 
Los resultados obtenidos mostraron como P. parvulus es capaz de colonizar el epitelio 
intestinal del pez cebra y como su presencia en el tracto digestivo disminuye con el 
trascurso del tiempo. Además, al igual que sucedía en el modelo in vitro, la presencia 
del β-glucano aumentaba la capacidad de colonización de la bacteria. Por otra parte, el 
pretratamiento de las larvas gnotobioticas con P. parvulus conllevó una disminución de 
la mortandad provocada en el pez cebra por la infección con el patógeno V. 
anguillarum. Este efecto fue superior cuando se utilizó la cepa 2.6[pRCR12] en lugar de 
2.6NR[pRCR12], llegando a reducir en un 50% la mortalidad de las larvas provocada 
por la infección de V. anguillarum a las 72 horas de incubación. 
Chapter 5 
 
103 
Las propiedades inmunomoduladoras del β-glucano se analizaron primero con el 
modelo gnotobiótico, donde las larvas se sumergieron en soluciones del EPS a 150 µg 
mL
-1
 durante 30 horas. El análisis mediante RT-qPCR de la expresión génica de un 
conjunto de genes implicados en la respuesta inflamatoria, mostró que el β-glucano era 
capaz de reprimir la expresión de dos citoquinas pro-inflamatorias, IL8 y TNFα y de la 
proteína acopladora MyD88 (3,4 veces, 2,2 veces y 2,4 veces respectivamente).  
Finalmente, se indujo un proceso inflamatorio en larvas de la línea Tg(mpx:GFP) 
mediante el seccionamiento de la región apical de la cola, y se analizó la migración y 
proliferación de los neutrófilos a través de la cuantificación de la fluorescencia debida a 
la proteína GFP expresada y emitida por estas células de las larvas. Los resultados que 
se obtuvieron revelaron que el β-glucano de P. parvulus tiene un efecto anti-
inflamatorio, ya que las larvas tratadas con el β-glucano presentaban una disminución 
significativa en el reclutamiento de los neutrófilos en la región de inflamación, y su 
proliferación se vio inhibida.  
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Lactic acid bacteria synthesize exopolysaccharides (EPS), which could benefit the
host’s health as immunomodulators. Furthermore, EPS could protect bacteria against
gastrointestinal stress, favoring gut colonization, thus protecting the host against
pathogenic infections. Pediococcus parvulus 2.6, produces a 2-substituted (1,3)-β-
D-glucan and, in this work, its probiotic properties as well as the immunomodulatory
capability of its EPS have been investigated using Danio rerio (zebrafish). To this end
and for a comparative analysis, P. parvulus 2.6 and its isogenic β-glucan-non-producing
2.6NR strain were fluorescently labeled by transfer of the pRCR12 plasmid, which
encodes the mCherry protein. For the in vivo studies, there were used: (i) a gnotobiotic
larvae zebrafish model for bacterial colonization, pathogen competition, and evaluation
of the β-glucan immunomodulation capability and (ii) a transgenic (mpx:GFP) zebrafish
model to determine the EPS influence in the recruitment of neutrophils under an induced
inflammation. The results revealed a positive effect of the β-glucan on colonization of the
zebrafish gut by P. parvulus, as well as in competition of the bacterium with the pathogen
Vibrio anguillarum in this environment. The larvae treatment with the purified β-glucan
resulted in a decrease of expression of genes encoding pro-inflammatory cytokines.
Moreover, the β-glucan had an anti-inflammatory effect, when it was evaluated in an
induced inflammation model of Tg(mpx:GFP) zebrafish. Therefore, P. parvulus 2.6 and
its EPS showed positive health properties in in vivo fish models, supporting their potential
usage in aquaculture.
Keywords: Pediococcus parvulus, exopolysaccharides, β-glucans, lactic acid bacteria, probiotics
INTRODUCTION
Many lactic acid bacteria (LAB) reside in the intestinal tract of vertebrates. In addition,
among these, it has been demonstrated that some strains belonging to the genera Lactobacillus,
Leuconostoc, Streptococcus, and Pediococcus are probiotic, since they have beneficial effects for the
health of the host organism (Guarner et al., 2017). The main mechanisms of action of probiotics
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are to strengthen the intestinal barrier, stimulate the immune
system, or counteract the effects of pathogens through
acidification of the environment, the production of antimicrobial
substances, and competition for nutrients and adhesion to the
epithelium (Guarner et al., 2017).
Many of these LAB produce a wide range of
exopolysaccharides (EPS) that are considered prebiotic
compounds (Salazar et al., 2016). These EPS could reach the
colon where they are selectively fermented by the gut microbiota
increasing beneficial anaerobic bacteria that contribute to the
homeostasis and have beneficial effects on health (Verbeke et al.,
2015). These bacteria and their EPS are used in the development
of functional fermented foods (Zannini et al., 2016; Linares
et al., 2017; Marco et al., 2017). Furthermore, the EPS, especially
β-glucans, can act as immumodulators. β-Glucans are recognized
by pattern recognition receptors such as dectin-1 and Toll-like
receptors activating the NF-κB pathway that lead to the release
of several cytokines (Chan et al., 2009; Lee and Kim, 2014). This
activation stimulates the proliferation of monocytes and the
maturation of dendritic cells and could be involved in anti-tumor
responses (Meng et al., 2016).
Pediococcus parvulus 2.6 is a LAB isolated from Basque
Country cider, whose genome has been determined (Pérez-
Ramos et al., 2016). This bacterium produces a 2-substituted
(1,3)-β-D-glucan of high molecular mass (Dueñas-Chasco
et al., 1997). Evaluation of this bacterium using in vitro
models showed the influence of β-glucan in some probiotic
properties such as adhesion to human enterocyte cell lines and
immunomodulation of macrophages (Fernández de Palencia
et al., 2009). This β-glucan provided enhancement of bacterial
growth and adhesion capability of lactobacilli (Russo et al., 2012),
and was also able to activate human macrophages with an anti-
inflammatory response (Notararigo et al., 2014). Furthermore,
a P. parvulus 2.6 fermented cereal-based matrix, producing
the β-glucan in situ resulted in improved technological and
functional features of the products (Pérez-Ramos et al., 2017a).
Moreover, these β-glucan enriched matrices have a protective
effect and improve the growth of probiotic LAB (Pérez-Ramos
et al., 2017a). Thus, the previous works support the potential of
the P. parvulus 2.6 strain as a component of functional human
food. In addition, we have previously shown that EPS-producing
LAB isolated from meat fermented products have potential as fish
probiotics and its EPS as antimicrobial and immunomodulator
(Nácher-Vázquez et al., 2015, 2017). Therefore, P. parvulus 2.6
strain could also have interest for the fish feed sector.
Fish is a good food for humans, because its proteins are
highly digestible, and it contains vitamins and minerals, and is
the most important source of ω3 lipids, which are important
for reducing cardiovascular risk (Marik and Varon, 2009). Wild
fish is a limited resource on earth, but fish farms could assure
the human supply in the future. To increase the profitability
of aquaculture, one of the most important aspects is to reduce
the cost of feeding. For this aim, in recent years, the use of
feed with 100% vegetable proteins has obtained successful
results. However, the use of these kinds of feeds present certain
problems related to the fish immune system, affecting their
intestinal morphology and producing diseases such as enteritis
and diarrhea. These pathological problems can lead to death
due to bacterial or viral outbreaks, which can cause considerable
economic loss in aquaculture (Subasinghe, 2005; Torrecillas
et al., 2007). To diminish this problem, β-glucans from plant,
fungi, and yeast are widely utilized to avoid the outbreak of
infectious diseases (Meena et al., 2013). Thus, the β-glucan
produced by P. parvulus 2.6 as well as the bacterium itself could
be of interest in aquaculture as an immunomodulant and as a
probiotic, respectively. To prove these potential beneficial effects,
its test in animal models is required. To this end, the zebrafish
model has become a powerful tool for the study of vertebrate
development, immunity, and diseases (Phelps and Neely, 2005;
Goldsmith and Jobin, 2012; Novoa and Figueras, 2012). This
is due to its high fecundity, small size, optical transparency
at the beginning of the developmental stages, availability of
genetic tools, and its immune system that possesses a high
similarity to that of other vertebrates. Moreover, gnotobiotic
zebrafish larvae are relatively easy to obtain and provide a
good model to study bacterial colonization (Rendueles et al.,
2012; Rieu et al., 2014; Russo et al., 2015) or host–pathogen
interaction (Oyarbide et al., 2015) without interference of the gut
microbiota or environmental microorganisms. In addition, the
optical transparency of zebrafish larvae allows the easy detection
of fluorescent-labeled bacteria for studies of host–microbe
interactions (Rieu et al., 2014; Oyarbide et al., 2015; Russo et al.,
2015). Thus, the development of fluorescence reporter systems to
label putative probiotic bacteria is useful for tracking them inside
the animal model used (van Zyl et al., 2015; Landete et al., 2016).
Accordingly, we have developed the pRCR12 plasmid (Russo
et al., 2015) derived from the pRCR promoter probe vector
(Mohedano et al., 2015), which expresses constitutively the red
fluorescent protein mCherry, it is useful for the fluorescent-
labeling and detection of LAB, and it has been already validated
in Lactobacillus acidophilus, Lactobacillus casei, Lactobacilus
fermentum, Lactobacillus plantarum, Lactobacillus sakei,
Lactococcus lactis, and Streptococcus pneumoniae (Mohedano
et al., 2015; Russo et al., 2015; Nácher-Vázquez et al., 2017;
Pérez-Ramos et al., 2017b). Moreover, the fluorescence labeling
of L. fermentum, L plantarum, and L. sakei with pRCR12 has
allowed visualization of these bacteria in the zebrafish gut (Russo
et al., 2015; Nácher-Vázquez et al., 2017).
Thus, in this work, we have labeled P. parvulus 2.6 and its
isogenic EPS-non-producing 2.6NR strains with the pRCR12
plasmid and zebrafish larvae models were used to perform in vivo
a comparative study of the probiotic properties of these strains
as well as of the immunomodulatory properties of the β-glucan
produced by P. parvulus 2.6.
MATERIALS AND METHODS
Bacterial Strains, Growth Conditions,
and Plasmid
The 2-substituted (1,3)-β-D-glucan-producing P. parvulus 2.6
and its isogenic non-producing strain P. parvulus 2.6NR
(Fernández et al., 1995) were used in this work. L. plantarum
90[pRCR12] (Russo et al., 2015) was used as source of plasmid
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pRCR12 to electrotransform the Pediococcus strains. Plasmid
pRCR12 carries a transcriptional fusion of the pneumococcal
Px promoter and the mrfp gene, whose codons are optimized
for expression in LAB, and which encodes a monomeric version
of the red fluorescent protein of Discosoma sp. (Garcia-Cayuela
et al., 2012). LAB were routinely grown at 30◦C in Man Ragosa
Sharpe (MRS) medium (Pronadisa, Spain) supplemented with
chloramphenicol (Cm) at 10 µg mL−1 for growth of strains
carrying pRCR12 plasmid. Escherichia coli V517 is a multiple
plasmid strain (Macrina et al., 1978) used in this work as
standard to determine molecular weight of plasmids, and it
was grown in LB broth (Pronadisa, Spain) at 37◦C. The Vibrio
anguillarum NB10[pOT11] serotype O1 strain used in this work
(O’Toole et al., 2004) was kindly provided by R. O’Toole from
Umeå University. This is a green fluorescent protein (GFP)-
labeled bacterium due to the expression of the inducible tac-
gfpmut2 transcriptional fusion carried by the pOT11 plasmid.
The bacterium was grown at 25◦C in TSB (tryptic soy broth,
Pronadisa) supplemented with Cm at 10 µg mL−1 and 0.5 mM
isopropyl-β-D-thiogalactopyranoside to induce expression of the
GFP protein.
Antibiotic Resistance Profile of
P. parvulus 2.6 and 2.6NR Strains
The bacteria were screened for antibiotics resistance. The
antibiotics recommended by the European Food Safety Authority
(EFSA, 2012) to identify bacterial strains with potential acquired
resistance to antibiotics were analyzed. The antibiotics tested
were: ampicillin, chloramphenicol, clindamycin, erythromycin,
gentamycin, kanamycin, streptomycin, tetracycline, and
vancomycin. The minimal inhibitory concentration (MIC) was
determined by the broth microdilution method reported by the
ISO 10,932/IDF 233 standard (International Organization for
Standardization, 2010). The strains were classified as susceptible
or resistant according to the cut-off values proposed by EFSA
(2012). A bacterial strain was defined as susceptible when its
growth was inhibited at a specific antimicrobial concentration
equal or lower than the established cut-off value and it was
considered resistant when its growth was not inhibited at a
concentration higher than the established cut-off value.
pRCR12 DNA Preparation and Transfer
to P. parvulus Strains
The pRCR12 plasmid from L. plantarum 90 was isolated using
the high pure plasmid isolation kit (Roche) as follows. The
strain was grown to stationary phase [109 colony forming
units (cfu) mL−1] and 1 mL of the culture was sedimented
by centrifugation at 10,000 × g for 10 min at 4◦C. The cells
were resuspended in solution I of the kit supplemented with
lysozyme (30 mg mL−1) and were incubated for 30 min at 37◦C.
Then, plasmid isolation was performed as described in the kit
protocol, eluting the plasmidic DNA in 100 µL at approximately
100 ng µL−1.
P. parvulus 2.6 and 2.6NR strains were electrotransformed
with pRCR12 using the method of Berthier et al. (1996) with
modifications, as follows. Bacterial cultures were grown in MRS
supplemented with 40 mM D-threonine to an optical density
at 600 nm (OD600 nm) of 0.8 (3 × 108 cfu mL−1), sedimented
by centrifugation at 5,500 × g for 10 min at 4◦C, and the cells
subjected to two cycles of resuspension in phosphate buffered
saline (PBS) solution at pH 7.2 and sedimentation as above.
In the case of the 2.6 strain, the bacteria were thoroughly
vortexed during resuspension to remove its β-glucan from the
bacterial surface to facilitate the subsequent incorporation of
plasmidic DNA. Then, the cells were resuspended in 1 mL of
lysozyme solution (final concentration of 2,000 U mL−1) in
PBS pH 7.2 and incubated for 20 min at 37◦C. Afterward,
bacterial cells were sedimented (3,300 × g, 5 min, 4◦C) and
subjected to cycles of resuspension in 1 mL (once in PBS
pH 7.2, twice in 10 mM MgCl2) and once in electroporation
buffer (0.5 M sucrose plus 10% glycerol) and sedimentation
(3,300 × g, 5 min, 4◦C), and the bacteria were resuspended
in the electroporation buffer to a concentration of about
4 × 1010 cfu mL−1. Then, 5 µL of pRCR12 plasmid (0.5 µg)
was added to 50 µL of the bacterial suspension and were
electroporated at 1.8 kV, 600 , and 25 µF in a 0.2-cm
cuvette using a Gene Pulser Xcell with ShockPod cuvette
chamber (Bio-Rad, Hercules, CA, United States), obtaining
a time constant of 12.5–13 ms. Transformants were selected
in MRS-agar supplemented with Cm at 10 µg mL−1. The
obtained recombinant strains were designated 2.6[pRCR12] and
2.6NR[pRCR12].
Growth and Fluorescence Analysis of
P. parvulus Strains 2.6[pRCR12] and
2.6NR[pRCR12]
Growth and red fluorescence emitted by the P. parvulus
strains were monitored simultaneously with the Varioskan Flask
System (Thermo Fisher Scientific, Waltham, MA, United States),
which provides quantitative data of cell density by measuring
the OD600 nm and mCherry expression upon excitation at
a wavelength of 587 nm and detection of emission at a
wavelength of 612 nm. Overnight cultures were diluted in
fresh medium to give an OD600 nm = 0.1 and 300 µL
of each culture was placed in triplicated in a sterile 96-
Well Optical White w/Lid Cell Culture (Thermo Fisher
Scientific, Rochester, NY, United States). The experiments
were performed in triplicate incubating in the Varioskan
at 30◦C and measuring OD and fluorescence at 30 min
intervals.
Fluorescence Microscopy and
Transmission Electron Microscopy
Exponential cultures of P. parvulus strains and V. anguillarum
NB10[pOT11] were sedimented and concentrated fivefold
by resuspension in PBS pH 7.2. Then, without fixing, the
suspension (10 µL) was used for phase contrast and fluorescent
microscopy analysis with a Leica DM1000 model microscope
(Leica Microsystems, Mannheim, Germany) with a light source
EL6000 and the filter system TX2 ET and GFP ET for
detection of mCherry and GFP fluorescences, respectively. The
microscope was connected to a DFC3000G camera (Leica
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Microsystems) with a CCD sensor. The image analysis was
performed using Leica Application Suite X Software (Leica
Microsystems).
Cultures of 2.6[pRCR12] and 2.6NR[pRCR12], prepared
as described for binding to Caco-2 cells assay (see below),
were used for electron microscopy analysis. A drop from
each bacterial solution resuspended in 0.1 M AcNH4, pH
7, was deposited on a carbon film copper grid, which had
previously been hydrophilized by a glow discharge process
for 1 min, and rinsed in water during 15 s. Then, the
grid was stained during 10 s with a uranyl acetate water
solution (0.2% w/v) in order to improve the image contrast,
and finally, rinsed again in water. The sample was air-
dried and examined in a JEOL JEM-1230 microscope (JEOL,
Peabody, MA, United States), operating at an accelerating voltage
of 100 kV.
Production, Purification, and Labeling of
the 2-Substituted (1,3)-β-D-Glucan
The β-glucan of P. parvulus 2.6 was produced and purified
by ethanol precipitation, dialysis, and chromatographic
fractionation as previously described (Notararigo et al., 2013).
5-([4,6-Dichlorotriazin-2-yl] amino fluorescein hydrochloride
(DTAF; Sigma-Aldrich) was used to fluorescently label the
β-glucan; 1.6 mg of DTAF and 4 mg of β-glucan were dissolved
in 2 mL of 0.1 M borate buffer, pH 9. The mix was incubated
for 16 h at 25◦C under an agitation of 600 rpm. The solution
was dialyzed for 1 day against distilled water (changed twice),
using a dialysis membrane having a cut-off of 12–14 kDa.
After dialysis, the solution was frozen at −80◦C, lyophilized,
and kept at room temperature until its use for detection in
zebrafish gut.
Quantification of the 2-Substituted
(1,3)-β-D-Glucan
To determine the total concentration of the β-glucan produced
by P. parvulus strains, bacteria were grown in MRS medium
until late exponential phase (OD600 nm = 3.0). Then, after
vortexing to release the β-glucan attached to the bacteria,
the bacteria were sedimented by centrifugation (16,000 × g,
10 min, 4◦C), and the β-glucan present in the supernatants
was quantified using a competition ELISA method (Werning
et al., 2014). This method is based on the S. pneumoniae
serotype 37 antibodies that can recognize specifically this
bacterial β-glucan. The purified β-glucan of P. parvulus 2.6 was
immobilized in each well of a 96-Well Nunc-Immuno MicroWell
MaxiSorp plate (Thermo Fisher Scientific, Roskilde, Denmark)
and used to compete with the β-glucan presented in the culture
supernatants for binding to the primary antibody (antiserotype
37, Statens Serum Institut, Copenhagen, Denmark). The whole
assay was carried out as previously described (Werning et al.,
2014).
The ELISA method was also used to determine the
concentration of β-glucan attached to the producing bacteria,
with or without its removal, that were used for the adhesion
assays to Caco-2 cells (see details above). Bacteria grown and
treated as described above were resuspended in PBS pH 7.2 prior
to direct determination of β-glucan concentration.
Plasmid Analysis and Detection of the
gtf Gene by Southern Hybridization
With the aim of confirming the lack of plasmid rearrangements
after transfer of pRCR12, the total plasmidic DNA of the
P. parvulus parental and recombinant strains was obtained
and location of the gtf genes was analyzed by Southern blot
hybridization. Total plasmid DNA preparations of P. parvulus
strains were obtained and purified by isopycnic CsCl density
gradient to eliminate non-supercoiled forms of the plasmids
as previously described (Pérez-Ramos et al., 2017b). Plasmid
samples were fractionated in a 0.7% agarose gel and DNA
molecules were revealed by staining with ethidium bromide at
0.5 mg mL−1. The images of the gel were obtained with the
GelDoc 200 equipment and the Quantity one 4.5.2 software (Bio-
Rad, Laboratories Ltd., Alcobendas, Spain). For Southern blot
hybridization, the DNA fragments were transferred to a nylon
membrane as previously described (Pérez-Ramos et al., 2017b).
An internal region of 598 bp of the gtf gene was amplified
as previously described (Werning et al., 2006) by PCR with
primers GTFSF (5′-TTGCCAGAACTAGAGAAAGTACGCA-
3′) and GTFSR (5′-ACTTCCTATTTTAGCTAAAAAGCAA-3′)
using as substrate a total plasmidic DNA preparation of
P. parvulus 2.6. The amplicon was labeled with digoxigenin-
dUTP by using the DIG high prime DNA labeling and detection
starter kit II (Roche, Mannheim, Germany) and the hybridization
was performed as previously described (Pérez-Ramos et al.,
2017b). The signals were detected with the LAS-3000 imaging
system (Fujifilm, Stamford, CT, United States).
Adhesion of P. parvulus Strains to
Caco-2 Cells
The Caco-2 human enterocyte cell line, obtained from the
cell bank at CIB, was seeded in 96-well tissue culture plates
(Falcon MicrotestTM, Becton Dickinson, Franklin Lakes, NJ,
United States) at a final concentration of 1.25 × 105 cells
mL−1 and grown as mono-layers of differentiated cells for 14
days as previously described (Nácher-Vázquez et al., 2017). Cell
concentrations were determined as previously described (Garai-
Ibabe et al., 2010).
To test the adhesion, overnight cultures of P. parvulus strains
were diluted to give an OD600 nm = 0.1 at 30◦C and grown for 20 h,
until late exponential phase. Then, samples of the Pediococcus
strains were sedimented by centrifugation (9,300 × g, 10 min,
4◦C), gently resuspended in PBS pH 7.2, and sedimented as
before. In addition, with the aim of removing the EPS present on
the surface of the P. parvulus 2.6[pRCR12] cells, a fraction of its
bacterial culture designated 2.6p∗ was thoroughly vortexed prior
to sedimentation as above and further subjected to two cycles of
resuspension in PBS and sedimentation. Afterward, the bacterial
samples were resuspended in Dulbecco’s Modified Eagle Medium
(DMEM, Invitrogen) at a concentration of 1.25 × 106 cfu mL−1
and added to the Caco-2 cells in a final volume of 0.1 mL per well.
After incubation for 1 h at 37◦C in an atmosphere containing 5%
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CO2, unattached bacteria were removed by three washing with
0.2 mL of PBS pH 7.2. Then, Caco-2 cells were detached from the
well by incubating with 0.1 mL of 0.05% (w/v) trypsin-EDTA for
5 min at 37◦C. The reaction was stopped by addition of 0.3 mL of
PBS pH 7.2. To determine the number of cell-associated bacteria,
appropriate dilutions were plated onto MRS-agar supplemented
with Cm at 10µg mL−1. Three independent adhesion assays were
performed in duplicate.
Animal Husbandry
Zebrafish embryos were obtained from wild-type adult zebrafish
(Danio rerio, Hamilton, 1822), which were bred and maintained
in the AZTI Zebrafish Facility (REGA number ES489010006105;
Derio, Spain) as previously described (Russo et al., 2015)
following standard conditions (Sullivan and Kim, 2008). During
experimentation, the fish were maintained at an average density
of 1.3 animals per mL in sterile petri dishes housed in an
air incubator at 27◦C on a 12 h light cycle. All experimental
procedures were approved by the Regional Animal Welfare Body
(Project ENVIPHAGE, NEIKER-OEBA-2015-004).
Production of germ-free zebrafish was performed as
previously described (Oyarbide et al., 2015). Briefly, embryos
were washed with a sterilized embryo wash buffer (EWB)
solution [embryo water (EW) solution (CaCl2 at 220.5 mg L−1,
MgSO4 7 H2O at 92.5 mg L−1, NaHCO3 at 47.3 mg L−1, and
KCl at 4.1 mg L−1) supplemented with methylene blue 0.01%
(w/v)], antibiotic solution (kanamycin 15 µg mL−1, ampicillin
300 µg mL−1, and amphotericin B 1.25 µg mL−1), and 0.02%
(w/v) polyvinylpyrrolidone for 2 min. Then, washed with 0.003%
(v/v) bleach solution for 1 h and finally washed with EWB
solution. Afterward, the embryos were incubated overnight in
antibiotic solution. The following day 50 embryos were collected
and transferred to a Petri dish (5.5 cm diameter × 1.0 cm) to
be immersed in 5 mL EWB solution and treated with two UV
light pulses of 1.6 kV (Pulsed UV System XeMatica 1:2L-SA,
SteriBeam Systems, GmbH) to inactivate bacteria present in the
sample. The entire procedure was carried out inside a laminar
flow cabinet to maintain sterile conditions; sterile solutions and
materials were also used. Sterility was routinely tested after four
days post fertilization (dpf), by culturing on general aerobic and
yeast and molds culture media (Petrifilm aerobic, and Petrifilm
yeast and molds count plates, 3 M).
Zebrafish Gut Colonization by P. parvulus
2.6[pRCR12] and 2.6NR[pRCR12] Strains
Cultures of P. parvulus strains were grown and treated in the
same way as for the Caco-2 cells adhesion assays. Groups of 40
gnotobiotic zebrafish larvae at 4 dpf were placed into each Petri
dish and were incubated with 30 mL of EW solution containing
one of the bacterial strains at 5 × 107 cfu mL−1. Larvae were
incubated at 28◦C with agitation (60 rpm) for 18 h. Then, the
larvae were transferred to other sterile Petri dishes and the
bacteria adhered to their surface were eliminated by washing
them five times with PBS pH 7.2, and maintained in 30 mL
of the same buffer. After, 6, 24, and 48 h post exposure (hpe),
larvae were euthanized with tricaine at 300 mg mL−1, and were
individually visualized using a Leica MZFL III stereomicroscope
(LeicaMicrosystems GmbH, Wetzlar, Germany) with a zoom
magnification range of 8× to 100×. The microscope was
equipped with a visible light and an ultraviolet light (Hg 100 W)
source. mCherry fluorescence was detected by exposure of the
larvae to ultraviolet light in the excitation range of 540–580 nm.
Images were captured using a Leica DFC 360FX camera and
processed with the LAS-AF (Leica Microsystems GmbH). In
addition, three pools of five larvae of each treatment were washed
twice in PBS containing 0.1% tween 20 to remove bacteria loosely
attached to the skin, once with PBS pH 7.2, and finally were
resuspended in 0.4 mL of the same buffer. Then, larvae were
mechanically homogenized with a Pellet Pestle Cordless Motor
(Kimble Chase Life Science and Research Products LLC), and the
solutions obtained were plated onto MRS supplemented with Cm
10µg mL−1 plates. Bacterial cfu were counted after incubation at
30◦C for 48 h. Three independent experiments were performed.
P. parvulus 2.6[pRCR12] and
2.6NR[pRCR12] Strains Activity Against
V. angillarum NB10[pOT11] in the
Zebrafish Model
Groups of 20 gnotobiotic zebrafish larvae at 4 dpf were pre-
treated with either 2.6[pRCR12] or 2.6NR[pRCR12] strains as
described above for 18 h. Then, the larvae were infected with
bacterial solutions of V. anguillarum NB10[pOT11] previously
grown during 16 h, sedimented by centrifugation (9,300 × g,
10 min, 4◦C), and subjected to two cycles of resuspension in
EW solution containing 0.5% NaCl and sedimentation as before.
Finally, they were resuspended in EW to give a solution of 108 cfu
mL−1. Also, 20 gnotobiotic zebrafish larvae were infected with
V. anguillarum without bacterial pre-treatment, and used as a
positive infection control. In addition, 10 gnotobiotic zebrafish
larvae were incubated in the absence of LAB and V. anguillarum,
and used as a control of lack of mortality in the absence of
infection. Larvae were individually placed into wells of 24-well
plates with 1 mL of V. anguillarum solution. Bacterial solution
was changed every 24 h and the infection was extended for 72 h.
Mortality was examined at 24, 48, and 72 h post infection (hpi).
Three independent experiments were performed in triplicate.
Antimicrobial Activity of P. parvulus
Strains Against V. anguillarum Tested
in Vitro
An agar spot test and a well diffusion assay were used, according
to Schillinger and Lucke (1989). For the spot test, overnight
cultures of Pediococcus strains were spotted (5 µL) onto the
surface of MRS-agar plates, and incubated for 30 h at 30◦C
to allow colonies to develop. Approximately 5 × 107 CFU
of V. anguillarum were inoculated into 10 mL of TSB-agar
(containing 1% agar) and poured over the plates on which
Pediococcus strains were grown. The plates were incubated for
24 h at 25◦C and checked for inhibition zones. For the well
diffusion assay, overnight cultures of Pedioccocus strains were
sedimented by centrifugation (10,000 × g, 15 min at 4◦C).
Supernatants were recovered and the pH was measured. Then,
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an aliquot of the supernatants was adjusted to pH 6.5 with
3 M NaOH and sterilized by 0.22 µm pore-size Minisart R©
syringe filters (Sartorius stedim biotech, Gotinga, Germany).
Approximately 5 × 107 CFU of V. anguillarum were inoculated
into 10 mL of TSB-agar and poured over sterile plates. After
solidification, wells of 3 mm of diameter were made in the
agar plates; 60 µL of the supernatants with pH adjusted, or
without, were placed into the wells; 0.1 M HCl and MRS medium
were used as positive and negative controls, respectively. The
plates were left at 4◦C for 2 h to allow diffusion of the tested
supernatants and then incubated for 24 h at 25◦C. The absence
and presence of inhibitory zones around the wells were recorded.
Immunomodulation of Gnotobiotic
Zebrafish Larvae by the P. parvulus 2.6
β-Glucan
To show if the β-glucan enters inside of the zebrafish gut, five
gnotobiotic larvae at 4 dpf were submerged in a solution of
DTAF-labeled β-glucan at 150 µg mL−1 during 16 h. Then, the
larvae were washed and after 6 h they were visualized using the
Leica MZFL III stereomicroscope and the DTAF fluorescence was
detected by exposure of the larvae to UV light in the excitation
range of 450–490 nm. For the immunomodulation assay, groups
of 20 gnotobiotic zebrafish larvae at 4 dpf were submerged in
EW containing β-glucan at 150 µg mL−1 (treated) or in EW
(control) solutions during 30 h. Then larvae were frozen in
liquid nitrogen and total RNA was extracted using Trizol Reagent
(Invitrogen Life Technology, Merelbeke, Belgium) according to
the manufacturer’s instructions. The quantity and quality of
RNA samples were determined by capillary electrophoresis, using
an Agilent 2100 Bioanalyzer (Agilent Technologies, las Rozas,
Spain); 20 ng of each RNA sample was used to synthesize cDNA
with the oligo d(T)16 in a reverse transcription reaction with
the TaqMan R© Reverse Transcription kit (Applied Biosystems
Life Technology, Belgium) and following the instructions of the
manufacturer. Changes in mRNA expression of several genes,
related to the innate immune system, were monitored by real-
time qPCR, performed with SYBR Green PCR master mix (Roche
Diagnostics, Rotkreuz, Switzerland) on a Roche LightCycler R© 96
Instrument. The gene tested and the sequences of the primers
used are listed in Table 1. The reaction conditions were: 95◦C
for 10 min followed by 40 cycles of 95◦C for 10 s and 60◦C for
30 s, and a dissociation step of 95◦C for 1 min, 65◦C for 1 min,
and 95◦C for 15 s. The mean CT of each sample was normalized
against the housekeeping genes (β-actin and elongation factor 1)
and the corresponding control. The relative quantification of each
gene was calculated by the 2−11CT method, using the REST 2009
software (Qiagen, Hilden, Germany).
Evaluation of P. parvulus 2.6 β-Glucan in
a Model of Induced Inflammation of
Zebrafish
The zebrafish transgenic line Tg(mpx:GFP)i114 (Renshaw et al.,
2006) whose neutrophils are GFP-labeled was used to make
an induced inflammation model. β-glucan of the 2.6 strain
purified as described in Section “Production, Purification, and
Labeling of the 2-Substituted (1,3)-β-d-Glucan” was dissolved in
EW solution at 150 µg mL−1.The inflammation was induced
on 14 larvae at 3 dpf by cutting off the apical region of
their tails. Then, the larvae were divided into two groups and
immediately individually submerged in EW containing β-glucan
(treated) or in EW (control) solutions. Fluorescence images
of each larva were taken at 0, 4, 8, and 24 h using the
Leica MZFL III stereomicroscope and the GFP fluorescence
was detected as indicated above for DTAF. The Images were
processed and analyzed using the ImageJ 1.51w software
(National Institute of Health, Maryland, United States). Three
independent experiments were performed.
Statistical Analysis
In the Caco-2 cells adhesion assays as well as gut colonization and
Vibrio infection analyses, the data are expressed as mean ± SD
calculated from three independent experiments. The data were
subjected to one-way analysis of variance (ANOVA) by using
the SAS software. Tukey’s test was employed to determine the
significant differences between the variables at p ≤ 0.05. In
the induced inflammation analysis, the data are expressed in
logarithms as a mean ± SD calculated from three independent
experiments. The two-sample t-test was employed to determine
the significant differences between the control group and the
treated group at p ≤ 0.05.
RESULTS
Construction and in Vitro
Characterization of P. parvulus
2.6[pRCR12] and 2.6NR[pRCR12] Strains
As stated above, previous results indicated the probiotic
potential of the 2-substituted (1,3)-β-D-glucan-producing
P. parvulus 2.6 (reviewed in Pérez-Ramos et al., 2015). In
addition, evaluation of this bacterium and its isogenic non-
producing 2.6NR strain according with the EFSA specifications
revealed that these bacteria were sensitive to all the antibiotics
tested (Supplementary Table S1), and consequently there were
not substrates for horizontal transfer of antibiotic resistance
determinants. Therefore, we envisaged the in vivo evaluation
of these pediococci in zebrafish models. Thus, with the aim
of visualizing pediococci in the gut of the zebrafish larvae,
the 2.6 and 2.6NR strains were fluorescently labeled with the
mCherry protein by transfer of the pRCR12 plasmid. The
resulting recombinant strains were designated 2.6[pRCR12]
(2.6p) and 2.6NR[pRCR12] (2.6NRp) and total plasmid DNA
preparations of these strains were compared with those of
the parental strains by analysis in agarose gels (Figure 1) to
confirm that the genetic manipulations have not affected the
former plasmid content. P. parvulus 2.6 carries three natural
plasmids: pPP1 (39.1 kbp), pPP2 (24.5 kbp), and pPP3 (12.7 kbp;
Pérez-Ramos et al., 2017b), and the 2.6NR strain was generated
from 2.6 by pPP2 plasmid curing (Fernández et al., 1995). Thus,
according with these differences, the plasmidic DNA analysis
revealed that 2.6p and 2.6NRp harbor the expected plasmids and
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TABLE 1 | Oligonucleotides used in qPCR reactions.
Primers Sequence (5′–3′) Gene NCBI ID
ACT-F TGCTGTTTTCCCCTCCATTG Beta actin NM_131031.1
ACT-R TTCTGTCCCATGCCAACCA
EF1-F GCCAACTTCAACGCTCAGG Elongation factor 1 NM_131263.1
EF1-R AGAGATCTGACCAGGGTGGTTC
IL1B-F CATTTGCAGGCCGTCACA Interleukin 1-β NM_212844.2
IL1B-R GGACATGCTGAAGCGCACTT
IL8-F CCCTCTGCTCCATGGGTTAA Interleukin 8 (Chemokine 8) XM_001342570.3
IL8-R CAGGTGATCCGGGCATTC
MyD88-F CACAGGAGAGAGAAGGAGTCACG Myeloid differentiation primary response gen 88 NM_212814.2
MyD88-R ACTCTGACAGTAGCAGATGAAAGCAT
NFKB-F AGAGAGCGCTTGCGTCCTT Nuclear factor kappa B NM_001003414.1
NFKB-R TTGCCTTTGGTTTTTCGGTAA
TLR2-F GGAAGGTGGCACTAAGAGCCT Toll-like receptor 2 NM_212812.1
TLR2-R TGATCGGTCGTGGAGGAGTT
TLR22-F CCAGCTCTCGCCGTACCA Toll-like receptor 22 NM_001128675.2
TLR22-R TTGGGCCAGCGGATGT
TLR4-F GGGAAGTCAATCGCCTCCA Toll-like receptor 4 NM_001121051.1
TLR4-R ACGGCTGCCCATTATTCCT
IL10-F ATATTTCAGGAACTCAAGCGGG Interleukin 10 NM_001020785
IL10-R ACTTCAAAGGGATTTTGGCAAG
TNFa-F ACCAGGCCTTTTCTTCAGGT Tumor necrosis factor alpha NM_212859.2
TNFa-R GCATGGCTCATAAGCACTTGTT
that these bacteria also carry the 4.4 kbp pRCR12 plasmid. In
addition, the plasmidic profiles showed that the establishment
of pRCR12 in these hosts did not modify significantly the ratios
of the natural plasmids. Consequently, it seems that there is no
incompatibility between the replication machinery of pRCR12
plasmid and those of the other plasmids. The pPP2 plasmid
harbors the gtf gene, which encodes the GTF glycosyltransferase
responsible for the β-glucan synthesis (Werning et al., 2006).
Therefore, we searched for the presence of the gtf gene in the
plasmidic DNA samples. A Southern blot hybridization of the
total plasmidic DNA preparations of the four P. parvulus strains
was performed using an internal region of the gtf gene as a
probe. As expected, hybridization signals were observed at the
position of the 24.5 kbp pPP2 plasmid only in the 2.6 and 2.6p
DNA samples (Figure 1).
With regard to the expression of the mCherry fluorescent
protein, P. parvulus 2.6p and 2.6NRp formed bright pink
colonies on MRS-agar medium (Figure 2A), and this coloration
was visible even after incubation of the plates for 16 days
(Supplementary Figure S1). This long-term detection indicated
the stability of mCherry labeling in these hosts. Moreover,
the colonies of the 2.6p strain retained the ropy phenotype
of its parental 2.6 strain (Figure 2A) indicating that both
produce the 2-substituted (1,3)-β-D-glucan. To validate this
hypothesis, supernatants of cultures of both pediococci were used
to determine the concentration of EPS released to the medium
by these strains, using an immunological method for specific
detection of the pediococcal β-glucan. The results revealed a
similar production of the EPS, e.g., at an OD600 nm = 1.0,
114.97 ± 2.58 and 130.95 ± 6.53 mg L−1 for the 2.6 and 2.6p
strains, respectively. In addition, expression of the mCherry
protein was visualized at the cellular level by fluorescence
microscopy. This analysis revealed an intense red color of the 2.6p
and 2.6NRp bacteria, and superimposition of phase contrast and
fluorescent images showed that all bacteria of both populations
were expressing active mCherry protein (Figure 2B).
The use of the recombinant strains 2.6p and 2.6NRp instead
of 2.6 and 2.6NR required that the genetic manipulation did not
drastically affect the bacterial growth. Thus, the growth of the
four P. parvulus strains in liquid medium was analyzed and the
growth rate at the exponential phase was calculated (Figure 2C).
The β-glucan-non-producing 2.6NR strain displayed a higher
growth rate (µ = 0.231 ± 0.024) than that of the 2.6 strain
(µ = 0.182 ± 0.005). The same behavior was observed, when
the growth rate of the recombinant strains was compared
µ = 0.184 ± 0.013 for 2.6NRp strain and µ = 0.174 ± 0.011 for
2.6p strain, but less differences between them were observed, a
good characteristic for further comparative studies of bacteria–
zebrafish interactions. In addition, the 2.6 and 2.6NR strains
grew slightly faster than the corresponding recombinant strains.
This behavior was expected, since only 2.6p and 2.6NRp
were grown in the presence of Cm, because the pRCR12
plasmid confers resistance to this antibiotic. The high level
of expression of the mCherry in the recombinant pediococci
made it possible to analyze in real time, and simultaneously
the growth (Figure 2C) and the fluorescence (Figure 2D) of
the cultures. The levels of the red fluorescence emitted by
the recombinant strains were increasing during the bacterial
growth and remained stable during the stationary phase.
These were similar in both strains and achieved a value of
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FIGURE 1 | Detection of P. parvulus plasmids and gtf gene. Plasmids’ preparations of P. parvulus 2.6, 2.6NR, 2.6p, and 2.6NRp strains and of E. coli V517 were
fractionated by electrophoresis in a 0.7% agarose gel, transferred to a nylon membrane, and the gtf gene detected by Southern blot hybridization. (A) The gel.
(B) The hybridized membrane. The headed and double headed arrows indicate the positions of the covalently closed monomeric forms of the plasmids and the
position of the hybridized bands in the corresponding gel, respectively.
111.27 ± 7.03 for 2.6NRp and of 93.18 ± 2.85 for 2.6p at
OD600 nm = 1.0.
The capacity to adhere to the intestinal epithelium is one
of the properties sought in probiotic bacteria. Therefore, we
have previously investigated adhesion of P. parvulus 2.6 and
2.6NR strains to colon Caco-2 human cells (Fernández de
Palencia et al., 2009), and detected a positive influence of the
β-glucan in bacterial–human cells interaction. In this work, we
had analyzed binding to these enterocytes of 2.6p with (called
2.6p∗) and without mechanical removal of its β-glucan and
2.6NRp alone or supplemented with P. parvulus 2.6 purified
β-glucan (called 2.6NRp+EPS; Figure 3). In these types of
experiments, prior to expose to the eukaryotic cell, the growth
medium of the bacteria has to be removed by centrifugation.
Thus, the β-glucan that remains attached to the bacteria after
sedimentation and resuspension as well as after mechanical
removal was quantified with the specific ELISA method. The
results revealed that during the adhesion assay, the EPS bound
to the 2.6p and 2.6p∗ samples, was at a concentration of 248± 11
and of 3.7 ± 0.1 ng mL−1, respectively. Moreover, as expected,
the immunological assay revealed no detection of the β-glucan
bound to 2.6NRp strain. Furthermore, analysis of the bacteria
by transmission electronic microscopy confirmed the presence
of the EPS bound to the 2.6p cells, the almost complete removal
in the 2.6p∗, and its absence in 2.6NR (insets in Figure 3).
The results of the binding assays showed that the 2.6p strain
had a level of adhesion to Caco-2 cells significantly higher than
that achieved by the EPS-non-producing strain 2.6NRp (4.7
versus 0.4%). These values of binding were similar to those
of the parental 2.6 and 2.6NR strains (6.1 versus 0.2% and
4.7 versus 0.7%, respectively, in Fernández de Palencia et al.
(2009) and in Supplementary Figure S2). Moreover, when the
β-glucan of 2.6p was substantially reduced, the adherence of
this bacterium was similar to that of the 2.6NRp strain (0.6
versus 0.4%). Conversely, when the β-glucan was added to
the 2.6NRp strain, the adherence of this bacterium increased
considerably (2.2 versus 0.4%), confirming that the β-glucan is
directly involved in the adherence of P. parvulus to enterocytes.
Therefore, the overall results demonstrate the suitability of the
2.6p and 2.6NRp strains, rather than the parental strains to
perform validated in vivo studies of zebrafish larvae–pediococci
interactions.
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FIGURE 2 | Comparative analysis of the P. parvulus 2.6, 2.6NR, 2.6p, and 2.6NRp strains. (A) Colony phenotypes of the recombinant and their parental strains as
well as colony lifting of the β-glucan-producing strains. Visualization of bacteria by optical microscopy with an objective of 100×. (B) Overlays of phase contrast and
fluorescence images of the four P. parvulus strains. Analysis of bacterial growth (C) and the red fluorescence emission (D) of the four P. parvulus strains measured
with the Varioskan Flask System.
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FIGURE 3 | Bacterial adhesion to a monolayer of Caco-2 cells. Enterocytes were exposed independently to four bacterial solution containing: (i) 2.6p strain, (ii) 2.6p∗
treated to remove most of the β-glucan, (iii) 2.6NRp, and (iv) 2.6NRp plus the amount of purified β-glucan detected in 2.6p strain solution. The insets show electron
micrographics of the bacteria. The arrows mark the β-glucan (EPS). Statistical significances are represented by different letters that mean P ≤ 0.01.
In Vivo Evaluation of Probiotic Properties
of P. parvulus 2.6p and 2.6NRp Strains in
Zebrafish Model
Animal models are necessary to validate the probiotic properties
of bacteria. Currently, the zebrafish models are used for this
purpose (Rendueles et al., 2012; Russo et al., 2015; Nácher-
Vázquez et al., 2017). Thus, the colonization capacity of the 2.6p
and 2.6NRp strains was tested by their exposure to gnotobiotic
zebrafish larvae and quantified by plating the bacteria present
in the intestinal tract of the larvae according to the protocol
depicted in Figure 4A. For the two strains and in all conditions
tested, the prevalence in the zebrafish gut decreased with the
time of incubation (Figure 4B). In addition, at all the times
tested (6, 24, and 48 hpe to the bacteria), the results corroborated
in vivo the positive influence of the β-glucan in adherence
capability of P. parvulus 2.6p. The colonization by this bacterium
was significantly higher than that of the EPS-non-producing
strain 2.6NRp (11.4, 7.1, and 2.8% versus 1.5, 0.6, and 0.5% at
6, 24, and 72 hpe, respectively). In addition, removal of the
β-glucan decreased the colonization levels of the 2.6p strain to
values (3.1, 2.2, and 1.2% at 6, 24, and 72 hpe, respectively)
no significantly different to that of the 2.6NRp. Furthermore,
these results correlated with those obtained in the bacteria–
Caco-2 cells’ interaction studies (Figure 3). Moreover, the
mCherry-labeling of the P. parvulus strains allowed monitoring
the zebrafish gut colonization by fluorescence microscopy. In
Figure 5, are depicted representative images of 2.6p and 2.6NRp
strains on larvae intestinal epithelium. In both cases, the levels of
fluorescence decreased with the incubation time and they were
higher in the case of 2.6p.
Also, the influence of P. parvulus colonization against
infection by V. anguillarum was investigated. To this end,
gnotobiotic zebrafish larvae previously colonized by either
P. parvulus 2.6p, 2.6p∗, or 2.6NRp strains were infected with
V. anguillarum NB10[pOT11] according to the protocol depicted
in Figure 6A. The results showed 100% of larvae survival in
the absence of treatment with bacteria (data not shown). In
addition, they revealed that both 2.6p and 2.6NRp strains were
able to decrease significantly the larvae mortality due to Vibrio
infection, being more pronounced the effect of 2.6p without
EPS removal (Figure 6B). The protective effect was extended
during the entire infection assay (Figure 6B). Thus, at 72 hpi, a
survival of only 17.2% was detected in the control group infected
with V. anguillarum and not pre-treated with LAB, whereas in
the 2.6p-colonized group, a 60.6% of alive larvae was observed.
Furthermore, the groups colonized by 2.6p∗ and 2.6NRp achieved
an intermediate degree of survival, 45.5 and 36.1%, respectively.
Therefore, colonization by the LAB seems to play a role in the
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FIGURE 4 | Zebrafish gut colonization by P. parvulus 2.6p and 2.6NRp strains. (A) The experimental procedure is depicted. Four-days-old larvae were colonized
during 18 h by 2.6p with (2.6p∗) or without β-glucan removal or 2.6NRp strains. (B) The pediococcal colonies presented inside the larvae were analyzed at 6, 24,
and 48 h after the bacteria were removed from the incubation buffer (hours post exposure, hpe). Differences between conditions were evaluated at each point time.
Statistical significances are represented by ∗P ≤ 0.05, ∗∗P ≤ 0.01, ∗∗∗P ≤ 0.001, and ns (P > 0.05).
inhibition of pathogenic effect of V. anguillarum NB10[pOT11].
Thus, the overall results support the potential use of P. parvulus
2.6 as probiotic to prevent fish infections.
Immunomodulatory Properties of the
2-Substituted (1,3)-β-D-Glucan in
Zebrafish Models
The zebrafish is currently used for immunomodulation studies,
since its innate immunological response is similar to that of other
vertebrates (Novoa and Figueras, 2012; de Oliveira et al., 2013).
Thus, the purified β-glucan of P. parvulus 2.6 could be evaluated
as an immunomodulator in zebrafish models.
Prior to this evaluation, the capability of gnotobiotic zebrafish
larvae to ingest the β-glucan was tested. The purified EPS was
green-fluorescently-labeled with DTAF and, 6 h after exposure,
fluorescence was detected in the zebrafish gut by fluorescence
microscopy (Figure 7A). Afterward, the unlabeled P. parvulus
2.6 β-glucan was evaluated in two zebrafish models. First, it
was studied its effect on the immune system of non-stimulated
zebrafish larvae. Gnotobiotic larvae at 4 dpf were submerged in
β-glucan solutions at 150 µg mL−1 for 30 h, after that variation
on gene expression of nine immune related genes was evaluated
(Figure 7C) according with the protocol depicted in Figure 7B.
The exposure of larvae to the β-glucan caused the downregulation
of three genes involved in inflammatory response. Expression
of two pro-inflammatory cytokine genes, IL8 and TNFα, was
repressed 3.4-fold and 2.2-fold, respectively, and the adapter
protein gene MyD88 was repressed 2.4-fold. In addition, the
expression of anti-inflammatory cytokine gene IL10 showed
a non-significant tendency to increase. The rest of the genes
evaluated did not show any change in their expression levels.
In addition, the β-glucan was evaluated in an induced
inflammation model using the zebrafish transgenic line
Tg(mpx:GFP)i114. In this line, the neutrophils are GFP-labeled,
allowing their detection during the inflammation response.
The inflammation in the larvae was induced by cutting the
apical region of the tail. Then, the recruitment and proliferation
of the neutrophils in the larvae, during the first 24 h of the
inflammation process, was visualized (Figure 8A) and quantified
(Figure 8B) by fluorescence microscopy and images analysis,
respectively. Quantification of the GFP levels at the tail region
revealed that in the control larvae group, not exposed to the
β-glucan, the recruitment of the neutrophils in the inflammation
area drastically increased (9.4 logs) during the first 4 h and
remained at this level (9.6 log) even after 24 h. However, the
larvae treated with the β-glucan showed a lower recruitment
of neutrophils with an increase of 8.0 logs during the first 4 h,
that was further reduced to 7.3 logs after 24 h. Attending to
the whole fluorescence signal in larvae, what is representative
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FIGURE 5 | Fluorescence microscopy images of zebrafish gut colonization by P. parvulus 2.6p and 2.6NRp strains. Representative images taken at 6, 24, and
48 hpe are depicted. White arrows mark the red fluorescence signal emitted by the bacterial cells inside the zebrafish gut.
of neutrophil proliferation, there were also differences between
the control and the treated larvae groups after 24 h, when
the fluorescence increases were 7.2 and 5.8 logs, respectively.
These results indicated that in zebrafish larvae subjected to an
inflammatory process, the presence of the β-glucan provoked an
anti-inflammatory response manifested by a decreasing of the
recruitment and proliferation of the neutrophils.
DISCUSSION
Disease control and prevention strategies in aquaculture have
been based primarily on the use of antibiotics. However, this
indiscriminate use can lead to major drawbacks such as the
emergence of resistant strains, contamination of the aquatic
environment, toxicity to the organism, and the accumulation of
residues in organs and tissues, as well as other potential negative
effects on human health. For this reason, it is necessary to
drastically reduce the use of antibiotics in aquaculture (Cabello,
2006; Defoirdt et al., 2011). On the other hand, the normal
microbiota of the digestive tract of fish plays a fundamental role
in the exclusion of pathogens and in the maintenance of health.
In this way, the use of probiotic bacteria (Newaj-Fyzul et al.,
2014; Hai, 2015) can improve the feed conversion efficiency and
live weight gain. In addition, probiotics can confer protection
against pathogens by competitive exclusion for adhesion sites,
production of organic acids (formic acid, acetic acid, and lactic
acid), hydrogen peroxide, bacteriocins, or lysozyme and also
modulate physiological and immunological responses in fish
(Nayak, 2010). Thus, the use of probiotic bacteria is another
strategy for improving production in fish farms.
Consequently, in this work, we have characterized the
probiotic properties of the 2-substituted (1,3)-β-D-glucan-
producing P. parvulus 2.6 in comparison with the non-
producing P. parvulus 2.6NR strain to evaluate its potential as
a probiotic in aquaculture, upon mCherry-labeling by transfer
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FIGURE 6 | Protective effect of P. parvulus 2.6p and 2.6NRp strains against V. anguillarum NB10[pOT11] zebrafish infection. (A) The experimental procedure. Before
infection with V. angillarum, 4-days-old larvae were colonized during 18 h either by 2.6p with (2.6p∗) or without β-glucan removal or by 2.6NRp strains. Also, as a
control, a group of larvae was incubated in the absence of bacteria during 18 h prior infection. (B) Cumulative mortality due to Vibrio infection was analyzed at 24,
48, and 72 h after addition of the pathogen (hours post infection, hpi). Differences between conditions were evaluated at each point time. Statistical significances are
represented by different letters that mean P ≤ 0.05.
FIGURE 7 | Immunomodulation of gnotobiotic zebrafish larvae by the P. parvulus 2.6 β-glucan. (A) DTAF-labeled β-glucan was detected inside the zebrafish gut.
(B) The experimental procedure for the immunomodulation assay. (C) Relative expression values of the genes involved in inflammation. The genes actin-β and
elongation factor-1 were used as housekeeping to normalize the values. Statistical significances are represented by ∗P ≤ 0.05 and ∗∗ P ≤ 0.01.
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FIGURE 8 | Anti-inflammatory effect of the P. parvulus 2.6 β-glucan in an induced inflammation model of the Tg(mpx:GFP) zebrafish line. The inflammation was
induced by cutting off the apical region of the tail. (A) Images of representative larvae treated and untreated with the β-glucan are depicted. Squares mark the areas
of inflammation, and the colors indicate regions (red) with less migration of neutrophils than others (white). (B) The green fluorescence emitted by the neutrophils was
quantified in the whole larvae and in their tails regions. The fluorescence values detected during the inflammation procedure were expressed as increased
percentages of the values detected at 0 h, and represented as logarithms. Statistical significances between groups are represented by ∗P ≤ 0.05 and ∗∗P ≤ 0.01.
of pRCR12 plasmid. There are a very few works reporting
electrotransformation of strains belonging to the Pediococcus
genus, e.g., transfer of derivatives of pRS4 plasmid of Pediococcus
pentosaceus (Alegre et al., 2005) by electroporation to Pediococcus
acidilactici (Rodríguez et al., 2007). In addition, as far as we know
this is the first report of plasmid transfer to and fluorescence-
labeling of P. parvulus strains, which did not significantly affect
bacterial growth and β-glucan production.
Prior having a beneficial effect in the digestive tract, probiotic
bacteria must resist among others to the stress due to the
digestive enzymes. Previously, the survival of P. parvulus 2.6 and
2.6NR strains under an in vitro gastrointestinal model system
was demonstrated (Fernández de Palencia et al., 2009), but
no influence of the β-glucan in resistance to the gut stresses
was observed. However, when the P. parvulus 2.6 β-glucan was
expressed in Lactobacillus paracasei, the presence of this EPS
increased the bacterial survival to gastrointestinal stresses (Stack
et al., 2010). In addition, the same effect of the polymer was
observed, when the survival of P. parvulus 2.6 and 2.6NR strains
through the digestive tract was evaluated using an in vivo mice
model (Lindström et al., 2012). Accordingly, the results presented
here revealed that P. parvulus 2.6 and 2.6NR remained viable
inside the zebrafish gut, and this viability was improved in the
presence of the β-glucan.
Many of the health effects exerted by the probiotic bacteria
are related to their capability to adhere to the intestinal cells.
Therefore, this is one of the main criteria for the selection
of probiotic strains. In general, the scientific reports support
that synthesis of EPS by LAB decreases the adhesion ability
of the producing bacteria to enterocytes. This is the case of
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heteropolysaccharides of Lactobacillus rhamnosus (Lebeer et al.,
2009; Polak-Berecka et al., 2014) and Lactobacillus johnsonii
(Horn et al., 2013; Dertli et al., 2015) as well as dextrans (α-glucan
homopolysaccharides) produced by L. sakei and Leuconostoc
mesenteroides strains (Nácher-Vázquez et al., 2017; Zarour et al.,
2017). However, Živkovic´ et al. (2016) detected a positive
influence of an heteropolysaccharide of L. paracasei in bacterial
adhesion to epithelial intestinal cells. Furthermore, we have
demonstrated in vitro that the presence of the 2-substituted
(1,3)-β-D-glucan promotes adhesion of P. parvulus strains to
enterocytes (Fernández de Palencia et al., 2009; Garai-Ibabe
et al., 2010; and this work). Moreover, the results presented
here support that the presence of this EPS enhances in vivo
the capabilities of P. parvulus for colonization of the zebrafish
intestinal tract, by contrast with the dextran from L. sakei, which
diminish the stay of the bacteria in the fish gut (Nácher-Vázquez
et al., 2017). Also, the results obtained in this work suggest a
transient colonization of the zebrafish gut by P. parvulus 2.6
strain. This behavior is expected for a probiotic bacteria, that by
definition should be administrated daily (Guarner et al., 2017),
and it has been previously detected with this zebrafish model for
L. plantarum, L. fermentum, and L. sakei probiotic strains (Russo
et al., 2015; Nácher-Vázquez et al., 2017).
Other property described for probiotic bacteria is to compete
with pathogens involved in infection diseases, which are frequent
in fish farms. Thus, in the last few years, there have been several
reports concerning to the beneficial effect of probiotic candidates
against various bacterial infections (Ran et al., 2012; Saini et al.,
2014; Mohideen and Haniffa, 2015). Among the fish pathogens,
V. anguillarum causes a deadly hemorrhagic septicemia disease
named vibriosis, which provokes high morbidity and mortality
rates and it is responsible for severe economic losses (Frans et al.,
2011). In this context, we have previously showed that L. sakei
MN1 competes with V. anguillarum in the zebrafish digestive
tract (Nácher-Vázquez et al., 2017) and the results presented here
revealed that pre-treatment with P. parvulus 2.6 has even a higher
protective effect that L. sakei against vibriosis. Competition
of probiotic with pathogenic bacteria could be due to either
displacement, blocking their interaction with the epithelium, or
stimulation of the immune system. In the case of P. parvulus, our
results demonstrated that its β-glucan significantly contributes
to its ability to compete with V. anguillarum, presumably by
blocking the interaction of the pathogen with the enterocytes,
and not by its displacement, since the zebrafish larvae were pre-
treated with the LAB. However, the results presented here also
suggest that the immunomodulation provoked by the P. parvulus
2.6 β-glucan (see details below) could contribute to the protective
effect of the bacteria against V. anguillarum infection. Moreover,
a killing of the pathogen by P. parvulus due to the LAB synthesis
of antimicrobial compounds could take place, and in fact, there
was in vitro detection of growth inhibition of a V. anguillarum
lawn, when the pathogen was exposed to P. parvulus 2.6, 2.6p,
2.6NR, or 2.6NRp strains (Supplementary Figure S3A). This
effect is presumably due to lactic acid secreted by the LAB,
since exposure of the pathogen to the acidic (pH 4.0) bacterial
culture supernatants yielded a small inhibition halo, which was
not detected after the supernatants neutralization to pH 6.5
(Supplementary Figures S3B,C). However, this does not seem to
be the major cause of the anti-infective activity of P. parvulus 2.6,
because the same inhibition pattern was observed with the four
strain tested. Nevertheless, independently of the mechanisms
involved in the performance of P. parvulus 2.6, the studies of
bacteria–zebrafish interactions performed in this work support
the potential utilization of this bacterium as a probiotic in
aquaculture.
Intensive fish farming causes animals to be subjected to
stress conditions that weaken their immune system, increasing
susceptibility to pathogens and thus promoting the emergence
of diseases. Therefore, to prevent and control infections, the
immunostimulants are currently utilized as feed additives, as
an alternative approach to control these problems (Ringø et al.,
2012). The most widely used is the β-glucan with (1,3)-linkages
from Saccharomyces cerevisiae yeast cell wall (Immunogen R©
and A-Max are commercialized products) containing β-glucans
and mannanoligosaccharides (Yar Ahmadi et al., 2014; Akrami
et al., 2015). These products have a positive effect on innate
immune parameters, growth, feed efficiency, and resistance
against Aeromonas hydrophila of rainbow trout. In this work, the
exposure of gnotobiotic zebrafish larvae to the P. parvulus 2.6
β-glucan produced the inhibition of gene expression of two pro-
inflammatory cytokines, TNFα and IL8. In addition, the protein
adaptor MyD88, which mediates activation of pro-inflammatory
cytokines via NF-κB, was inhibited. TNFα is one of the most
important cytokines involved in inflammation responses (Zelová
and Hošek, 2013). On the other hand, IL8 (also called CXCL8) is
a member of the chemokines family, which facilitates in immune
cells (mainly neutrophils) their migration, accumulation, and
activity at the inflammation sites (de Oliveira et al., 2013). The
neutrophil recruitment is mediated by two G-protein coupled
receptors, CXCR1 and CXCR2 (Oehlers et al., 2010), and the use
of an induced inflammation model in the Tg(mpx:GFP) zebrafish
line has allowed us to study the behavior of the neutrophils
in the presence of the P. parvulus 2.6 β-glucan. The results
showed that the recruitment and proliferation of the neutrophils
in the larvae exposed to the β-glucan were inhibited. Thus,
these results support that the 2-substituted (1,3)-β-D-glucan
specifically affects the signaling pathway of IL8 producing an anti-
inflammatory response, corroborating the anti-inflammatory
activity of this polymer on human macrophages (Notararigo
et al., 2014). However, Lindström et al. (2012) showed that the
purified P. parvulus 2.6 β-glucan did not produce any anti-
inflammatory response in an in vivo mice model, and this
discrepancy could be due to differences in the procedures for
isolation and purification of the EPS. Nevertheless, in the mice
model was detected a higher pro-inflammatory response to
2.6NR than to 2.6 strains (Lindström et al., 2012). Thus, this last
result correlates with our previous findings showing differential
in vitro immunomodulation of human macrophages by these two
strains (Fernández de Palencia et al., 2009). In addition, they
support that the natural presence of the β-glucan attached to the
cell wall of 2.6 strain counteracts the pro-inflammatory effect of
P. parvulus.
Finally, the current problems in aquaculture indicate that
a combination of polysaccharides with immunomodulatory
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capacity and a probiotic bacterium could be of interest for the
improvement of fish production, since they can be utilized to
generate functional symbiotic feed for use in fish farms (Huynh
et al., 2017). In this context, the study presented here supports the
use of P. parvulus 2.6 as a probiotic producing in situ its β-glucan
for the elaboration of fish feed with potential anti-inflammatory
and anti-pathogenic properties.
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Resumen 
El uso de bacterias ácido lácticas (BAL) probióticas para la fermentación de alimentos, 
o simplemente su adición a matrices alimentarias para el desarrollo de nuevos alimentos 
funcionales, actualmente es un proceso de gran interés. A su vez, los exopolisacáridos 
(EPS) de BAL son también de gran interés para la industria alimentaria por su 
capacidad para mejorar las propiedades organolépticas de los alimentos. Por otro lado, 
en países del norte de Europa y de Asia el desarrollo de alimentos fermentados de 
matrices no lácteas tiene una gran aceptación por los consumidores. En este contexto, el 
objetivo de este trabajo fue realizar un estudio comparativo de la capacidad de P. 
parvulus 2.6 y 2.6NR, cepas productora y no productora de (1,3)-β-D-glucano 
ramificado en posición O-2 (β-glucano) para fermentar matrices basadas en cereales. Se 
generaron 3 matrices liquidas diferentes, utilizando harina (18% w/v) de avena, de 
arroz, y de cebada. La capacidad fermentativa de las cepas de P. parvulus se evaluó 
durante 64 horas monitorizando la viabilidad bacteriana y el decrecimiento del pH de 
las matrices. Los resultados mostraron, que las cepas eran incapaces de fermentar la 
matriz de cebada, por lo que fue descartada. La viabilidad de ambas estirpes fue mayor 
en la matriz de avena. Sin embargo, el pH disminuyó más rápidamente en la matriz de 
arroz, alcanzando un pH de 4.0 a las 24 h de fermentación, mientas que en la matriz de 
avena se necesitaron 40 h para alcanzar dicho pH. La producción del β-glucano de P. 
parvulus en las matrices se valoró mediante el método inmunológico desarrollado en el 
Capítulo 1 de esta tesis. Las matrices no interfirieron en su cuantificación, ni siquiera 
los β-glucanos de origen vegetal y presentes en la matriz de avena, demostrando la alta 
especificidad del método inmunológico. La mayor viabilidad de P. parvulus 2.6 en la 
matriz de avena se tradujo en una mayor producción de β-glucano, 340 mg L-1 a las 40 h 
de fermentación, frente a los 130 mg L
-1
 producidos en la matriz de arroz. Esta 
diferencia en los niveles de EPS estuvo correlacionada con la viscosidad de los 
productos fermentados con la cepa 2.6, siendo superior en la matriz de avena que en la 
matriz de arroz. Además, como era de esperar las matrices fueron más viscosas que 
aquellas fermentadas con la cepa 2.6NR. Así, los resultados obtenidos mostraron que las 
matrices de avena y arroz pueden ser utilizadas para la elaboración de nuevos alimentos 
funcionales fermentados por P. parvulus 2.6. 
Como ya se ha descrito en el Capítulo 5 de esta tesis y en Notararigo y cols. (2014), el 
β-glucano producido por P. parvulus 2.6 es capaz de modular el sistema inmune y 
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promover un efecto antiinflamatorio. Además, resultados previos de nuestro laboratorio 
(Russo et al., 2012) indican que este EPS podría ser fermentado por otras bacterias de la 
microbiota ejerciendo un efecto prebiótico. Así, podría utilizarse como ingrediente 
alimentario, pero debido a que los niveles de producción son bajos la mejor opción es su 
producción in situ por la estirpe 2.6 en las matrices. Por esta razón, en este trabajo 
también se analizaron las matrices fermentadas por las estirpes de P. parvulus como 
vehículos para la administración de otras bacterias probióticas, comparando las matrices 
enriquecidas en β-glucano bacteriano con las que no lo estaban. Primero, las matrices 
fermentadas se esterilizaron a 80 ºC durante 20 min, se inocularon con Lactobacillus 
plantarum WCFS1, y se analizó su viabilidad durante: (i) una fermentación de 120 h a 
37 ºC; (ii) un proceso de almacenamiento en frio a 4 ºC durante 21 días y (iii) un 
proceso de estrés gastrointestinal simulado. 
Durante la fermentación a 37 ºC en la matriz de avena, la viabilidad incrementó durante 
las primeras 48 h, siendo el doble en la matriz enriquecida con el β-glucano bacteriano y 
posteriormente se mantuvo estable. En el caso de la matriz de arroz, a partir de las 48 h 
la viabilidad disminuyó drásticamente (posiblemente debido al menor pH), siendo dicha 
disminución 10 veces superior en la matriz no enriquecida, por lo que presumiblemente 
el β-glucano debe ejercer un efecto protector sobre L. plantarum WCFS1 en esta matriz. 
El almacenamiento a 4 ºC durante 21 días de los productos fermentados no afectó la 
viabilidad de la cepa WCFS1. Por último, las matrices que contenían L. plantarum 
fueron sometidas secuencialmente a un estrés oral, gástrico e intestinal. En general en 
todas las matrices, la viabilidad de L. plantarum disminuyo al ser sometido a los 
estreses oral y gástrico, mientras que al someter la bacteria al estrés intestinal provocó 
una recuperación de sus niveles de viabilidad. En la matriz de arroz no se encontraron 
diferencias entre la matrices enriquecidas o no con el β-glucano bacteriano, mientras 
que en la matriz de avena durante el estrés intestinal la recuperación de la viabilidad fue 
significativamente mayor en la matriz enriquecida, lo que indica que la presencia del β-
glucano de P. parvulus 2.6 confiere un efecto protector a L. plantarum WCFS1 en esta 
matriz.  
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Mi aportación a este trabajo 
Para lograr la consecución de este trabajo científico, mi aportación fue la siguiente. 
Contribuí a la realización de todo el trabajo experimental. También, realicé el borrador 
de los apartados de materiales y métodos y resultados del manuscrito, así como las 
figuras y tablas que contiene. 
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Abstract: Bacterial exopolysaccharides produced by lactic acid bacteria are of increasing interest in
the food industry, since they might enhance the technological and functional properties of some edible
matrices. In this work, Pediococcus parvulus 2.6, which produces an O2-substituted (1,3)-β-D-glucan
exopolysaccharide only synthesised by bacteria, was proposed as a starter culture for the production
of three cereal-based fermented foods. The obtained fermented matrices were naturally bio-fortified in
microbial β-glucans, and used to investigate the prebiotic potential of the bacterial exopolysaccharide
by analysing the impact on the survival of a probiotic Lactobacillus plantarum strain under starvation
and gastrointestinal simulated conditions. All of the assays were performed by using as control of
the P. parvulus 2.6’s performance, the isogenic β-glucan non-producing 2.6NR strain. Our results
showed a differential capability of P. parvulus to ferment the cereal flours. During the fermentation
step, the β-glucans produced were specifically quantified and their concentration correlated with
an increased viscosity of the products. The survival of the model probiotic L. plantarum WCFS1
was improved by the presence of the bacterial β-glucans in oat and rice fermented foods under
starvation conditions. The probiotic bacteria showed a significantly higher viability when submitted
to a simulated intestinal stress in the oat matrix fermented by the 2.6 strain. Therefore, the cereal
flours were a suitable substrate for in situ bio-fortification with the bacterial β-glucan, and these
matrices could be used as carriers to enhance the beneficial properties of probiotic bacteria.
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1. Introduction
Bacterial exopolysaccharides (EPS) are extracellular polymers which can be tightly adhered (i.e.,
capsular), loosely associated to the microbial cell surface, or released into the environment [1–4].
Lactic acid bacteria (LAB) are a heterogeneous group of Gram-positive prokaryotes characterised
by a long history of safe use by humans, and are of outstanding relevance for the production
of fermented food and beverages [5,6]. Several LAB strains are able to produce EPS, either
heteropolysaccharides or homopolysaccharides, mainly including β-D-glucans, α-D-glucans, levans,
and β-D-galactans [2]. Based on their functional and technological properties, bacterial EPS are
of interest for new developments in food, biomedical, and pharmaceutical applications [7,8]. It is
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7. Unpublished results 
7.1. Effect of different abiotic stresses on the growth of P. parvulus 
strains 
The subject of this thesis has been the β-glucan-producing P. parvulus 2.6 due to its 
potential as a probiotic bacterium and that it could be used for the development of 
various functional fermented foods enriched in 2-substituted (1,3)-β-glucan. I have 
shown in chapter 6 of this thesis the suitability of the bacterium for the production of 
cereal-based products enriched in this bacterial β-glucan. 
During the production of fermented food, and depending on the matrices used, the 
starter bacteria could be exposed to different abiotic stresses. The production of dairy 
products, such as yogurt, is characterised by the acidification of the milk to values even 
lower than pH 4. Osmosis is also an important factor in the preparation of some 
fermented foods such as cheese or meat, and the starter bacteria should tolerate a certain 
concentration of salinity. Moreover, during the fermentation processes, production of 
oxidative agents could occur and could affect the metabolism and growth of the 
bacteria. In addition, the manufacture of fermented beverages such as wine, beer or 
cider entails the production of ethanol that can also affect the bacterial growth. Thus, in 
this work I subjected the β-glucan-producing P. parvulus 2.6 and its isogenic non-
producing strain 2.6NR to the above technological stresses to evaluate their resistance. 
To determine the tolerance to the different stresses, the bacteria were grown in MRS 
(Pronadisa) media and the optical density at 600 nm (OD600nm) of the cultures was 
monitored. To analyse the bacterial response to the acidic stress, the growth medium 
was adjusted to pH 6.2, 4.5 or 3.5. To evaluate the response of the pedioccoci to the 
other stresses the medium was supplemented as follows. For the osmotic constraint, 
NaCl was added at either 2% or 4%. For the oxidative stress, concentrations of 
N,N,N´,N´-tetramethylazo-dicarboxamide (diamide) from 0.5 mM to 2 mM were tested. 
Finally, for the ethanol stress, concentrations of the alcohol from 2 % to 8 % were 
tested. 
Our results revealed that the initial pH of the MRS media affected the growth of both 
pediococcal strains, which showed the same pattern for each condition tested (Fig. 1A). 
The growth rate for both strains was almost identical, whether grown at pH 6.2 or 4.5 
(ranging from 0.048 ± 0.005 to 0.054 ± 0.005). However, upon growth at pH 4.5, both 
Unpublished results 
 
146 
strains reached the stationary phase of growth earlier and at lower OD600nm (0.8) than at 
pH 6.2 (1.1).  
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2.6 EtOH 0 % 2.6 EtOH 2 %
2.6 EtOH 4 % 2.6 EtOH 8 %
2.6NR EtOH 0 % 2.6NR EtOH 2 %
2.6NR EtOH 4 % 2.6NR EtOH 8 %
Figure 1. Analysis of tolerance of P. parvulus 2.6 (black symbols) and 2.6NR (white symbols) strains to 
abiotic stresses: pH (A), osmosis (B), oxidation (C) and ethanol (D). The bacterial growth was 
monitored by measurement of the OD600nm. The symbols are described in each graphic. 
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In addition, in MRS pH 3.5 the growth of both strains was drastically reduced. At the 
middle of the exponential phase, their growth rate (0.014 ± 0.002) was about 4-fold 
lower than that in medium at pH 6.2. Moreover, the final OD600nm in MRS pH 3.5 was 
very low only about 0.3. The final pH of all the cultures was determined at the end of 
the growth and the values were around pH 3.3-3.4 for the cultures with initial pH 4.5 or 
3.5, and values of more than pH 4 for the cultures with initial pH 6.2. These results 
indicate that P. parvulus strains are not able to acidify the medium below pH 3.3 and at 
this point the growth is seriously affected. 
The results obtained after applying salinity stress showed that the pediococcal strains 
could withstand a NaCl concentration of even 4% (Fig. 1B). However, the exposure 
resulted in a latent period more pronounced for 2.6 than for 2.6NR. The cultures grown 
in the presence of 2% NaCl showed a similar growth rate (0.047 ± 0.004) in the middle 
of the exponential phase as that of those not subjected to osmotic stress, achieving a 
final OD600nm of 0.9. However, when the bacteria were exposed to a salt concentration 
of 4% the growth rate decreased about 2-fold (0.025 ± 0.001), and the OD600nm achieved 
for the cultures only reached values of 0.5 or 0.6 for 2.6 or 2.6NR, respectively (Fig. 
1B). Thus, the overall results revealed that P. parvulus 2.6NR is more resistant than 2.6 
strain to the osmotic stress. 
Diamide is a thiol-specific oxidant that generates reactive oxygen species. The exposure 
to this compound had no negative effect on the growth of either pediococcal strain at 
any of the concentrations tested (Fig. 1C). Moreover, a slight growth improvement was 
observed in the presence of diamide. 
Finally, the bacteria were subjected to an ethanol stress. During the production of 
fermented alcoholic beverages, bacteria must withstand different alcoholic 
concentrations; besides P. parvulus 2.6 was isolated from natural cider which can 
achieve ethanol concentration of 5-6%. Consequently, and as expected, the results 
showed that both strains could grow even in the presence of 8% ethanol with only 10% 
decrease in the growth rate (from 0.097 ± 0.011 to 0.086 ± 0.006) (Fig. 1D). In addition, 
an increase of viscosity in the P. parvulus 2.6 cultures was observed in the presence of 
ethanol. This fact could mean an increase in β-glucan production, therefore we analysed 
the β-glucan levels as well as the cell viability in cultures subjected to ethanol stress. 
For this study, the bacteria (10
8 
cfu mL
-1
) were subjected to 4%, 8% and 12% ethanol. 
Both strains, 2.6 and 2.6NR, grown in MRS without ethanol reached the stationary 
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phase at OD600nm of 1.1 (Fig. 2A) with the same growth rate (0.068), after 48 h of 
growth. Regarding to viable cells, the cultures reached values of 3.5 × 10
9
 cfu mL
-1
 or 
5.4 × 10
9
 cfu mL
-1
 for 2.6 or 2.6NR strains, respectively (Fig. 2B). Then, after 72 h of 
incubation, the cell viability decreased to 2.7 ×10
9
 cfu mL
-1 
and 4.2 × 10
9
 cfu mL
-1 
for 
2.6 and 2.6NR, respectively. These results were taken as a control to analyse the 
behaviour of both strains in the presence of ethanol. Thus, these viability values of both 
strains, at 48 h and 72 h, were taken as the 100% values. 
The presence of 4% ethanol did not substantially affect the bacterial growth. Both 
strains achieved the stationary phase after 48 h with an OD600nm of approximately 1.0 
and a growth rate of 0.062. The viable bacteria detected at this point, were 2.5 ×10
9
 cfu 
mL
-1 
for 2.6 and 3.4 × 10
9
 cfu mL
-1 
for 2.6NR, corresponding to a decrease in cell 
viability of 30% and 40% compared to the controls. Furthermore, after 72 h of growth 
the survival of 2.6 remained stable, while the cell viability of 2.6NR decreased 60%. 
 
 
 
 
Figure 2. Analysis of the ethanol effect in growth and viability of 2.6 (black symbols) and 2.6NR (white 
symbols) strains. The bacterial growth was detected by measuring the OD600nm (A) and the viability was 
measured by platting determination of the cfu mL
-1
 (B). All the symbols are described in each graphic. 
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In the presence of 8% ethanol, both strains had a growth rate of 0.04, however the 
OD600nm reached after 48 h of growth was higher for 2.6 (0.73) than for 2.6NR (0.57). In 
addition, viable cells were different for both strains at this point, achieving 1.3 × 10
9
 cfu 
mL
-1 
for 2.6 and 6 × 10
8
 cfu mL
-1 
for 2.6NR, and these values showed a reduction of cell 
survival of 60% and 90% respectively, compared to the controls. As happened in the 
presence of 4% ethanol, 2.6 viability was stable after 72 h of growth, while 2.6NR 
viability was reduced in 95%. 
Finally, the results showed that 12% ethanol was a limiting dose for the pediococcal 
growth, since cultures of 2.6 and 2.6NR strains only reached an OD600nm of 0.22 and 
0.15, respectively, which growth rates of 0.025 and 0.019. In addition, the study of the 
viable cells showed that this ethanol concentration impaired bacterial growth. Moreover, 
2.6 retained its viability (about 1.0 × 10
8
 cfu mL
-1
) during all the treatment period. By 
contrast, 2.6NR maintained its viability only during the first 24 h of treatment, and then 
its survival was reduced 73% and 87% after 48 h and 72 h of treatment, from 1.5 × 10
8
 
cfu mL
-1
 at the beginning of growth to 4.0 × 10
7
 cfu mL
-1
 and 2.0 × 10
7
 cfu mL
-1
, 
respectively. 
The analysis of the 2-substituted (1,3)-β-glucan production by P. parvulus 2.6 showed 
that in the presence of ethanol the bacterium increased its production of EPS (Table 1). 
There were no significant differences in the total concentration detected. However, 
when production per cell was calculated (mg of β-glucan/cfu), these results revealed 
that the production increased when the ethanol concentration in the medium increased. 
The production of the β-glucan was 3-fold higher in the presence of 8% ethanol and up 
to 10-fold higher in the presence of 12% ethanol. These results suggest a protective 
effect of this β-glucan against ethanol stress, and ethanol is likely to trigger activation of 
expression of genes involved in the biopolymer production, but to prove this hypothesis 
requires further work. 
 
Ethanol dose   β-glucan (mg L-1)    Viability (cfu mL-1) Ratio (mg of β-glucan/cfu) 
EtOH 0 %     467.7 ± 56.3          3.46 × 10
9
      0.14 
EtOH 4 %     470.1 ± 52.9          2.50 × 10
9
      0.19 
EtOH 8 %     529.8 ± 60.4          1.30 × 10
9
      0.41 
EtOH 12 %     164.5 ± 29.0          1.05 × 10
8
      1.57 
Table 1. β-glucan production by P. parvulus 2.6 strain in MRS cultures after 48 h of growth in 
the presence of ethanol 
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The overall results showed that the technological properties of P. parvulus 2.6 are 
adequate for its inclusion in the manufacture of fermented foods. This perhaps is self-
evident in the production of alcoholic beverages since strains of P. parvulus have been 
isolated from cider and wine. It also offers the possibility of use in other foods, in which 
the salinity does not exceed 4%, acidity would not be lower than pH 3.5 and even if 
oxidative agents were to be produced. Thus, this bacterium could be used for the 
production of yogurt-like foods based on cereals, as shown in Chapter 6 of this thesis. 
7.2. Improvement of sorbitol uptake by P. parvulus 2.6 
As already mentioned in Chapter 4 of this thesis, the efficiency of 2.6 strain to 
metabolise sorbitol was very low, compared with its utilisation of other carbon sources, 
e. g. glucose. In this work the bacterium was grown in a non-commercial MRS made by 
components without carbon source and supplemented with 30 mM sorbitol and without 
adjusting the pH (pH of the medium 6.5). Under these conditions, the growth of P. 
parvulus 2.6 was very poor taking more than 10 days to achieve an OD600nm of 3.0 (see 
supplementary material Fig. S1 of Chapter 4). Therefore, this study was performed with 
the aim to identify the optimal growth conditions to improve sorbitol metabolism. The 
influence of the pH of the medium and the usage of other carbon sources at limiting 
concentrations (15 mM) together with sorbitol was tested and the results are depicted in 
Figure 3. The growth of the 2.6 strain in MRS pH 6.5 in the presence of the three carbon 
source glucose (MRSG), fructose (MRSF) and maltose (MRSM) was quite different 
(Fig. 3A and 3B), having a growth rate in the exponential phase of 0.2, 0.3 and 0.1, 
respectively. The graphs depict the late exponential and the stationary phases to assess 
the influence of the sorbitol on the bacterial metabolism. However, no differences were 
observed between cultures in the presence (S) or absence of sorbitol, achieving a final 
OD600nm of 2.2 in MRSG and MRSGS and 3.1 in MRSF and MRSFS. The growth of 2.6 
in the presence of maltose was slightly improved when the medium contained sorbitol, 
achieving a final OD600nm of 2.8 MRSMS versus 2.0 in MRSM. This behaviour of 2.6 
strain during the co-metabolism of maltose and sorbitol was also detected at pH 5.0 and 
4.0 (Fig. 3D and 3F), but under these conditions the growth rates were in all cases less 
than 0.04. These results obtained in the presence of maltose, made us discard this 
carbon source to perform further studies of co-metabolism with sorbitol. 
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Figure 3. Analysis of the influence of pH and additional carbon sources on co-metabolism with 
sorbitol in P. parvulus 2.6. The pH was evaluated at 6.5 (A and B), 5.0 (C and D) and 4.0 (E and F). 
MRS was supplemented with 15 mM glucose (squares), 15 mM fructose (triangles) or 15 mM 
maltose (circles) or adding 30 mM sorbitol (white symbols). The bacterial growth was measured by 
monitoring the OD600nm. 
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The growth of 2.6 in MRSG and MRSF at pH 5.0 had similar growth rates of 0.20 and 
0.22 respectively. In these conditions, the 2.6 cultures in MRSF and MRSFS reached 
the same final OD600nm of 3.3 (Fig. 3C). However, the 2.6 growth in MRSGS reached a 
higher final OD600nm that in MRSG (2.8 versus 1.9). These behaviours were maintained 
in medium adjusted to pH 4.0, but under these conditions the growth was reduced (Fig. 
3E). The growth of 2.6 in MRSG as well as in MRSF at pH 4 showed growth rates 
below 0.1, and achieved final OD600nm of 1.6 and 2.0, respectively. Under these 
conditions, the presence of sorbitol also slightly improved the growth in MRSG, up to a 
final OD600nm of 2.0. The overall analysis of the results, made us discard also the 
MRSFS and a pH medium of 4.0 to improve the sorbitol metabolism. For this reason, 
further analyses were performed in MRSGS. In addition, the concentration of glucose 
was reduced to 10 mM to appreciate better the influence of the sorbitol in growth. 
Moreover, the influence of the aeration was tested incubating the cultures under aerobic 
conditions (shaking at 180 rpm). The results are depicted in Figure 4. In all conditions, 
the cultures had similar exponential phases, with growth rates ranging from 0.17 to 
0.19. 
After 9 h of incubation the 2.6 cultures grown in MRSG entered into the stationary 
phase, and the final OD600nm reached for these cultures was around 1.8. However, the 
2.6 cultures grown in MRSGS had different behaviours depending on growth 
conditions. The pH as well as the aeration of the cultures affected the growth of 2.6 in 
the presence of sorbitol. Thus, at pH 6.5 and under static conditions the use of sorbitol 
was not very efficient, reaching the cultures only an OD600nm of 2.0. When aeration was 
provided, the final OD600nm of 2.6 strain was 2.25. Also, when the MRSGS was adjusted 
to pH 5.0, without aeration, the final OD600nm was 2.7, and when the culture was aerated 
the best yield was achieved, with a final OD600nm of 3.8. 
Thus, the better conditions for sorbitol uptake and metabolism by P. parvulus 2.6 were 
growth of the bacterium in MRS supplemented with 10 mM glucose plus 30 mM 
sorbitol at pH 5 and under aerobic condition (Fig. 4D). Consequently, these preliminary 
experiments defined the conditions for the characterization of the sorbitol metabolism 
performed in Chapter 4 of this thesis. 
Unpublished results 
 
153 
                 
 
 
 
Figure 4. Study of glucose and sorbitol co-metabolism by P. parvulus 2.6. The influence of 
the pH was tested at 6.5 (A and B) and 5.0 (C and D). Also, the incubation was assayed 
under either static (squares) (A and C) or aerobic (triangles) (B and D) conditions. MRS 
was supplemented with 10 mM of glucose (black symbols) or with 10 mM glucose plus 30 
mM sorbitol (white symbols). 
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7.3. Analysis of the regulation of the expression of the gut operon in L. 
plantarum WCFS1 
The gut operon for sorbitol utilization detected and characterised in P. parvulus 2.6 
carries the gutR and gutM genes, which encode the GutR and GutM regulatory proteins. 
In Chapter 4 of this thesis, a functional study of expression of both proteins and the 
promoter region Pgut of the 2.6 was carried out, using two heterologous systems: L. 
plantarum 90 and L. casei BL23, which had gut operons and promoter regions, 
respectively with high and low homology to that of P. parvulus 2.6. 
However initially, during the development of this PhD work, we had chosen to perform 
the study the L. plantarum WCFS1 that had a gut operon equal to that of L. plantarum 
90, instead of the 90 strain. The WCFS1 strain is the prototype of L. plantarum strains 
and for this reason has been better characterised than the 90 strain and more information 
was available. Therefore, it was deemed to be a better choice for the study. The gene 
expression study was carried out using the pRCR16-pRCR19 plasmids, which contain 
regions of the sorbitol utilization genetic determinants. They were constructed as 
described in Chapter 4, using the promoter-probe vector pRCR (Mohedano et al., 
2015a), which carries the reporter gene mrfp that encodes the monomeric red 
fluorescence protein mCherry. Thus, WCFS1 was transformed independently with the 4 
plasmids: pRCR16 (4.2 kbp, carrying the promoter region Pgut), pRCR17 (6.1 kbp, 
carrying the transcriptional fusion Pgut-gutR), pRCR18 (4.8 kbp, carrying the 
transcriptional fusion Pgut-gutM) and pRCR19 (6.6 kbp, carrying the transcriptional 
fusion Pgut-gutRM). Recombinant strains were successfully obtained in all 4 cases. 
The complete genome sequence of L .plantarum WCFS1 has been determined and 
revealed that this bacterium carries 3 natural plasmids: two small that replicate via the 
rolling circle mechanism, pWCFS101 (1.9 kbp) and pWCFS102 (2.4 kbp); and one 
large that replicates via the theta type mechanism, pWCFS103 (36.1 kbp) (Kleerebezem 
et al., 2003; van Kranenburg et al., 2005). Therefore, the plasmid profiles of the WCFS1 
and its recombinant derivative strains were analysed in an 0.7% agarose gel (Fig. 5). 
The analysis revealed the expected pRCR derivatives in the corresponding bacteria. 
However, the results also revealed that all the recombinant strains had lost the 
pWCFS102 plasmid. Analysis of the DNA sequences of the replicons of pWCFS102 
and pRCR revealed that both belong to the pMV158 family (Lorenzo-Díaz et al., 2014). 
This fact could provoke incompatibility between pWCFS102 and the pRCR derivatives. 
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We were able to establish the pRCR derivatives in L. plantarum WCFS1, due to the 
selective pressure imposed on the strain by plating in media containing chloramphenicol 
(since the plasmids encode a chloramphenicol acetyl transferase). Thereby, this 
selection and further growth of the transformants in the presence of the antibiotic 
presumably resulted in the loss of pWCFS102. This event led us to discontinue the 
usage of L. plantarum WCFS1 for studies of sorbitol metabolism and regulation and to 
include as heterologous system L. plantarum 90, which has not presented problems of 
plasmid incompatibility to perform the experiments described in Chapter 4. 
                                 
 
 
Nevertheless, supplementary regulation studies were performed with WCFS1 
recombinant strains, which were not included into the published manuscript (Chapter 4 
of this thesis). First, the induction of Pgut from 2.6 by the regulatory proteins of 
WCFS1 strain in the presence of sorbitol were analysed (Fig. 6). To this aim, L. 
plantarum WCFS1[pRCR16] after growth in MRS supplemented with 1% glucose, was 
transferred to MRS fresh medium supplemented with either 1% sorbitol or 1% glucose, 
Figure 5. Plasmid analysis of L. plantarum WCFS1 carrying pRCR derivatives in a 0.8% 
agarose gel. Plasmidic DNA preparation of, Lines: 1, E. coli V517, a multi-plasmid strain used 
as standard (plasmid sizes are depicted); 2, L. plantarum WCFS1; 3, WCFS1[pRCR16]; 4, 
WCFS1pRCR18]; 5, WCFS1[pRCR17]; 6, WCFS1[pRCR19]. The arrows indicate the 
position of the different plasmids and their sizes. Question-mark indicates an unknown band. 
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and the OD600nm as well as the fluorescence emitted by the cells were monitoring. The 
results revealed that the promoter Pgut in the presence of glucose was not activated, and 
the presence of sorbitol as inductor was needed for its expression (Fig. 6A and 6B). 
Thus, in the presence of sorbitol the cultures started to emit fluorescence, progressively 
with time, and at the end of the experiment (6 h), almost all the cells in the culture 
became fluorescent (Fig. 6A). 
         
 
 
Figure 6. Trans-complementation of the sorbitol utilization regulatory machinery in L. plantarum 
WCFS1[pRCR16]. The Bacterium was grown in MRS supplemented with 1% glucose, and at time 0 was 
transferred to fresh MRS supplemented with 1% sorbitol (white symbols) or with 1% glucose (black 
symbols). Fluorescence (A and B) and OD600nm (C) of the cultures were monitored every hour. 
Fluorescence/OD600nm ratio of the cultures was determined (D). Overlays of images of the cultures taken at 
time 0 and after 2, 4 and 6 h of incubation by phase contrast and fluorescence microscopy are depicted. 
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The analysis of the OD600nm showed that the bacterium metabolises glucose better than 
sorbitol, since the initial growth rates were 0.9 and 0.5, respectively (Fig. 6C). After an 
incubation of 2 h the culture supplemented with glucose entered into the stationary 
phase, and the culture supplemented with sorbitol changed its growth rate to 0.21. 
However, the ratio fluorescence/OD600nm still maintains the exponential increase of 
fluorescence in the presence of sorbitol (Fig. 6D). These results showed a trans-
complementation of the L. plantarum WCFS1 regulatory proteins on expression driven 
from the P. parvulus Pgut promoter. 
In addition, the analysis of the other constructions transferred to WCFS1 strain was 
made. In this case, punctual measurements were taken at different phases of the growth 
(Table 2). The results show that in the presence of the genes that encode for the 
regulatory proteins of 2.6 strain (pRCR17-19), the expression from the promoter Pgut in 
the exponential growth phase is greater than in the strain that carries the pRCR16 
plasmid. In this host, it is not possible to elucidate the role played by each of the 
proteins, since the system is regulated by the host proteins. However, the model 
proposed in Chapter 4 suggests that GutR (expressed from pRCR17) acts as a 
transcriptional activator and GutM (expressed from pRCR18) helps to stabilize the 
regulation process (see more details in Chapter 4), for this reason when both genes are 
present (expressed from pRCR19) the expression from the promoter is lower. Thus, in 
the stationary phase of growth, expression from the Pgut promoter is equal in all 
constructions except for the strain that overexpresses the gutM gene (from pRCR18), 
where gene expression levels are higher by more than 60%. These results suggest that 
an overexpression of the protein GutM, without the same levels of the protein GutR 
produces a deregulation of the system (see further details in chapter 4 of this thesis). 
 
Strain Exponential phase (5 h) Stationary phase (10 h) 
WCFS1 0.03 0.24 
WCFS1[pRCR16] 10.09 24.89 
WCFS1[pRCR17] 16.44 24.38 
WCFS1[pRCR18] 14.84 38.67 
WCFS1[pRCR19] 12.03 22.06 
 
Table 2. Fluorescence emitted by the L. plantarum strains carrying the pRCR-derived plasmids. 
Fluorescence values (a.u.) were normalized with OD600nm values. 
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P. parvulus 2.6 isolated from Basque Country ropy cider (Fernández et al., 1995) is the 
prototype of the 2-substituted (1,3)-β-glucan-producing bacteria synthesised by the GTF 
glycosyltranferase (Werning et al., 2006), and this LAB as well as its HoPS have been 
the subjects of this thesis. P. parvulus 2.6NR (non-ropy) does not produce the polymer, 
because it was generated by chemical treatment of the 2.6 strain (Fernández et al., 
1995), which resulted in the curing of the plasmid carrying the GTF glycosyltranferase 
coding gtf gene (Fernández et al., 1995; Werning et al., 2006). Consequently, 
throughout this thesis work, we have performed a comparative analysis of the 
performance of P. parvulus 2.6 and its isogenic β-glucan-non-producing 2.6NR strain, 
which has allowed us to infer the influence of the HoPS and its synthesis on the 
probiotic, metabolic and technological properties of the 2.6 strain. 
1. Genomic characterization of P. parvulus 2.6 
In this work, the DNA sequence of P. parvulus 2.6 genome has been determined 
(Chapter 2). This allowed us to obtain in silico information of the coding sequences 
(CS), including among others those related to the metabolic capacities that this 
bacterium possesses (Fig. 1). The genome includes 2175 CS, among them 914 CS 
belong to a known subsystem category recognised by the RAST database. These 914 
CS correspond to 875 genes with homologues in the databank, and 39 hypothetical 
genes. On the other hand, there are 1261 CS, which do not belong to a known 
subsystem category, of which 561 are hypothetical genes. 
 
Figure 1. Distribution of coding sequences detected in the genome of P. parvulus 2.6. The colours refer 
to different coverage or categories. 
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Production of the 2-substituted β-glucan by Pediococcus strains isolated from beverages 
has been extensively described (Dueñas-Chasco et al., 1997; Dols-Lafargue et al., 
2008). Furthermore, we have reported this year, for the first instance, a Pediococcus (P. 
ethanolidurans CUPV141), which produces in addition to the β-glucan a HePS 
composed of glucose, galactose, glucosamine, and glycerol-3-phosphate (Llamas-Arriba 
et al., 2018). 
The analysis of the genome allowed the identification of a cps cluster of 12 genes 
involved in HePS synthesis and secretion, homologous to one of those of L. plantarum 
(Fig. 2). Nevertheless, the synthesis of HePS by the 2.6 strain has never been detected 
and this could be due to a lack of polymer synthesis or production at not detectable 
levels, because there is  a lack or decrease of functionality of one or more of the cps 
genes products e. g. the p-GTF or priming-glycosyltransferase (undecaprenyl-phosphate 
galactosephosphotransferase product for the 2.6 cluster), which initiates the 
polymerization.  
 
 
Figure 2. Cluster of genes of P. parvulus 2.6 encoding putative proteins responsible for the synthesis and 
secretion of a HePS. The BLAST alignment with L. plantarum WCFS1 clusters was generated with the 
RAST software and based on the homology of the p-gtf gene. Numeric codes for genes encoding: 1, 
undecaprenyl-phosphate galactosephosphotransferase (EC 2.7.8.6); 2, UDP-glucose 4-epimerase (EC 
5.1.3.2); 3, exopolysaccharide biosynthesis glycosyltransferase EpsF (EC 2.4.1.-); 4, manganese-
dependent protein-tyrosine phosphatase (EC 3.1.3.48); 5, glycosyltransferase; 6, tyrosine-protein kynase 
EpsD (EC 2.7.10.2); 7, polysaccharide polymerase; 8, tyrosin-protein kynase transmembrane modulator 
EpsC; 9, O-antigen flippase Wzx; 10, capsular polysaccharide biosynthesis protein; 11, dTDP-4-
dehydrorhamnose reductase (EC 1.1.1.133); 12, d-TDP-glucose 4,6-dehydratase (EC4.2.1.46). 
 
In addition, the analysis of the genome also predicted the existence of 3 independent 
proteins involved in plasmid replication. These findings are consistent with the results 
obtained in this work from the analysis of plasmidic DNA preparations of 2.6 in an 
agarose gel, which revealed that P. parvulus 2.6 strain harbours 3 natural plasmids 
called pPP1, pPP2 and pPP3, whith estimated sizes of 39.1 kbp, 24.5 kbp and 12.7 kbp, 
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respectively (Fig. 4 of Chapter 4 and scheme in Fig. 3A). On the other hand, the 2.6NR 
strain harbours only two plasmids, the pPP1* and pPP3 plasmids (Fig. 4 of Chapter 4 
and scheme in Fig. 3A). The lack of the pPP2 plasmid, which carries the gtf gene 
encoding the enzyme responsible for the synthesis of the β-glucan impairs the HoPS 
production (Werning et al., 2006; Llamas-Arribas et al., 2018; and Chapter 4). As a 
consequence, only EPS (Fig. 3B and Fig 3 of Chapter 5) and mucous colonies (Fig. 3C 
and Fig. 2 of Chapter 5) were detected for the 2.6 strain. The pPP1* plasmid carried by 
the 2.6NR strain migrates slightly above the pPP1 of 2.6, with an estimated size of 40.0 
kbp.  
      
Figure 3. The P. parvulus 2.6 and 2.6NR, ropy and non-ropy strains. (A) Scheme of the plasmids 
harboured by the bacteria, their sizes and genes of interest are indicated. (B) Electron microscopic images 
of the bacteria. (C) Images of colonies of the bacteria in MRS medium, the typical ropy phenotype of the 
2.6 is characteristic of EPS-producing bacteria and detected by lifting the bacteria. The presence of EPS is 
indicated by arrows. 
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The in silico analysis of the P. parvulus 2.6 genome also revealed the presence of a 
cluster of six genes gutFRMCBA (gut operon) involved in the transport and metabolism 
of sorbitol. The genetic detection of the gut operon by Southern blot hybridisation 
demonstrated that this operon is located in the pPP1 plasmid of 2.6, but not in the 
pPP1* plasmid of 2.6NR (Fig. 5 of Chapter 4). DNA sequencing analysis of both 
plasmids showed that a 9,473 bp region encompassing the gut operon, confirmed that is 
not present in pPP1* plasmid. This was an unexpected finding, since the 2.6NR strain 
was derived from the 2.6 strain, with the only a priori apparent difference being the loss 
of the pPP2 plasmid (Fernández et al., 1995). 
The 2.6NR strain was obtained by treating the 2.6 strain with the chemicals ethidium 
bromide, DNA intercalating agent, and novobiocin, a bacterial gyrase inhibitor. The 
treatment with these compounds induce DNA mutagenesis interfering with the 
replication mechanisms and thus provoking curing of the plasmids (Liu et al., 2016). In 
the original pPP1 plasmid sequence of 2.6, a transposase and a serine recombinase are 
flanking the gut operon sequence. The region of 9 kbp could have been mobilised from 
the plasmid by the transposase, but if this were the case, the final product would have 
generated a smaller plasmid, and the pPP1* plasmid, as stated above is larger than pPP1 
(40 kpb versus 39.1 kbp) according with its migration in agarose gels (Fig. 4 of Chapter 
4). However, a serine recombinase can also act as a resolvase, catalysing the resolution 
of a co-integrate previously generated by recombination between two specific sites 
(Rice, 2015). In addition, the sequencing of pPP1* indicated the presence of a different 
sequence in the region of 9 kbp. Therefore, the most feasible hypothesis is that there 
was a recombination event between the plasmid pPP1 and another, presumably the 
plasmid pPP2, leading to the formation of the plasmid pPP1* and the loss of the 
plasmid pPP2. 
2. The synthesis of the 2-substituted (1, 3)-β-glucan by P. parvulus 2.6 
Werning et al. (2006) showed that the GTF glycosyltransferase catalyses the synthesis 
of the β-glucan in P. parvulus by usage of UDP-[14C] glucose as substrate for in vitro 
synthesis of the polymer and quantifying the reaction product by measuring the 
radioactivity retained on Whatman GF/A filters. In Chapter 1, an in vitro reaction 
confirmed that the enzyme catalyses the synthesis of the β-glucan using UDP-glucose as 
substrate. The nature of the product was established by determining its monomeric 
composition and structure, and the quantification was performed by the specific 
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immunological method. Thus, the overall analysis of the reaction product confirmed the 
specificity of the immunological method. 
The metabolic pathway for the pediococcal HoPS production from glucose, fructose and 
maltose in 2.6 strain has been previously investigated, confirming the monomer 
composition and the structure of the EPS by HPLC and MNR analysis, respectively 
(Velasco et al., 2007). The authors described the activity of a phosphoglucose isomerase 
(PGI) that converts reversibly the fructose-6-P into glucose-6-P, connecting fructose to 
the β-glucan biosynthetic pathway (Fig. 4). Nevertheless, they found that the synthesis 
of the β-glucan was more effective from glucose than from fructose, the latter being a 
very poor substrate for the EPS synthesis. For the maltose metabolism, Velasco et al. 
(2007) detected two enzymatic activities: maltase and maltose phosphorylase, which 
generate by hydrolysis two glucose molecules or one glucose plus one β-glucose-1-P 
molecules, products that can enter into the β-glucan biosynthetic pathway (Fig. 4). Also 
in that work, it was observed that the activity of the α-phosphoglucomutase increased 
significantly in the presence of glucose and maltose, while in the presence of fructose 
the activity was low. This enzyme catalyses the reversible conversion of glucose-6-P to 
glucose-1-P, that communicates the sugar catabolism with the β-glucan biosynthetic 
pathway (Fig. 4).  
The metabolic study of P. parvulus 2.6 performed here showed that indeed the 
bacterium uses this polyalcohol as an alternative carbon source for both the production 
of energy and the biosynthesis of the HoPS (Figs. 2 and 3 of Chapter 4). The analysis 
was carried out in a complex medium (MRS) and the immunological method developed 
in Chapter 1 was used to determine the EPS production during the bacterial growth. 
This method has an advantage over those previously used due to its specificity and 
simplicity. The polymer production took place mainly during the exponential growth 
phase (Fig 3 of Chapter 4), as previously described (Dueñas et al., 2003). Furthermore, 
the results obtained here showed that the efficiency for β-glucan production from 
glucose and sorbitol is similar, since equivalent amounts of the HoPS were produced 
per unit of biomass (Fig 3 of Chapter 4). However, the growth rate in the presence of 
sorbitol was drastically reduced, indicating that the bacterium does not effectively 
metabolize this substrate. The conversion of sorbitol-6-P to fructose-6-P needs NAD
+
 as 
cofactor, which is reduced to NADH. A gene coding for NADH oxidase was detected in 
the genome of P. parvulus 2.6, indicating the existence of this enzyme, and its catalytic 
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activity should improve under aerobic conditions yielding higher concentration of the 
NAD
+
. Accordingly, when bacterial cultures were subjected to aeration conditions, a 
significant increase in bacterial growth was observed (Fig. 4 of Chapter 7). These 
results could indicate that the conversion to fructose-6-P by the system is not very 
efficient, which may promote the action of the PGI in the conversion of glucose-6-P and 
thus enter into the β-glucan biosynthetic pathway (Fig. 4), obtaining a similar yield in 
the presence of both glucose and sorbitol. 
 
 
 
Figure 4. Schematic representation of the proposed pathway to synthesise β-glucan in P.parvulus 2.6. 
Phosphoenolpyruvate–sugar phosphotransferase system (PTS), glycosyltransferase (GTF), sorbitol-6-P 
dehydrogenase (S6PD), 6-phosphofructokinase (6PFK), fructose-1,6-bisphosphatase (FBP), fructose-1,6-
bisphosphate aldolase (FBPA), triose-P isomerase (TPI), phosphoglucose isomerase (PGI), 
phosphoglucokinase (PGK), α-phosphoglucomutase (α-PGM), maltase (M), maltose phosphorylase (MP), 
β-phosphoglucomutase (β-PGM) and UDP-glucose pyrophosphorylase (UGP). 
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3. The promoter-probe vector pRCR and its utility for the analysis of 
regulation of expression of the gut operon in P. parvulus 
In order to characterise the sorbitol utilization by P. parvulus 2.6, the expression of the 
gut operon was investigated in this thesis work, using the promoter-probe vector pRCR 
(Fig. 5 and Chapter 2). This plasmid carries the broad host range pSH71 replicon from 
L. lactis, and it contains a multicloning site upstream of the mrfp gene, which encodes 
mCherry, a monomeric variant of the red fluorescent protein of Dicosoma sp. (Garcia-
Cayuela et al., 2012). The vector was constructed and first validated in Chapter 2 by the 
study of the L. acidophilus lbaB gene expression, cloning its PlbaB promoter in the 
multicloning site of the vector, producing the pRCR11 plasmid (Fig. 5). The lbaB gene 
encodes the lactacin B, and its expression is regulated by the RR_1798 response 
regulator of a three-component system (Altermann et al., 2005; Tabasco et al., 2009), 
which would bind to an inverted repeat located at the promoter sequence and including 
the transcription initiation site, inhibiting the gene expression. The transcriptional 
repression is inhibited when the HK_1799 histidine kinase detects the presence of 
another bacterium in the extracellular medium, which triggers the phosphorylation of 
the repressor inactivating it. Accordingly, in this thesis an indution was observed in L. 
acidophilus[pRCR11] of the mCherry expression from PlbaB, when co-cultured with S. 
thermophilus (Fig. 2 of Chapter 2).  
Subsequently, other promoters have been tested in our group using the pRCR vector. 
The Px promoter, which controls the expression of genes involved in the metabolism of 
maltosaccharides in S. pneumoniae, was cloned in pRCR generating the pRCR12 
plasmid (Russo et al., 2015). Px is controlled by the repressor MalR inhibiting its 
expression. However, outside of the pneumoccocal environment and without the 
presence of MalR, Px becomes a constitutive promoter. This behaviour makes this 
plasmid a powerful tool for fluorescence-labelling of LAB. In this thesis work, P. 
parvulus 2.6 and 2.6NR strains have been fluorescently labelled by transfer of pRCR12 
(Fig. 2 of Chapter 5). The constitutive production of mCherry from pRCR12 did not 
affect growth of these strains nor the β-glucan production by 2.6. The use of these 
recombinant bacteria in the evaluation of their probiotic properties will be discussed in 
section 4 of this Chapter. 
 
General discussion 
 
168 
       
 
Figure 5. Scheme of the pRCR vector and its derivatives. Plasmids pRCR11-pRCR19 were generated to 
generate transcriptional fusions of the PlbaB, Px, P1, P2 and Pgut promoters and the mrfp gene. 
Measurements of the mCherry levels indicated the strength and activation of the promoters. 
 
 
In addition, pRCR was employed to test and evaluate the putative promoter regions 
involved in expression of the dsrLS gene, which encodes a dextransucrase responsible 
for the production of dextran in L. sakei MN1 (Nácher-Vázquez et al., 2017c). Three 
possible promoter regions named region A, region B and region C were cloned into 
pRCR generating the pRCR13, pRCR14 and pRCR15 plasmids, respectively (Fig. 5). 
The authors detected two functional promoters, named P1 and P2, by the activation of 
mCherry expression in L. sakei carrying either pRCR13 or pRCR15. Also, the 
evaluation of the fluorescence of the recombinant bacteria showed that P1 was stronger 
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than P2, and that the presence of sucrose (the substrate for dextran production) in the 
growth medium did not induce dextransucrase synthesis. 
In this thesis, the activity of the Pgut promoter has been evaluated using the pRCR vector 
(Chapter 4). This is the first time that the functionalities of the bacterial regulatory 
proteins GutR and GutM have been evaluated by generating the recombinant plasmids 
pRCR16-pRCR19 (Fig. 5, and Fig. 1 of Chapter 4). The GutR and/or GutM coding 
genes were cloned upstream of the mrfp gene as a transcriptional fusion under the 
control of their natural promoter (Pgut). The study was carried out in two heterologous 
hosts that metabolise sorbitol: (i) L. casei BL23 whose gut operon has been well 
characterized, but it has low homology with the operon of P. parvulus 2.6 (Chapter 4) 
and, (ii) two L. plantarum strains: 90 (Chapter 4) and WFS1 (Chapter 7) strains, whose 
operons have not been characterized but have a 98% homology with that of 
Pediococcus. The results revealed a trans-complementation of the L. plantarum 
regulatory proteins on expression driven from the P. parvulus Pgut promoter, in cultures 
grown in the presence of sorbitol. Moreover, the results indicate that in the presence of 
glucose a catabolic repression controlling expression from Pgut takes place. Supporting 
this hypothesis, a cre sequence is located downstream and next to Pgut (see Fig. 7). 
Furthermore, in L. casei the presence of sorbitol in the growth medium and the 
pediococcal gutR in the genome was required for Pgut functionality, and therefore that 
GutR of 2.6 acts as a transcriptional activator. 
Blast analysis (Fig. 6A) and clustal multialignment (Fig. 6B) revealed that P. parvulus 
2.6 GutR belongs to the family of transcriptional activators that include GutR of L. 
casei BL23 as well as MtlR and LicR of B. subtilis, which control the PTS transport and 
metabolism of oligomeric β-glucosides and of mannitol, respectively. The regulators 
contain the PDR and PTS_EII domains, which contain phosphorylateable His or Cys 
residues (Tobisch et al., 1999; Alcántara et al., 2008; Joyet et al., 2013; Deutscher et al., 
2014). Moreover, after phosphorylation at one of these residues located at the PDR 
domain the regulators become active by dimerization or inactive by phosphorylation at 
the PTS_EII domain (Joyet et al., 2013). In L. casei, it seems that when P-His-HPr 
phosphorylates His
310
 of GutR, triggers its activation (Alcántara et al., 2008). The 
multialignment depicted in Figure 6B shows conservation of this residue at positions 
310, 342 and 333 in GutR of 2.6, MtlR and LicR, respectively, supporting the notion 
that the His
310
 residue is the phosphorylatable residue involved in activation, as in other 
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regulators (Deutscher et al., 2014). In L. casei GutR, phosphorylation of its His
537 
by 
EIIBC triggers its inactivation (Alcántara et al., 2008). Moreover in LicR, mutagenic 
analysis indicates that the His
559
 is the key residue involved in inactivation
 
(Tobisch et 
al., 1999). The equivalent residue His
537
 is present in GutR of P. parvulus and it is 
missing in MtlR (Fig. 6B). Thus, MtlR is subject to a different mechanism of 
modification. It is negatively regulated by EIIA, which phosphorylates its 
Cys
419
(Bouraoui et al., 2013). The equivalent residue is present in LicR (Cys
413
) (Fig. 
6B) and it can have also a role in this activator. In addition, it has been reported that 
MtlR needs to interact with EIIB for its activation. Also, EIIB has to sequester MtlR to 
the membrane for its activation, since interaction with soluble EIIB in the cytoplasm 
does not trigger MtlR activation (Bouraoui et al., 2013). Furthermore, this interaction 
occurs only with the unphosphorylated form of EIIB. If this is phosphorylated the 
interaction does not take place (Joyet et al., 2013). GutR of 2.6, but not of L. casei 
BL23, has a potential phosphorylable Cys
480
 like the MtlR regulator. Nevertheless, this 
Cys
480
 is out of the EIIA domain of the protein, and does not align with the Cys residues 
of the B. subtilis regulators (Fig. 6B). Therefore, inactivation of 2.6 GutR could be 
regulated by EIIBC, in a way similar to that postulated for L. casei. 
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Figure 6. Regulators involved in genetic activation of the PTS systems. (A) Prediction of the PDR and 
PTS phosphorylation domains of the proteins by BLAST analysis. (B) CLUSTAL 2.1 multiple alignment 
of the protein amino acid sequences. Background colours of the amino acids: His residues predicted to be 
phosphorylated by HprK (yellow); His (green) or Cys (violet) residues predicted to be phosphorylated by 
phosphotransfer from HPr; Cys (blue) residue present in P. parvulus GutR and not conserved in the other 
proteins. Proteins: P. parvulus 2.6 GutR (P. parvulus GutR), L. casei BL23 GutR (Lc GutR), B. subtilis 
MtlR (Bs MtlR) or (Bs LicR) regulators. Symbols: (*) indicates positions which have a single, fully 
conserved residue; (:) indicates conservation between groups of strongly similar properties, equivalent to 
scoring > 0.5 in the Gonnet PAM 250 matrix; (.) indicates conservation between groups of weakly similar 
properties, equivalent to scoring =< 0.5 and > 0 in the Gonnet PAM 250 matrix. 
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Furthermore, it has been postulated that in L. casei, GutM should favour the activation 
of transcription of the gut operon, but the mechanism of action is unknown (Alcántara et 
al., 2008). The results obtained in this thesis work revealed that the overexpression of 
GutM of 2.6 in L. plantarum provoked the highest induction of expression from Pgut 
(Fig. 8 and Table 4 of Chapter 4). Thus, this result suggests: (i) that GutM has a role in 
the regulation of the gut operon and (ii) that a protein-protein interaction between the P. 
parvulus GutM and the L. plantarum GutR could potentiate the activation of the Pgut 
promoter. Nonetheless, in L. casei and L. plantarum a decrease of expression from Pgut 
was observed when GutM was overexpressed in combination with GutR. Moreover, in 
silico analysis of the overlapping regions of gutR and gutM suggested a possible 
phenomenon of post-transcriptional regulation by means of a -1 frameshift translation, 
which may lead to the synthesis of a fused protein GutR-M (Fig. 9 of Chapter 4). 
Presumably, this putative fused protein would occur at a low rate and only in the 
presence of both genes in a high copy plasmid in the heterologous systems. The 
existence of GutR-M and if the fused protein has a role in lactobacilli, could explain the 
antagonistic effect of overexpression of the pediococcal gutM gene alone or together 
with the gutR gene (Fig. 8 and Tables 3 and 4 of Chapter 4). Furthermore, the analysis 
of the amino acid sequence of GutM predicted a transmembrane region in the N-
terminal, thus presumably GutM is a protein anchored to the membrane. Therefore, 
GutR fused or bound to GutM would be recruited to the membrane. 
Finally, based on the overall results presented here and the current knowledge, I propose 
the following model of regulation of expression of the gut operon in P. parvulus 2.6 
(Fig. 7). In the presence of glucose, the ratio PEP/PYR would be low, so the 
autophosphorylation of EI from PEP should be reduced, therefore the phosphorylation 
cascade to the EIIgut domains would be inhibited. In addition, the increase of the 
intermediate fructose-1,6-bisphosphate (FBP) metabolite would promote the generation 
of the P-Ser-HPr form by the kinase activity of HprK/P. P-Ser-HPr will interact with 
CcpA, and this complex will repress gene expression from Pgut by binding to the cre 
site. Presumably, GutR will be recruited to the membrane by GutM, favouring its 
inactivation by P-EIIBC (Fig. 6A). In the presence of sorbitol and without glucose, the 
level of FBP will decrease and the level of inorganic phosphate will increase, promoting 
the phospholyration activity of HprK/P that produces dephosphorylation of P-Ser-HPr. 
In addition, the ratio PEP/PYR will increase and the autophosphorylation of EI would 
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be activated, triggering the phosphorylation cascade from P-His-HPr to the EII domains. 
In this condition, EIIBC would transfer its phosphate to the sorbitol instead of 
transferring to GutR. Thus, GutR would be activated by P-His-HPr, promoting its 
dimerization, its further binding to its operator located upstream of Pgut and provoking 
induction of the gut operon expression (Fig. 6B). 
 
 
Figure 7. Model for the regulation of the gut operon of P. parvulus, in the absence (A) or in the presence 
of sorbitol (B). 
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4. Probiotic properties of P. parvulus 2.6 
The characterisation of the probiotic properties of P. parvulus 2.6 has been pursued for 
years. In this work, analysis of the P. parvulus genome, determined in Chapter 2, 
revealed that it does not contain any genetic determinant for the production of biogenic 
amines, undesirable compounds in fermented foods and beverages (Mohedano et al., 
2015b). Moreover, production of putrescine, histamine and tyramine by the 2.6 strain 
has been tested using thin-layer chromatography and the compounds were not detected 
(unpublished results of Mª Goretti Llamas). 
Transmissible antibiotic resistance is a property to be strictly avoided in probiotics, due 
to the risk of horizontal transfer of the genetic determinants to other bacteria. Thus, the 
2.6 genome was analysed and no genetic determinants for resistance to antibiotics were 
detected. In addition, the antibiotic resistance profile of P. parvulus 2.6 (Supplementary 
Table S1 of Chapter 5) was performed according to the recommendations of EFSA, and 
the following antibiotics were tested: ampicillin, chloramphenicol, clindamycin, 
erythromycin, gentamycin, kanamycin, streptomycin, tetracycline, and vancomycin. 
The minimal inhibitory concentration of all the antibiotic tested were under the cut-off 
values determined by EFSA (EFSA, 2012), thus 2.6 is sensitive to all of them. In 
addition, the P. parvulus species was catalogued with the QPS status and included in the 
official list of the EFSA in June 2016 (Ricci et al., 2017), supporting the safety of this 
bacterium for its use in animal and human health. 
An essential requirement of a probiotic is to remain viable until it reaches the 
environment, mainly the colon, where it exerts its beneficial effect. This entails facing 
the acid and enzymatic stress conditions of the upper digestive tract, both at an oral 
level resisting the action of lysozyme, and at a gastric level supporting acidity that can 
reach pH 2.0 or lower, as well as at an intestinal level where probiotics must resist the 
action of bile salts and pancreatic juices. The EPS form a polysaccharidic matrix that 
envelops the producing bacteria and can create a protective environment against these 
stresses. There are some works that report a beneficial influence of the EPS on the 
resistance of producing bacteria to gastrointestinal stress (Alp et al., 2010; Dertli et al., 
2015), and other studies do not report a direct influence of an EPS (Nikolic et al., 2012). 
In this thesis, the resistance conferred by the β-glucan of P. parvulus was evaluated. L. 
plantarum WCFS1, included into the cereal-based foods fortified with the pediococcal 
β-glucan, was subjected to an in vitro simulated GIT stress (Fig. 3 from Chapter 6). The 
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bacterial EPS present in the oat matrix conferred to WCFS1 resistance to bile salts and 
pancreatin of the intestinal stress. Previously, Stack et al. (2010) expressed in multicopy 
the gtf gene of P. parvulus 2.6 in Lactobacillus paracasei NFBC 338, producing 
heterologously the β-glucan. The presence of the EPS conferred to L. paracasei 15-fold 
and 5.5-fold increase in survival under simulate gastric juice stress and bile stress, 
respectively. The same effect of the EPS was observed when, in this case, the survival 
of P. parvulus 2.6 and 2.6NR strains through the GIT was evaluated using an in vivo 
mouse model (Lindström et al., 2012). By contrast, Fernández de Palencia et al. (2009) 
did not observe any influence of the β-glucan when P. parvulus 2.6 and 2.6NR strains 
were subjected in vitro to simulated GIT stress. 
In Chapter 7 of this work the 2.6 and 2.6NR strains were subjected to other stresses 
relavant to food manufacturing. Although the bacteria can tolerate oxidative or salinity 
stresses, the influence of the β-glucan was only detected for the ethanol stress (Fig. 2 
and Table 1 of Chapter 7). In the 2.6 strain, β-glucan protected the bacterium improving 
its survival in the presence of ethanol and, in addition, the production of the EPS 
increased. 
Once probiotics viably reach their target environment they need time to further adapt. 
For this reason, the ability to adhere to the intestinal epithelium promotes the 
persistence of these probiotics in the GIT, allowing them to exert their action. Thus, the 
adhesion capacity of probiotics is one of the most important criteria for their selection. 
In this thesis the adhesive capability of the recombinant P. parvulus 2.6[pRCR12] 
(2.6p) and the 2.6NR[pRCR12] (2.6NRp) strains was assayed in vitro by testing 
bacterial binding to Caco-2 cells. The 2.6p strain showed a higher adhesion than 
2.6NRp (Fig. 3 in Chapter 5), demonstrating the positive contribution of the bacterial β-
glucan described previously for P. parvulus 2.6 (Fernández de Palencia et al., 2009). 
Similar results were reported for the β-glucan-producing strain P. parvulus CUPV22, 
whose adhesion to Caco-2 cells was decreased when the EPS was mechanically 
removed from the cells surface (Garai-Ibabe et al., 2010). In addition, for other bacteria 
belonging to other genera such as P. freudenreichii and O. oeni, it has been suggested 
that the presence of this bacterial β-glucan influences their adhesion capacity 
(Nordmark et al., 2005; Dols-Lafargue et al., 2008). 
Furthermore, in Chapter 5 of this work the quantity of β-glucan attached to the 2.6 strain 
(0.25 mg mL
-1
), during the binding assays to Caco-2 cells, was determined by the 
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immunological method. The addition of this amount of purified β-glucan to bacterial 
solution of 2.6NRp leaded to a 5.5-fold increase in its adhesion capability to enterocytes 
(Fig. 3 in Chapter 5). The increase of the amount of β-glucan added did not lead to an 
increase in bacterial adhesion (results not shown). Russo et al. (2012) reported the same 
adhesion increase for L. plantarum WCFS1, but upon addition of 5 mg mL
-1
 of the 
purified β-glucan. 
The overall results showed the positive influence of the pediococcal β-glucan in 
bacterial adhesion to enterocytes. But, in the literature the influence of various types of 
EPS on this property is controversial. The HePS, ESP-SJ, produced by L paracasei 
subsp. paracasei BGSJ2-8 conferred better adhesion capacity to the bacterium in a 
comparative study with a non-producing mutant (Živković et al., 2016). Other studies 
have reported that EPS-producing bacteria have a high adhesion capacity, but they have 
not proven the direct influence of the EPS on this property (Alp et al., 2010; García-
Ruiz et al., 2014). On the contrary, other studies have reported the negative influence of 
the EPS on adhesion of the producing bacteria to epithelial cells. A HePS non-
producing mutant of L. johnsonii FI9785 showed an increased adhesion capability to 
human HT29 cells (Horn et al., 2013) and to chicken gut explants (Dertli et al., 2015). 
The same effect was reported for the dextran-producing Lactobacillus sakei MN1. This 
bacterium produces its EPS only in the presence of sucrose, and when it was grown in 
glucose (non-EPS production) showed a greater capacity of adhesion to Caco-2 cells 
(Nácher-Vázquez et al., 2017b). Therefore, the removal of the EPS might enhance 
bacterial attachment, exposing adhesins and/or other cell surface factors that favour the 
process of bacterial adherence. In addition, other EPS produced by L. rhamnosus 
(Lebeer et al., 2009; Polak-Berecka et al., 2014), L. salivarius (Mercan et al., 2015), 
Lactobacillus paraplantarum (Nikolic et al., 2012), L. mesenteroides (Nácher-Vázquez 
et al., 2017b; Zarour et al., 2017) or bifidobacteria (Ruas-Madiedo et al., 2006) have 
been reported to reduce bacterial adhesion capability to intestinal epithelial cells. 
Furthermore, there are cases where the presence of the EPS did not affect the adhesion 
capacity of the producing strains (Ruas-Madiedo et al., 2006; Zarour et al., 2017). 
To further investigate the influence of the β-glucan, the ability of P. parvulus to 
colonise in vivo the zebrafish GIT has been investigated (Fig. 4 of Chapter 5). The 
results showed that 2.6p colonised better the zebrafish epithelium than that of its 
isogenic strain 2.6NR. These in vivo results validated those obtained in the in vitro 
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models, and confirm the positive effect of the β-glucan on the bacterial adhesion. Also, 
the zebrafish model was used previously to confirm that the production of dextran by L. 
sakei MN1 reduces the adhesion capacity of the bacteria, and therefore restrains the 
colonisation of zebrafish GIT (Nácher-Vázquez et al., 2017b). Furthermore, the 
fluorescent-labelling of P. parvulus strains allowed monitoring in vivo of the bacterial 
colonisation by the detection of the mCherry signal inside the larvae using fluorescence 
microscopy (Fig, 5 of Chapter 5). In addition, the plasmid pRCR12 has been already 
validated as a useful tool for labelling and colonization studies of L. plantarum, L. 
fermentum and L. sakei (Russo et al., 2015; Nácher-Vázquez et al., 2017b). In addition, 
the use of other fluorophores such as the green fluorescent protein GFP has been 
validated for the study of zebrafish colonization by L. casei (Rieu et al., 2014). 
However, the use of fluorescent markers is not essential for in vivo colonization studies 
in zebrafish, since we have recently evaluated non-labelled strains of L. mesenteroides 
(Zarour et al., 2018). 
One of the most important uses given to probiotics is their ability to fight or prevent 
pathogen infection. Thus, probiotics are of importance with regard to the aim of 
stopping the indiscriminate use of antibiotics in the livestock and aquaculture industries 
for weight gain and prevention of epidemics, which leads to the emergence of resistant 
pathogen strains that can be transmitted both to other animals and to humans (FAO, 
2016). In the long term, this can cause economic losses and health problems. Many 
enteric pathogens such as E. coli or L. monocytogenes need to interact with the host's 
intestinal epithelium to establish their infection. Thereby, the adhesion of probiotics to 
these epithelial cells can displace or block the binding of pathogens and prevent their 
infection (Westermann et al., 2016). With the aim of studying pathogen inhibition by 
probiotic bacteria, zebrafish could be a suitable model (Rendueles et al., 2012). 
For the first time, and in this work, the ability of P. parvulus 2.6 to fight the infection 
produced by pathogens was tested (Fig. 6 of Chapter 5). An in vivo zebrafish model was 
used to analyse the activity of the bacterium against infection induced by the specific 
fish pathogen Vibrio anguillarum. Thus, larvae were first colonised by bacterial 
solutions of P. parvulus strains and then were infected by exposure to bacterial 
solutions of V. anguillarum. Larvae pre-treated with 2.6p bacterial solutions responded 
better to Vibrio infection than those pre-treated with 2.6NRp. Therefore, the higher 
colonization capacity of the β-glucan-producing 2.6 strain was related to its protective 
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effect. The results obtained suggest that the mechanism of action of this bacterium is 
based on the steric impediment to adhere to the intestinal epithelium of the zebrafish, 
blocking the pathogen binding sites. This protective effect against V. anguillarum 
infection in zebrafish has been reported for L. sakei MN1, and also under conditions 
that improve adhesion of the LAB to the epithelium a higher anti-infective effect was 
detected (Nácher-Vázquez et al., 2017b). 
5. The 2-substituted (1, 3)-β-glucan as immunomodulator 
In this thesis work, the immunomodulation properties of the β-glucan of P. parvulus has 
been analysed in an in vivo zebrafish model (Figs. 7 and 8 of Chapter 5). The results 
obtained revealed that the exposure of the gnotobiotic larvae to the β-glucan purified by 
molecular exclusion chromatography (Notararigo et al., 2013) did not affect the level of 
expression genes encoding TLR2, TLR22 and TLR4 receptors of immune zebrafish. 
TLRs have been described to be involved in β-glucan recognition (Leulier and 
Lemaitre, 2008). In addition, Dectin-1 is the best characterised β-glucan receptor 
(Brown, 2005) and in previous works, the ability of the β-glucan to bind to Dectin-1 and 
trigger its signalling pathway was tested in vitro, but there was no recognition by this 
receptor (Notararigo, 2015). The fact that the expression of TLRs is not induced in the 
presence of the β-glucan, and that dectin-1 alone does not recognize the β-glucan, does 
not mean that they cannot be involved in its recognition. Maybe, the receptor involved 
in the recognition of P. parvulus β-glucan consists in a heterodimer formed by units of 
some of these receptors. Nevertheless, further experiments are needed to determine if 
this hypothesis is true. 
Nevertheless, the analysis of gene expression in gnotobiotic zebrafish larvae exposed to 
β-glucan showed a repression of gene expression of two pro-inflammatory cytokines, 
TNF-α and IL8 (Fig. 7 of Chapter 5). In addition, the repressed expression of the protein 
adaptor MyD88 was co-expressed, which mediates activation of pro-inflammatory 
cytokines via NF-kB. These results correlated with those previously obtained in vitro 
from immunomodulation assays conducted on monocyte-derived macrophages with 2.6 
and 2.6NR strains (Fernández de Palencia et al., 2009). The authors showed that the 2.6 
strain induced less production of TNF-α and IL8 and higher production of IL10 than 
2.6NR strain. Thus, the presence of the β-glucan favoured a lower pro-inflammatory 
response. The same influence of this HoPS counteracting the pro-inflammatory effect of 
P. parvulus was described when testing in a mouse model (Lindström et al., 2012). 
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However, when the researchers treated the mice with the purified β-glucan they 
observed no response (Lindström et al., 2012). These contradictory results prompted 
Notararigo et al. (2014) to use the purified β-glucan as well as the pro-inflammatory E. 
coli lipopolysaccharide (LPS) to stimulate production of cytokines by human 
macrophages in vitro. The authors observed that pediococcal EPS did not induce the 
JNK and p38 signalling pro-inflammatory pathways in M1 macrophages. In addition, 
the ratio TNFα/IL10, that indicates an induction of pro-inflammatory response, was 
higher in the presence of LPS than of β-glucan. Also, the production of anti-
inflammatory IL10 was induced to a greater extent by the pediococcal HoPS, indicating 
the anti-inflammatory potential of this polymer (Notararigo et al., 2014).  
Thus, to try to confirm this effect in vivo, in this thesis work, the purified polymer of the 
2.6 strain was tested in an induced inflammation zebrafish model, using the 
Tg(mpx:GFP) zebrafish line, whose neutrophils express constitutively the green 
fluorescent protein. In this assessment, an anti-inflammatory effect of the β-glucan was 
observed, reducing the recruitment and proliferation of the neutrophils of the treated 
larvae (Fig. 8 of Chapter 5). Neutrophil are recruited to the inflammation zone by the 
action of the chemokine like IL8 (de Oliveira et al., 2013). Also, the usage of the 
pediococcal β-glucan in an ex vivo model of biopsy colonic tissue from patients 
suffering from Crohn's disease, resulted in the inhibition of IL8 secretion (Notararigo, 
2015). All this evidence indicates that the β-glucan of P. parvulus 2.6 exerts its anti-
inflammatory response via the IL8 pathway. 
6. The usage of P. parvulus 2.6 for the production of functional food 
The results obtained in this thesis work support that both P. parvulus 2.6 and its β-
glucan could provide health benefits. Thus, this bacterium could be used for the 
production of functional foods. The fermented foods are important vehicles for the 
delivery of probiotic bacteria, and the cereal-based fermented products have emerged as 
significant ones (Russo et al., 2016). Historically, the most important fermented foods 
are the dairy products, but due to the raising lactose intolerance and allergies to milk 
proteins the cereal-based foods entered into the market with great acceptance 
(Gawkowski and Chikindas, 2012; Vijaya Kumar et al., 2015). 
A previous work already showed that this bacterium could ferment oat-based matrices, 
and that the administration of this food in human resulted in an increase of the 
bifidobacteria content and in a reduction in blood cholesterol level (Mårtensson et al., 
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2005). Moreover, the results presented here (Chapter 6) have shown how P. parvulus, 
besides fermenting oat matrix, is capable of fermenting rice matrix. Also, in this work, 
it has been possible to evaluate in situ the production of pediococcal β-glucan in food 
matrices due to the use of the immunological method developed in Chapter 1. Neither 
the carbohydrates nor even the oat's β-glucans interfered with the detection and 
quantification of the β-glucan synthesised by P. parvulus. Although the bacterium is 
capable of fermenting both matrices, it ferments the oat matrix more effectively and is 
capable of producing greater amounts of EPS, resulting in a higher viscosity confer to 
the matrix (Fig. 1 and Tables 1 and 2 of Chapter 6). 
Cereal products such as oats have important benefits for the health, since oat β-glucans 
have been reported to exert beneficial effects on insulin resistance, dyslipidaemia, 
hypertension and obesity (Daou and Zhang, 2012; Shah et al., 2017). Thus, the 
development of a functional food containing the beneficial effect of the oat as well as 
the anti-inflammatory properties of the pediococcal β-glucan could have interest for the 
new markets. Furthermore, these β-glucan enriched cereal-based foods could be used 
for the elaboration of a symbiotic food in combination with one or several other 
probiotics. 
Therefore, the β-glucan enriched matrices, generated in this work by in situ synthesis of 
the EPS by P. parvulus 2.6, were used to study the prebiotic and protective effects on L. 
plantarum WCFS1. Then, the evaluation of the fermentation capability of WCFS1 on 
both oat and rice enriched matrices showed that the viability of WCFS1 was higher in 
the oat matrices than in the rice matrices (Fig. 2 of Chapter 6). In addition, considering 
the oat matrix, there were differences between the matrix containing the bacterial β-
glucan and the one not containing it, indicating that the EPS of P. parvulus favours the 
viability of L. plantarum. Furthermore, the matrices containing L. plantarum were 
subjected to a simulated GIT stress and a protective effect of the β-glucan on the LAB 
survival was observed, when the enriched oat matrix was used (Fig. 3 of Chapter 6). 
Thus, these cereal-based foods seem to be adequate for the administration of probiotic 
bacteria. 
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The results obtained in this thesis have allowed to infer the following conclusions: 
1. A ELISA method for the specific detection and quantification of the bacterial 2-
substituted (1,3)-β-D-glucan produced by LAB has been developed. The immune 
detection assay is based on a specific antibody against S. pneumoniae serotype 37 
which produces a similar capsular β-glucan. 
2. The promoter-probe vector pRCR has been developed. The plasmid carries the mrfp 
gene, that encodes the monomeric mCherry, as reporter, and it is based on the broad 
host range replicon of the L. lactis pSH71 plasmid. In this work, the usage of pRCR 
has been validated in three species L. acidophilus, L. casei and L. plantarum. In 
these bacteria, the fluorescence of mCherry was quantitatively determined by 
fluorescent spectroscopy. 
3. The draft genome of P. parvulus 2.6 has been determined. Its size of 2.236 kpb was 
stablished and 2.241 genes were identified. 
4. P. parvulus 2.6, but not its isogenic β-glucan non-producing 2.6NR strain, is able to 
transport and metabolise sorbitol. Moreover, 2.6 strain can use sorbitol as substrate 
for the production of its β-glucan. 
5. The gut operon is located in the 39.1 kbp pPP1 plasmid of 2.6 strain, but not in the 
40.0 kbp pPP1* plasmid of 2.6NR strain. The sequence analysis of both plasmids 
showed that they are different, and suggested that pPP1* was generated from pPP1 
by DNA rearrangement. 
6. The heterologous study of the gut operon regulation indicated that: (i) expression 
from Pgut is activated in the presence of sorbitol, (ii) glucose exerts catabolic 
repression on gut operon expression, and (iii) GutR of 2.6 acts as a transcriptional 
activator, while GutM is needed for the operon expression. In addition, a model has 
been suggested for gut operon regulation. 
7. P. parvulus strains have been fluorescently labelled by transferring the pRCR12 
plasmid. The labelling confers pink colour to the bacterial colonies as well as red 
colour to the bacteria detectable by fluorescent microscopy and spectroscopy. 
8. After labelling with mCherry the 2.6 strain retained the previously observed higher 
binding ability to Caco-2 cells compared to that of 2.6NR. The addition of the 2.6 β-
glucan to 2.6NR strain increases adhesion of this bacterium, supporting the positive 
influence of the polymer in binding capacity of P. parvulus to biotic surfaces. 
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9. P. parvulus strains were able to colonise the zebrafish GIT. The β-glucan-producing 
2.6 strain had a better colonising capacity than 2.6NR. Thus, the β-glucan improved 
the adhesion capacity of P. parvulus to enterocytes in an in vivo zebrafish model. 
10. Zebrafish larvae colonised by P. parvulus strains were able to survive after the V. 
anguillarum infection. Although both strains were able to counteract the effects of 
Vibrio, the better colonizing capacity of 2.6 strain provided to the zebrafish a greater 
protective effect against infection. Competition for the sites of attachment of the 
pathogen to the epithelium is presumably the mechanism by which P. parvulus 
exerts its effect. 
11. The purified β-glucan of P. parvulus 2.6 was able to modulate the cytokine profile 
of zebrafish, reducing the expression levels of pro-inflammatory cytokines such as 
IL8 and TNFα, as well as of the protein adaptor MyD88. In a model of induced 
inflammation, β-glucan had an anti-inflammatory effect, inhibiting the response of 
neutrophils presumably through the IL8 pathway. 
12. New cereal-based foods were developed by fermenting oat and rice matrices with P. 
parvulus strains. The β-glucan produced in situ in the matrices was detected and 
directly quantified with the ELISA method, without interference with the complex 
components of the matrices, even the naturally oat β-glucan. The prebiotic 
properties of the enriched matrix were validated by growth of L. plantarum WCFS1 
in them. 
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